-- MariaDB dump 10.19  Distrib 10.11.3-MariaDB, for debian-linux-gnu (x86_64)
--
-- Host: localhost    Database: clg
-- ------------------------------------------------------
-- Server version	10.11.3-MariaDB-1

/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;

--
-- Table structure for table `config`
--

DROP TABLE IF EXISTS `config`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `config` (
  `name` varchar(100) NOT NULL,
  `value` text DEFAULT NULL,
  `value_blob` mediumblob DEFAULT NULL,
  `help` varchar(200) DEFAULT NULL,
  PRIMARY KEY (`name`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `config`
--

LOCK TABLES `config` WRITE;
/*!40000 ALTER TABLE `config` DISABLE KEYS */;
INSERT INTO `config` VALUES
('eq_color_code','{\"C\":\"lightpink\",\"I\":\"red\",\"A\":\"cyan\",\"D\":\"#00F5E0\",\"6\":\"violet\",\"K\":\"#6699ff\",\"E\":\"mediumvioletred\",\"U\":\"#FFA500\"}',NULL,''),
('examination_id_for_verification_record','10007',NULL,'a datetime examination which will be updated when verification/calculation is done'),
('footer_notice','Verify authenticity of report by scanning QR Code in mobile browser',NULL,NULL),
('header_route','Header',NULL,NULL),
('horizontal_status_lot_size','100',NULL,''),
('nabl_symbol',NULL,'PNG\r\n\Z\n\0\0\0\rIHDR\0\0\0\0\0J\0\0\0.mr\0\0DQzTXtRaw profile type exif\0\0xڭm与m_!5Cf=~E̺73뗑\'qD{\0]_rzrmrӟ_~?W]_緑__Pb_5\\%(BυREsXw#e}}???[ow?J/{MOjOt]]ܕn)__g߷}tSXz;~p鼬_j;u{k\"\'/u->qgL{-L>=\n_\Z{6wv34x~2.4^4[\'̂\Z!~\r	_vgwҎf|-,؁C	w:6B-\' w\nӢkj8?s}b#2Tٚ^ذ4l)?9kn緤\\JE{kO͵Z[m=-jkW\'1koM_xG\Zȣ:㝘|feٮJXeV_Sλ0/}ϗկ}{޵pv-߻KkA8;Ww\0˭s̥1}׾ſvro/;??杮Cz\'܏zc_bҿ|`Sm~Tj\nӸ4%19M}C,[Y\nߍk\nov+<_\Zţo/	},r.,7+[Xy]\0M$F\')dcsadU*_jp6ۼ^qb/|^uJk/f}xYrvXx.ڵr_X8x7qO6;~weowe2o}wMaf`	3K]r<[Mi~[W~woWn#k6ʛ{/SAd<355y-HR3\Z|V,ybk%KW.\r[kܻw[mϳ\"7x螧U_Qy]=9\\0+F}9>җ_ϸY	oc>O}+%]zR_%\Z`5Xl[+KZhe^&>c;WWq]aI/˗B	!7p7h+|n㹠vQƬ+?nO\ZGݏ윶}#OW9MEYQCϕUʁ1ŷ	ݼ0J^X/{WY[a(7ޏgpyl<bq#ńUww??\\@ٻ*U;\\}Bu/\nF&;_quqR1XuC<	A3]\0V\r|lRtw.V\"k\0n-ȑg#	ZP!VݼWI\0>+W&y/]:Y@Gxyڹ޽\0k c[t	ာ07\\2xGJ\rWxj[r9#Zzk<+nIg@\'½	#n׾Yύ!\\|8\\aQx狐jhJh	<y6wc!&a/~	.oPg7r<Tġbnx	2cI+>3/w#OO\'] yxV\Z\n0r26z^x\Z^[ZG\"dH0L1x;k[\")?_1ͻ.Ag#8XR!0\'.0m\0)%k a=zx&\ZU;ٞ/ldB,\n\'a,uhC0h&4׾7*D^?n?$8R\'(.>,3ak~|հ;~aA`!hKaW70C_ pW@YO%c)a0cb5cyZ	ە\0{^apFiNXJ\rsޱN\rf=5ea7\"	3\ZXӂw`kO\'a>E\\\0MX<;x.!8ĉ\'{bf`t4+JU\"ټ\ZN63M7s\\E3g`l0R `Ǻe&0jU<yxnQ\"EDM3q|ە0csKDΫ\ZXxO\0w\"1\"i@$\"\'!]2{]ByO6e RG/taOa$rm`ce配냤7^gᝠxbV\"I J%AmQ\"(|B+֔=MvWzI/ax斡*D>(avc_{KfA--\nw\r=xأDiȤa/w\r	:7DG+\\O$\\5m ܀-4_#5Lw\r|\rd7Z`n~I`x8$WXZwn4XZ0\03$/>\Z:O~[s||%bLL_G/{D4-Dxt}\0yǇs{~>w#{\0?,(>\\Ha#	jBjfbJv_Oln]p:[({gnqP(~-G5ߐh#hjM@$\0TE==}\\l9<;A-!۸YM~PN^;\ZR|s.>=಻dJ:CfY>>l1>Pᢇ?tĢ+X׀&I>f4ɺ4)n;X$Xj)\\ťGDb׍x7bjG\nc VJK@1\rUvo $\0hڛ@;b] #_yXBAEz0vI{!1n5#qf@¸YFC_5x4XhsZ+@Ο|G߂j,_P?\';F8m=˨H\rٰ?$\Z1DT*\0<%2_E;N`P@>54TYpCܯI[m!4Jj>-@(dއZwf)BMϜ\rNK -`qnk\rƀd-꠴\rh4/\"Ca\Z0Ucʥ?񭠃@TΫbps\ZIU_Jh3L\Z]Īg8w_+s?<$\\EtQx-ᜈ]PQP\"h1ƂFKmo\\RVfF5E.P#8k)sFA8P߲$~2&ӑl6SV| x)D\"@*{ErQn+b,(B(r\r!rL@Z9d]oIZ  L9r1\0`K:-wFE)̭6A_8֟6:Z	w[Ê^r6&)a+FyƨP80m?صz\"X 2~HNfĄyc(;x#1o`][D\reپ݆#ũo?/\r䚙n}c{55ċ0VuJÕd.	ʗ1g$MTƼx{sGH1|&~[#/	2FMvR-j@wFઘCPԳhgd¶B/4Iͨh5a?Bg2I;d$PlHӰ/CpXBXZA;Y^sʞMaa\"tQ`5BjXоwa\";C\']D$8eQA\07G]c9\rB!;A\09B=h])Π_>%]#w]}sBn҃9vE0~Sl^PE3U;mQc\"* IE?&\'M2:h0_${5#vuRo\Zs\r$|3y\0Dӣ\"x0ߧqiH\'rs!c1+e!`8G(Kxf1>.9\0c}!oI?in^ׯb!O}_ז\n3Bqs=䃿f31S#|ւ{Pr(aDn5>/\"\"s\r?b{xcߨub9@\n^G֑Ӽ:	\rn1az\rAfG3nˌ6l\nҵ>.Ex@8$LeP1wWʅȃ]40m8!Фmȣ<<`ޗǆPXM8&ZX.8A\r$Ao..0`\n%T<H5ފIbRpsS\rձde4 Wl>fԧdXlT1wuafuƆ\\ 9oQ=E,\n Rsd$߈ҋDU	`R5I2\r`vlʡ>(E{\Z=|7^@On̗YL- O\0ya,`9A4PyfϲeV0E\"q7;?K>q|#+=Onl*Â\"zf\rIȳ,t,[D|10x8nP\"9jwp7L#1	?bA#HpA)Xp=Iw|ʵ	VHa,9!?FN\\ܯǘf2`*I|[vĎ0F; !lt_^}[5Ea7p`쁦K	e	\n+	G.׉N9q֓R<^b\'OѰ|/&	%.\0l[`#\0\ryi?ϕee\r(sJ	S\".ytt~V(7~!ʺ#zQ~h[u\"Uf}ovsյr5X^̑BۣST\r`uj	0_qu	$/6޸\ndAL!i{7bx\nawX\nE)P__c`wG/L%8`U Qs\'߿Ӏl6u۬c3B 3~?.EoOj\"~0<Cj<~5ه>+I+l8↑\0ƎL=\Z>hzn%x\Zfiś$mvn_\"R&_#΄z|s.;QKF$N3U`q!EUNӕ봷\"aY*FUr??@@qxV4#&0.ȎOYN6z~VfcC$dI1?͢#5dZ\n`yXiƆћ-\ZFN4\n}sYI&1Î2L7\'^5uCvm,xܘlq2_:}\n!brC;fґ]yqx	vz0{l]\ZC_u@0$McAJFqzIt{JcTD7=c!KTѰGr`?=P0Sw`+KGD!r`@d4rs3sH}5fP\nxVX(P;[y<q+*y\Zj1zuB\095zxHw+-$FT(i?B<EyX=JyWuqe5R17%ыau|;<DFF0=ufgJ\rCRfm@ݗ#t:ШDo2^{R?bкf\\1ciJ-z:\0fR,i\"ty\n8a:,\0f;OU$IT㤩b|`8xQ\"r*\rO3(Ae%p0Q@m>khc6	8YylP.6\nXؒqq佹j\"@s6)5f=l .\nHo\0ԭ_hX\r6ni]*\"ĄBtg`AMw?7kM8HP&WjCbC<1k@t{{\r\\`@N_ɥnM}bႨz!@!1V@5׳~f+x7D(9W(	u̑-AYMǙVɸM]PxERՒuP,0(ukI\'$EʼM.A:XX^Id\0COvC?o\'\0\0`m?}YCT$\"r.fp*z%`\0{;(\"pʍ	;Ƌ2}\0C!Jn@nvpAX=L%jj`6\Znfk	Sb(rۜ6zXQⱶ},O%#_[a\rd@@CH¼v:\n.Ĭ\'e:@z.X\"~YK~:i9(1]#^QֆB09L,dlg%/yNX6n#tUg%?AZ`l,Miq`\\\\wttjYܦzaǦ5PtǾ߂E)`S~KFnN8W{b֬mc.UzL\\ths՚[@67U\"|HAKI1**`\"M}$fzޮ?\rSb؞W%.jeff+vvW7$30)j\n{VZ?[$΋cώ5/\rÛهǌP1;XIW̟&Գ$ۦn (SAVPP`灼,\r7>Ò\'\\YX%Н\"\0ICq½QjtlḬ%ց\nc-XF`Wis\Z݌!<TD?ڒݼKehgu&\nno-1*\rGZ\Z\r,\'#BmH-1r>QΩ!L+\0d$`v_yJ\\\n?VcAXA\r\0)dIZ8$+Ī\\^+ߵ!\0m7F<Ӌ+5d}p	<F~7}Ə@X~᳀`\"x`\\!xFWLibWSĄ4Mp6XU jTœ?t1[!V?|j IsAL7^YY(-EGqDYÜ%x6;~ǳ؆]y\':8|[~X	=\\U2N!+XU`ܩej@\"kTє$ݳ{]~ZzvBaB`]<Z}{b肘0\ZY{YLg=q?z6=1,~܁eOC-0!eoio)\"h!j,q팆7w?Zⵀ(]X\'7\0>w\'Y\nL#7\'\rV%Jœ\"}ʵh><ZqG/6^\'1#\Z{Ws%)k. c{*+0ݎ@c/?eX\r60ZjRV?$b[@Ezݸ~ż@%(=#쳘afQt=єR=}<YMgӌ an\rܜV?)5oLCe<	(Հؔ!8\'؆X6a2{na=Jg%M<hߟ{]0w\"mݿ-<K|&?fjc= {!ڿyA16R `<e-b֊cH	ݖ\0/OeZ٫yfh2ST}\r7$\0Ɋc\"Xpp>YsMd)7RaXL\ZK\'҅_	%	@enϜ<&6dW\riovR&/#|BMCԾ6)bNn@PAf{޳`cVlX]ĩK#bQԼD!V 7Ae?x\"u0{0dٴaM(Pb_.f=6f87Ujť7M3?\ZFbg\rY\rԽ`*`\na~N>b=n	`	C.puc&|1j\rK5NW\'sH\0ͱ_&sp;\'Puۆ\ZJ̥ Rby{OZρ{ͳ~2)A\Z\r;nM]G?1DCllH@KD~lzb&\n]\'@~s>9`y0bo)_C\rMA_1ijv=׼RlhMh&&Fwf[YQIh`Z{]c<w us9&=hz\"J\Zi#<m~0\ZfAދldN/OV_	:-3|_keJò6\ZPhj\ZOdsue:j>ʋ!`Ie9@[1=+@!2jb<A#>14x@]k~[qCWvN*|=O 2}[3Wy7+Vsm^}6(a«X[\"3@r\rC>{,^asߣltkB|1Z_ܧWf5/>^)Fl5s6<H0b_8SP>Y~A70Kt9wX3[~Zjߺw[uue#3!Z=c;SuE}b)<wUCFzYgSXm_{#0y&kܐ,2B^߯o\\Pq	ki@=}hGDqGŧƚ+֖,RFKȶX4T]blpXzUevB1(3=ڈ󳧙Y#ۨB8ۑv|]0ʑ~%[񇅨6eeBCŭ\"dD-;KXjD MsDUav e1X8 x2?Y!,av.0Mi}B@VI5#eí0wY3,^4AaA|{Mj,W uX{Yqf]\'r!Y1cy@xI\'_ѡ*NqbilR@5yуD@D;֪ o%n)}rQk\rQ o7\n]TuVy41L|Շ>l\ZxL\0yin+)UX\0b$4\0/Pg¿,Bcx˸05:\'$mR\r8x%S\nOё 8]0Lײ]kʕp\Z-kc/ AyVC;GT`7mEi\Z1mWTks6jPL0yfYB]!\" L)4&xW_xѳ\\\'PG<=c\nA_qAD@DgЈx_nsdg8)tiv+h\'%\ruMźce<bkNC[y?؊Ykqi$4PfJt(5lna*kAbknVȰhu+h-5M8iIvD2uX2ڤLR&kՍ,yLvA{rDSR`֏أgӓy^.b87</| nmt\"\'py$l5uj8 &<-~Ժbj=~gFBJՓٰ}*\Zgo-AE(AYpC97t[QãXN]IXEh|\r\rs~(|\Z1y@Cϧ^K9NhSݬݞu5<Cëْlˌkv@,&Lf%˘އ4wM\"籑/ZIⰪP.h7PmY`٫:v184cT5D[Z8+2,M$x&7<)Bj_mҍf?qydw~=dVCx*X=,99x] }lm\'!kAv4+!NL׾n!I`QevdeysilJKa[aX~\0r¤ʁ{J|R	ur).!<6!IhM1K(mKV\"G5d^m;7rGoɣW<Eb+9	#l\"b2qm1eO}G+Ze\ro:f$)-_,G{kĪ[,?K	C\'A/+X$!,KXl=:{K|wrw<BL=d|h9%lId\\㱓~1ORd,auXJ6{$\rbhUy~GbFB ;J2\"+6[!BЀ\\ЉelYM-wbբ7#d\"5ϡ*R\\jm̠dF\"%PmIԫA[95E\\A	%65\Z%BZ#3Ɵ>D\\C[L`a	T \';f,}AM{dCxG+]_@͟&^L>hOp\r`9(N7/RgmciZ3PeZ?y&uvA.DcnEɷ؝2N<nxXr\\Nc8fWVŖB#/4	P!}C_lqM[#ci%Yɚy\Zsp`k1(Yi%O=fSGVse\n;`z[m]ǩ<E82|K}f(NGG\\32bjs}Ef`ki\'6zl\"<=Ŭxt؞*MB~0E>#{\ZP~#Pqg~·6k-tQ(NfmmgW_+&&&y u(<D}Ι7$\r;2$%kbbPIbӪx\\\\c,H=ÿ0Qhل )s;|N+d{8\'{(h3uJih00ú`=1VgBkbBlQLJZeGv `,|ϾM&+0p^V<GGY\nkm<0c751vTOe5ۖITPZvU+Ze#9B	*%VO\' ؐh}<\",M!٢߃R(#°&)f#^\"c<QgYK\rwy &s֟X?e+ܦKy	^\\෼\ZA.!G:$u;`	8{OGQ\\~)80;ՊX$ivV򼞚;hoWv|T/8IT6B\n:R$٭X|#V0T\\*$N(sƗ8Au6pZ`kF(1gՊZ`%K{qO6E%WutJ0UJLz\"OP;x2öJ&6+BFmӍbcD<)p*+?YR`|YOTYt3\rspLgճ\Z]7H!n+dsv}vrPwaUn2@ّGඵ8Ί\'>B6JtT׍P{pf{*:RqG ,[!kPaa/£\rHt\'e,5l\r:ǄȢi4PN8Qy=r*m$ӊEc(]Y;\0Z.+~\Z>uIiCm8r5ܨ^\nX\0ogc93%1y9O\"Lbq59^j:vhE1:hawaDq_05ݺ[:a߯XT/\"w xU7rǑ%V7Y̻^с<fKH/:\nF,Ӵ%&1~l!7yG3s`i0m+ˉMژ=񴁀,jlVד#?9dq?$l:G	A&Vπ\rwO1?A?tB-;Ӛ{fzWjȓ]Q-#緅@{\"B\0v	$d{Lbbi:gB{@CX#!UJ[ݞf4@n\n3o9m©FaFzYE7=lFg^ll[lCUi,&My݂CթMaѶ3yz-y&@\0m=Q9luӮd\0j=O61ʏӀljTO=&p8ӝLgjjHbF<q%gýN{	$n72i³:NLpިge؍xTJ.tY{O*u{6$bD#a~ǌnxH=Yb@\"7bЎ9ư&5Zct<;Sc\\~q:Dw|s)XڬL\ZXie\r?8Yqq&49蜻.&T͜:F^oyl(#|̆q٫S!ID>Ŋ(ԭzAfr>a\Z\'x\r\n{8VX[t}akkOoJq.>g\Zc??XsXzprFrkI\ZtmP:ϑ	dQhim?\'ooc	Ho0\rolK^j8,~êTiE9&j&ߔrKٝߎt*{\nv&Bc38촿 )Z\'-<#>ѱW s*#}엿@}q>\n4W>{!Ru?u8G6[<MS]g\r-8YokDv3<	7h[sw=c YI<[\rmX>!ǕOe$](:I~v\"W<`hkfg`WiP@@Srlhm-)PӸWCiޠRl;Ʊ^5ܣ\rzhxXdyL+|yrRQX&TN=GJX(Gu䉯owQv6ȃCLvxOm(8EQknCOЁ-2z-˱9ԑFDD#-Hy1WK;<b[bM+\04Ǒ4CۑDWTVi<F=6\'),9Ӥ)V|bCݼ2 C/7st+7Q]/FzC?|byZ7ot`\rUMXYle>T/Ǩu=~=? F\rܣI7ng2waHeд)bC\0r9@X[:g$6ܿ=pcz\0ub?ɩ8C|>E˵\Zˁ>)hgdT{ڜdSbI6}^%*@?8;1e\"`CYq\0MΡW{.i+}za;qqo\\&	}5ng0ۍ[)?:/_Kz֐lgx)ɎMade{S@˥DZ+!֙%\Z8GTá[! Iۖ~RlG-րW8\"U&9;^yFMGb\ZLɰ:YQ{wm\rexjӅ̓k\0ۼx	?I`;Бz:\rq{gn&wy>d+u]ebEׯP\"vypIpdvfԽi#EH7մ,iSPRyXɾ\'^&[d;~nLy {T9(Io8$7p	t5eTIX@\"q=d7{Zo{PN2z=%~fj DDhhD3[t皩VtϏ@gq-Ql<ub\\ek3	F~PMYD(v)ώ{x6eˎs{Du]s$xR(gVJ7srBMSGIm)#Xg$Aq&( Ei9RSIL@\Z;٥JL?	07BA9lۦ&8\rȮZa?hܩ\ZgQ	[0kS=XϽ67< h^޽5\'S9Jj=/iNDG9nHsK\Zw|2irU9&a˒.\'m۬]<2TjZ3t?ޠT5w`9,0Z!K9<SBS11%6Xl$vf\'8Q;欘j-q`byYIc°ejg0gP6\'g\"Ȟv1OZ8	b ktK\Z,}g~_:Erl\\}	;>D?a5LDDPWiHE~T5iKO5H,[,~WsS̼(jU\Z`>AU;	ݶu%ivS${kt\\/bf]gU5Xô2)h)v4+R7}U3ĞQ<а+@@ס\\/0FB\Z[kΉvwlZ`xޏ)w+EFeJP$̂˦y#[lPu11zNGfͭdb#~Kz\n!42\' sD:w*NL{t$r4BY\0w`}~^sg6E=m(5#`iN7`mzo-\'OF|\nK>P(2+RVq!c_5FI=gzä~\'ɨL&F	@sgRCo3<u|1~K\'`mqY!P:	i.s#©rt˙x\\sT\'&^N/\'~GY$L8W%S=bS;m9|$\ndzL:[9Im[x C(V !3oh)P=9/.d5bn9L=-t;܊PZJ<A9b唪{\0|Hz\0#B,f i;%Pr&CvQö\\O\0n[VxY]jlqf1wn\nwv~VX݂aM5CF1_?\'Bp΄3#B@D<zq7ϊ| d7ixGNcJGE>	0Mv{ռsqgϴWMS@\0*>`^Y쾴>fRs5Y)9{o:pN+cti\Zjǎ*;!~&׉NH\0#ުSV4~@&N(kƒyfU\0ayX\'kGRWs)*U{NAL(_8GbL˽,\Zӥ 鴣\\p]o=\rMݦS(G1\'9v5lA+-+c}lD[s)X%<*|@g:ccx*#y,^f:T#5`pE\\sX@q\Z<E<MXOfJ~EgȀ߀}{ĸGxƢܖ)|cXyJ 9LaoDnH!HFMj<#db,Z4Q#·Xg`K?81Dtipi3\0\0iCCPICC profile\0\0x}=H@_ST ␡:Yq*BZu0GbYWWA\0quqRtZxp܏ww\0Qe5hmfRI1_C$eJR\Z%x?GZgaSy8ʲJ|N<jxƹ3cf63G#Kt0+\Z$q\\tr8k\Zkݓ0ZЗNs),`D(*lO]D.\\0rc\Zd^R4	t80u>v	|L^ok#onkp<)RP,gMyzq\0d\rpp({=77rN9\0\0iTXtXML:com.adobe.xmp\0\0\0\0\0<?xpacket begin=\"﻿\" id=\"W5M0MpCehiHzreSzNTczkc9d\"?>\n<x:xmpmeta xmlns:x=\"adobe:ns:meta/\" x:xmptk=\"XMP Core 4.4.0-Exiv2\">\n <rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\">\n  <rdf:Description rdf:about=\"\"\n    xmlns:iptcExt=\"http://iptc.org/std/Iptc4xmpExt/2008-02-29/\"\n    xmlns:xmpMM=\"http://ns.adobe.com/xap/1.0/mm/\"\n    xmlns:stEvt=\"http://ns.adobe.com/xap/1.0/sType/ResourceEvent#\"\n    xmlns:plus=\"http://ns.useplus.org/ldf/xmp/1.0/\"\n    xmlns:GIMP=\"http://www.gimp.org/xmp/\"\n    xmlns:dc=\"http://purl.org/dc/elements/1.1/\"\n    xmlns:tiff=\"http://ns.adobe.com/tiff/1.0/\"\n    xmlns:xmp=\"http://ns.adobe.com/xap/1.0/\"\n   xmpMM:DocumentID=\"gimp:docid:gimp:62b9c2c5-63b0-4042-ae44-38deb0c4db21\"\n   xmpMM:InstanceID=\"xmp.iid:764239dc-1631-456c-bf35-7390e91b8b80\"\n   xmpMM:OriginalDocumentID=\"xmp.did:44c3c0f6-69eb-4ed3-901f-baf1f93b67e8\"\n   GIMP:API=\"2.0\"\n   GIMP:Platform=\"Linux\"\n   GIMP:TimeStamp=\"1688899848462183\"\n   GIMP:Version=\"2.10.22\"\n   dc:Format=\"image/png\"\n   tiff:Orientation=\"1\"\n   xmp:CreatorTool=\"GIMP 2.10\">\n   <iptcExt:LocationCreated>\n    <rdf:Bag/>\n   </iptcExt:LocationCreated>\n   <iptcExt:LocationShown>\n    <rdf:Bag/>\n   </iptcExt:LocationShown>\n   <iptcExt:ArtworkOrObject>\n    <rdf:Bag/>\n   </iptcExt:ArtworkOrObject>\n   <iptcExt:RegistryId>\n    <rdf:Bag/>\n   </iptcExt:RegistryId>\n   <xmpMM:History>\n    <rdf:Seq>\n     <rdf:li\n      stEvt:action=\"saved\"\n      stEvt:changed=\"/\"\n      stEvt:instanceID=\"xmp.iid:8ef5fa44-aaa4-4d83-ac73-d9ebc2762956\"\n      stEvt:softwareAgent=\"Gimp 2.10 (Linux)\"\n      stEvt:when=\"+05:30\"/>\n    </rdf:Seq>\n   </xmpMM:History>\n   <plus:ImageSupplier>\n    <rdf:Seq/>\n   </plus:ImageSupplier>\n   <plus:ImageCreator>\n    <rdf:Seq/>\n   </plus:ImageCreator>\n   <plus:CopyrightOwner>\n    <rdf:Seq/>\n   </plus:CopyrightOwner>\n   <plus:Licensor>\n    <rdf:Seq/>\n   </plus:Licensor>\n  </rdf:Description>\n </rdf:RDF>\n</x:xmpmeta>\n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                           \n<?xpacket end=\"w\"?>t)\0\0\0bKGD\0\0\0\0\0\0	pHYs\0\0\0\0od\0\0\0tIME	\n20΃\0\0 \0IDATx]gXTI=3bĈ	52PQŰYv\rs&0k\n3*% 9g&Ѱ;}S]]]uED\"Baa!b1\n\n\n\\\"\'\'yyA^^rssBEEɤ\0\0G\r5kBV-ԭ[Cݺuz~uAڵQV-bO󑙙T$&&\"!!qqqFtTbbTTJ\'%gRZm?uhѢZhMaÆSΏA΄cg%//))Edd$B니0l\0P)U\nUmD<\\.Gݹ3ڵk֭[CSSu1?#ChH|s|R\0a`eSjժ\0dϯV{4DM٫B\r~`wD,#66AAAx<ݑ\0O4XJD.Yh߾=ZiyhҤ	\Z6jK5j@\Z5pffbrrd2H$H$fdfd 55ɈCXh(RSSĊ4lB__]vjժcr\0K/_gVO)r9t\n;tO?f͚G\0׮]jj5\"JQPPddd ))	>|@Dx86]*yD˅\0cǎ1i~\053!%%꧓fDh߾zk׮h׮-7oF\ZkVdff\"11QQQDDf(4>(V>|zΝ;0\00CBBc\\t	ii rŉ\\ܥ\r@ ]h޼y^eLT4i䛯ҟ#HJJBDD|߿S/@.++:M61ah?<ׯ_wJ+sb 1={K.hժj׮]bߠ\rt__G`` ||6[ikRz%\nEmHu?&`o`XJfvܸI>={66mZ{&Mr\\\ZǏejj*?*k̄\\JaI011ǃ؟/x9.99WJGM\r\'[Ob3aÆ_QQQ\rq!?Ɠ\'Op	f%Wz0nxQF?&`W]p}!#=\r2\\d$\"4i=OZZ\Zm݊\0f͚>OMMpܺyS*bXp8hTf͂QhѢŏKll,n߾f+LU֘4y2\r\rѶmoCF-[S-HTT?~瑘W*˱xl7nN/޹c5\nzzz٫N<=֕R_˝ׯ_Ws8\\CѪUܼy{\0]9~D>]v.`hh3R)d2XJII-nݼ\Z\ZظqDϞA*AMM\rchР\Z6lu~w\\Rpuu\04VDeVajjZm`%\'\'س{TN9sǐ!CСCypxC,#88AAȀ%hhh`ʔ)6m\Z\nf*<d&M`%<yD98l6$v292z;@K57oMMMf͚hڴ)444%<<7nq{;ʸ~}\rX-_^z? 2Ϟ=LK\0Ǽy:tڴi͟HKMEBb\"\"\"[7o2@󮩦&x<>ڴidffbyx9c:y?i 33			x͚A&i[0[qD^\rѡChkkM6ܹ7Qtt4p8ٺ`իs>A	\r\r\'p\r@Lܙ3g᷑#?SEpz\nwnfKc\'m\r\rsgaohkkv\ngΞŞݻ7֭̝;B͛7f*x޻ƍ|B!++HMM7\r98ԬY[ӧ#\Zk8yÆǴiѱc`O-dggڵkkGaK\0m6z&Nmmo<鈎~~~`XH17L67cq455իW耆\r<+б#8jl۶\r۵óg`hz\n䃈 H|NuuuQF駟W!B߶mb%bj\nGG\\z8R.ׯX\0]|||`gL53w.3\"66x%_5kB&OZ\Z\\.?mgYصsB.5\0ԫWsvUHOOCY-]%c[Um\r\Z4@\rмy[(R)sذa#\rcǎsdrFٽ..׆;--\rϟǉ:p8[.֮[cc㯒h Px{{ィjԨ1.Z~FF1c&ڷo_fO?F||5\r\Z4\\.GJJJիQXXcǐ6>}((0T\nT;77jjj*&//ѩޏ̙3UhFBnr-7A,C&A*!f9s1iҤ2!?76mڈXUfc?~|VD\"pX,R)N=z]vXb9׀b1TFl >>NDՃL&C\\\\r?wo߂fx\0BݕDI2VBrr2ڶ-[B-LSM55vUl6.իs)022Bǎqbڵ1l0t\rq	&H*޽u)`g9lSSzzz_)))x\r._ \"lݶ\n\"w^~8mǍW5i2JcNT1118lk.¸OWfy)WZ8ڴiǏ\"0bR.Wz|V()0~8dda[;\n@\'@__)-Z`%/ރ@He2d2DFcOL8?u4vpp0oߎo^3tsl2=\\AAq]\\pt\0͆@ -[ѽ{wlRakk.ܽsC[[l...ػ\Z^^^cm\0~ة޽}<ސH$QDL	\'I(	ww4MMMp,Zjݻ)))HJJ7q񱱱HOÞA(ptt5!1qdSN_dagg+W.c_6⩗V^_]_.rH%NWt%G/~|w><.;ƌM>Õ/((Q#GHHO<!T|M֯\']~k.qu(77WGǥL{I$1c=}Ts#G);;[;nݺz\ZP?qc*Cud$A\"P`` %K7o7oސD\"b;4q\"	<fy\\tMvXпzʂΟ;7&NE6\ns:xx8u>|hQA\"55X\Zu]1eT\\WWW3Y;u555ddd(-[\0AnnIMM\r۶mRKKxyy &:\Z.]BJJ29?{cL0RRRp3fΚjjjҥtN:a|	׮^PWٳgǾ=vϟ#G +ٳg\Z),,,,̕/}\\>Gb1=~&LO\"0a<=~bu>SAAA\"WByyy^\"=^zp銄_ft22GB|-^߻Gta@y	tڵOQ@@@׬Yz4hrwKF$=]\Z5}\"\"CJ޴iS)\"\"_b+ŘN%!iŊ_%I&tQQ={ΙL(D߻G\"ze\'>>|\\d)001+iiiΝ;ӕ+/_Th\"x2ftuXX銄t%ڷoѦMTn{LFIW$h8Zl)	ʦ^$e0ߙ2555XY-͛VeI@@\0&OڋBRx{?ܹs0ox)m߁K._~eA\"յg(.0|gVF J\Z[\r\r\r*qJi\ncȉЬYjaHHBC0m29;HA)nXr^1fp1$%%UwCVZamXl9}\\\\)߃k]PP`J \"}QL674?#T*˗/ʆX,\Z4hLܻwnnnxR8f\r0}L8;_-3$,,[nšCpeHccck֭>}ŋ\nL}BddTsĉP݊p8ԑV%III8w&M6WyՠA7nsp-0ƕ+W]ձrJ^|\0VuuuXXXCT*Ö͛q!;--HXj?-h^ɓ\'sRKK	WO}6W<yG/-t+$],YB\nm\\]]T{銄qI(-[J)))*߿?銄`RΝ;LJnnn͇mmiџ5999MO}ٳgIO$Jbr\n+R߾}ӓ\n6FY滇+yͅ|XBaglܸqx`e^O0\ZF\Z-[TT֭6mڠuHOOQQQu	8P555฽=|X.s`j:Exܽ`\Z41+5j{#GR2u555XWoCab2XYܦMԮS[fX,ѽ{wp8j\"ԬYJH$5kBOO˖ZBY3lْ	]MNNҥ04I&Uj;{n̛\0saaa8{4>|@.]Tzl6{{CCCCUnFпddd ,4ax\"61$+W+WVd?>ݽ{WAHH˗/YfH䥽~\Z(00P}(##9/ݼy3-\\@4%&Qhi&ڸq\r8D>xBo^zE!!Cyyyte2ѝBׯttΚ5\\R3ґ#GH(+8Ն\\eGݻ1quH(iݻ$\nW/zJ+dj:lCOWH>OLL$OԳД)Sh)D+k24M\"!:q\\NKK#G\"x\\quH_OݕodD|tEB5k)(	)x++WP\'WwPQ!o߾sJD3cC022l\'ܩS\'aŋɏo#1hIey1b$aԩ:ԪUذa_<@cc;999Xr,,,d 4$,#GBFfFFAFF:._t̞=&>-uDGƙʊ\Z6l%1Jsrr0~X;\0@Ycc&ٰ*y ]|ڵsvv&=]={L/|.ݻwJu	\r_{RPPfjcػ툣#:tܶ>}Jz\"z*OE$OOjU_FzfLƜ!Y,ԙrv~~>/^>8fgLZVW`	UrQŋWW7[2{*D\"X,V+**BQQQq[	]\r5kf͚UҟkN2++Liv5bUhƎA:upy/^`խֳb򤉟X,:]6|77oAfCA8qdԩSfg.tС܂KlXl<uZeXڵ\Z_r9$$$ >.񈍋Ç1H+]U/y$mּ9~\rZkiAKKs5CƍQ~B\nXBDhl<kB6m܀*%WSSC\n6c4,]F*K|>.]ƌӐ0u={Bwba	chԨ1N<Կyyy`X*;??ÛWpmhiiNdd$ƘD*B:u\ZӦOǯŋ!))			?^zlRj;%~\Z\Z\Z֭;t\\hwꄟ۶EfͪH$*W)ڵ/8`u֭㻈1qd,_\\w>|زe+90uW444ӧOCvV&rb%t0qxŌiӠaC>}@\\r^OCsp\\L4I4663g@6?eJpuuWѹsg\Z45kĺu된kׁV;멨		7o	\"f@\0 R\r^E@\"8>rvY`\0ȉо}64H$6[RCfQ^=Püy\\mۂꂍ6lmW6,,S,,>:uE̸)`a)HNNbkRj\'r;{{;tbhڴ)p.nJQ)Sx*oO>cG0zҾ?22_Y,ѪUzn׮~\r455ѨqchhhnݺUաƘrR+6ҐpOYS=ztuЮ]RZ?԰z/~W ׯ1}T\0SŮcF+Xp?t̟?~~Y,.\\t6Q\\.3gp~m\'Ob}SRR0ׁ0ҥ&Ecp8l۾U7:w\\aܢ\"yBg/=X.g^骃ڡUhT\r\Z4@:uٕ9Jd/	x{?g*N*C-(ҡWY###a>y2uþ}7n<ղe\r\r;1xj9&}#γl޴	bGTuA\r/{\0-RJVx	]E]\Zڵ>3`.Ij-[/}hѢ\Z6lU%ԩMMMD\"AVV___<y		r9(^zc޽%tttD~~,--@aRC\0\0 \0IDAT077/\'Nukz*\'y^x<8y\n3gL\\^L-[`_	[r9 -}\r~/bC[[[a]]]n\Zhn\rsss͛אIeVm07X>K.#((wVB.3łL.C:::rrr\0xyy*׳X,g͚A&&ܹgy?z%KabK[X(|qcǂaWjSSS?jjjoXĲʴ<Ev)Xl7/ṕݻv2jjjؼe+FU77W=rl6Ӧπ\"\"\"`{1;s}HH&#رcG݅x\r^;o1fзot-Z|W.\"DDɓǸrG!U\0\0\"Z}\n{pm|QQV\\=qC9Xp!޼~VЕÎ;*TFij\Z?7*|jH$mVϣ;w(\0늄JH+ŋt?XL=YfrE8T֭[E5//(99\"\"\"(--͛kz1	(rӫĤRIHH7nЂ}싒xk!GsQI3Udff>~8ҍne&$HRڸq#\n	*B\r{W+MѣJtȳP\Z88Fau_u(IZѯWtYؽZ 33cI֊R)|||p)x{?\\&c3ѯ_?tС,JUѣ>VZiaܹ000H\0HZH͛cHKKÞ={DFQQ^x---hjjnݺն$d2=ą\n66zaiֽ{XXbi򚴴47_#))	YU1vX%oqca2x6lP%D\"Mr2q^͎	0}42%`E=浞8q6q0z]6|}}q)xx+A.]`nn^zU{VVkz\Zq6m\Z\r4aCV0ppum*_!capqu&n\Zt2SSSS9{!!JOlԩSBdbDFEL fddoC=LZprr®1t(֮[W%\'Xvv6wg|.]\'	W\'Zؽ{zy1puuuWY,K+B\0eK!ati\\q=֯[Ijjja`+Vb޼yxj_\" 992yf1w!j%~mR,f!\'\'9-,,իW!o߾ųg JѶm[#h6m`޼hԨjժѲh3gNz^4im۶Ŏۑ!++N:uc0>_ԴT$%%1V\\^LfpoҤ	^nL7o ?/FFjjpI ,,ӫBSWWGp@qto߾_ߗmW|}}lU$\"\"lmmSEN...LnݻUG@S/Χ)S,ÇU3иqhq|*3hy\\U5  <nTJdl^ArrrG ޽{O666\nfׯ_3f(;C/^0<󛜜*wAA=x,Kx\\ruur_\'rfΘA(55y$ϗܹC\"*ٳgJI-+F	J_[r9҅hŊd8,oV Z`IUa2ܹSi\'Tff&smhh(	|\\#P0L8/\"sss	Uf7nܠӦ1DPXXHvs(!!DB{fmdkcIH,Sn$(...]Jnݪѭ[dJepB\nMYbBCC	<˗.>\\={V>LvYYY4jH>V\\SbɩR\ZXL/^P*#T=}J{OԩS4hЯKDDvvrJ%ԩSŋ($8ilӓ<.~$hٴvZڸq#ؐT*%K9{<==H(QLLGIwKY4wtCSۈ4yd\"XL|W$>>bcc+]2\'--Μ9_B$EVﲞ\'00)}oggGz*+/DBVVH<.3\\*AaalK~Uxe>UqDEE᯿£6r$M^R!CpY&\nF\ZUG8b\0tƒ%KpmNRZ;u;v0ׯ_.\0rl[nõk`oo:us۬,DFF0)\0+\Zd\0qN??_s.hӦ\ro>\\-Zs.\Z7n\Z\ZpuuQ(m<}/VFUNPɨ[Ν;M^ZZZ_	soA.#$8Xdɿgc}EuPy4OOCQ߾}{UvZZd1c~޿R)H(`LZ28Q(3V\\.2_BrrrŅ]璗CqqqBcFy`vEcǌdtPULX*\'\ZVY<*4ɛׯI$ӀUU1bpchX8\nm*|q`ao\"踽}ڒdm6ꦯDZ5%77lll:%;vTp0::<.9rL۷og˷lBz\Z;cR\')++hquHQJJ\neddPW/YzTEi۶m*ȑ\nΪ#/||H$СÇ2\\TT޽zќٳs1<ҷH]{˖-4eEԕȅH_WDNNNlҼy\\%<<<*}||<]|ܹrҭ\\)i{XLWʊ<]2+9ٳi`\"\"%Wr9ݻח\n\n\n]zW.r6>,X`TE>}J\"!3M_,X@!!!;quHW$$k=Ug~~>M<yG;v	.,(޽l¾}~SɉӖ-[h)͙=[۷o^\\~(%`{)|:^iHpp099]8###i޼?Y>KU>+$sj.d2h	|x\":p\0\n+Uwk_L\"gΙ/*KKNK{vvv2OB呉	=zTi{tĉo<LFRRg\\|\r{͛7JGG>Z\"!=]]x.]Z,^c1Gz*=RwXv-$\"M6^TΜ9Tquh\nV)ݱd!\"]W95333g@VVfϙ۶vڰ?wUK.a-Lc	޿cj#..C+u/0\0\0󒨾\\dee!==HOGVv23BqH5PK]jFÆ\r@\Z5n&Qhܸ1\Z4hz}VZ۷oꆨHW ))	Xx.]-̔bwww,[j䴗T[G			p8eVd*+2220bp1˗@NNΙ\0?ݬt6XAAfΜ	!1+	1*O\\T8y4B!1<dfc1\\^X/~IchѢ%8P󇇇ÐXfeVZḽ=<yܹp8(((AqVGtt4Bwo 33\"Ri>P隆h_\Z6lv:m۶hٲ=\'O(33<y:t1bĈ*-~~~Xx#1555,sO^-$Jaog@XR%a[[hٲ%bbb0b0p<=vɓ&*etJXnb?|`̝[fӸx6oeH4551q8`x}.H`kc;c9zefH$ܺu˖-q\r:kNBhiiʕ+HOdsj=D\"s\\x;vl/N8{/_DTd\n.EWW^^n.kJV,#:2^ݻprr\r7\"//5j@ݺuMdg~HfkL0Uf͚a\n\nBRb\"He2W			\\h|AJmDDF\'b:TݺԩD^*7͚5D\"۷o#1!&&&Mw\'O`Ӛ5k[U>nٌigFuQ&9Tի.**piP:l)39w^k/{@(i0hg,]߼AnNlVlLС޳E^nnq\\cil68l6XY\0yjĄ_~ \"šaÆh|2^r\\/\n\nQVm4hРJQ	!ɪɭ###$&&!\"<oQ 3I+\ro.Ϊĉkb1ll!C,f̜Ō5k{cׯ_&\rkTqqҵk)\rQT-԰}0`@)((k@vvv9tl6W:WX\"`߾}p8&NƢEʤfo`)r*υ03CE׮]pgzURRRKܼy>`TL&Co>ԩZBf҆\r\";;Ǐ,Ĵ5{F\\Ą$%\'ÇXӧ ~Fajj\n}}JgݿgϞAXԪ]vvJYYiii{.ЧOѣ9o>8]pTܲ2-\"ュ1;{f#>jtsu`ӡغuB#\"L:͛5Ǯݻ+޽VVJ`XjK/ׯ#5%af44죲h^\\\\!ѬY34mThի!&\"\\zmmX(*,_Gݺ\\\rmj>}͟_);.VZqcb(3>L67=V^]>\r	;>jvڣ!~$P9iñ\Z|QZq8:8`Ϟ\03f(R)ą͌GiPSSY믃бcr߻ׯ`mmYBK?#ׯԩS,Tvm,[kӧ J!JqiԨQ,4z聉\'~͚^A*b0h	*U\00Ϟ~TpuuT/b\'&&bЯÁ&ApuqÁLVL._Cڵ1yD3k׮Uy\\oq\\-Z~PWWGQ^=hhh^z5kVuvvv8lk\0Y?PiIR`lll/$	f͚^z1|iiiiHHH6j֬YQ/|}}쌫W.3JՐ0A۷/\\.*QXXgggڹKa1e3DQDEEa-u&\r2ּ<?X,UQ1caȑxb3ݺ\nl6l27n*bT*a[[88/sfΜYiKtYXjq\'Ѷm[7 A&hܸ}===sdCMM\r7oݮIɓ<<Uյdc|m۶UL22G\"?>zR)==(44WO\Z=ڌ233+\04ɡH$pR}ʍfғ\'OcccIW$$OO*]F)S|͝3_F111U:w)\"\"\\!rKsz4\n|JՍdM׮]ٳg3LѺkUa\'߿\'>TPP@fff\nxH$w^K.Uy\nqEEFFhҥt=ya*͛0Wau/<@ }\Z7IR>|@\'O˭{1s	\rJq;vT\nٳ3\Z1|8͛7޼yCDDwܡׯWvޭ\nWlmm߿12n޼I\"Ν=[!U;,,NV-[\r7J?:tH]>uͿ|I4}STTD[nUHU|P,ի$I(|.\\ }==|{Ν\nmߺutE22LP	4|Pf=<<O\\^hybŊJǯ?}&ODb6lXOR4\'\'wT$ɠATDڰa͚9,UI瑕ղJD4p@~v\ň)((<y2/7c,??~/a-/4fh(h9\'իV)X,ӧQ##ήt<xP[{v6PLPiիI(3rhџRbb\"EDD0f*O:z4`&ǥӧ>dlܟƎCG\"Tׯi\nBɀ:p ]~	TQlP*tV <i\"jٜܪzHzz:9;;\0cc%](9c%IIIb\nF(<z1͟?>YXff&M2x\\24M*$77Ο?O\"|HHNr4M2\rsǏ7RT+PH,Rfk>3gP_,3G,Ӂuk۶xJ;;;UK>+U/##<HgϢR9VGCVVV՚\\iiityt>ɖaNeVoTJ			Hcǌ9gM<Ξ9SsǓQ??\Z)߿	ƓmVrb|^)Nc{U%`(,iȐ4eʕ \"\"-[Jz\"s2)*	V<T̗Ȟݻi͚ՔL4o<\Z7nbz-yJҔ)S7%	%w\08q]\n4~Xjբ9V*&&vܩDX(hԩ:Jf͚I|BCB(%%<nd	^	WϣTz#]땻H$C\Z`lL\"!-nzq*m>zU$vvǪ<ȏ>$=]\r#H֭[LSݻw<9MJ:g>??5׮X,&OO\n\'u3B\0\0 \0IDATjJ63lf|:s͝3[5@)r9:H:]T{.޿>QF*x\\*-E.3>oҘ1iΜtNHHH5ww9!K+ٔAvɒ%+qƒ7d2rtt$=]=y}ua;v\0;%%t<S,N<~۷RrqFѴiS+ulI|WرP\\\\	<%#YZZV\ntR4%α#GTxW\n	ӥR_ЪVwhQ3VQr	| =]*D/0\'WGQ||鄄:x 銄$Ed#7\'Lz\ZPn%	ccc}=rʧRXq7WW<xI6}\r\ZT37o฽\npw@\rYf]q3Rx<(BZqbʕ֫W!!x}E\Z5@D8zK.冂nڴ	W.;1Ul6\Z7nbԨQ.*J3gNc͚ٳ̭o\'-ZѨQv؎֮&xiUwPǏd{5bbbWn+W@Y33EEE9Cxb%t|>|}$^DEEaP99\Z\Z\Z*pM̜1޽ŜscN)Ϛ5k⧟\r7t]aT^=sr}x|deCf4ϫW&тd zYZZ<.9:8TxܓDO\'O={Ty{BruuGhh3\Z`lL\'OWGFF*B>ZZV޺u+9;_GVVׯ^јfԥ6TK/V:;fL(88rssiRK\ZlbR=h4)CHAd2=}~mJ%])S,haPV.V-i#ʪZNnztefі-[HWTǏW+((H),&KLF631/_Poٲ\\\\\\\024	;VmE\"vl]SpgeeqYj9K߾%==&N@֭VGURHHH̤5kVUF񤾞n+ordP/XD-h8z%z(,,L	)S,H$H(={vSHb1M6M nme^	ڸq#h릯GӦMTأ/atss\"m~qcǐwғt)iwH|ϟY\\Rv9hqlGK/.sJJ\n]x\\yfYfVhyHH.]ӹ.ia4eEӧO%KW*B`)fff_RѸq$HW$k۷o+t\\tyyWyMzCbƌC7owTڼ}z/ Q:v]{ek/k`tM:$9#䘐}s]{33~5mgkS/ (Mm\ZNV&ET袢Bzuts3ܬ9mmeI[[Y3fL)/޽KKKKi7ݻ>ޡ5p:I#%mn2(y!!!\rÆk֬=C-]TTTn#FVgjJҊ6bbb褤$w.//ummeIwhO$!UO߿:thBڧf@Z~~>mkc]g^>&&FRλj ?aѮ-mĐv>\nǭh:mĈB,0a?UP$ޱ\\wNNݵKg:33r+Wh{;;*)]+0EѧO;:3CvҽtuׅM\rʴfR4NN\nݿw\'\rnXp!RRRĈ޾񅫫\08ѣG]@ vڃI	3LIpqqeFJ===,^SL۷Byy9,Y[lKMMŴS87oֶQgA l6[TtWXxfΘ4H\"WTT6Tp\r=s|UxCCC<{Xx1N:	k1j(`EXh1kK>}0dPyt׮]#Gp!yg_``x`Bŗ/_:	(\n^^^(++7d}=Lhquw|	lܸ{ѣpybuMŋ@@UU?`\0X[[KMEDEEbcΜz;A7n8ŋe8lmm1MyyyXd1JKK&\\3P΢i\ZZZZp88vFW[֭ׯCKKjjjR ?\\.Qmii)܅Xl\n\n\n$FDD3XXXhٲ%TC9w<M*>=\'%%aοp-8===͛1$\0пx<xyzuf͚m;ӣQՙǾp>$]$/Y*6>¦MbՌm֬3!  \0vv Yl=7m۶rx7mڄbaŪpR011C`J[{IŐJ4⚗T\"IΆ72Щ&\n.T,_\\.N6M49{iرgOx3[aAзo_oվ}{زe3N?cO	ӦNH=PSW fdNvB[nԩQC-::\Z&&ة˗/a!rуh\Z kʼ뼼<f!\\ϟ=EQ\nЬ	DZWlڴ	8p\0t통kV#33s!8(f&9rc}||.Zj˗˜y	O1u_q.EWWW:.]WWܿw吝ϟW<yPQQ(iT7uˏ8	Vr|~NᕗaAPWWǫ׾	8sL\rhʼ;5cXa޽L~aäpջ؟64Mr]\Zx{K^UHj>I;f,eʢA@lw---œ\'И?P6Ȉz9,Ǽt2|i4Maعs\'~GsLE$RH0g͛o\n㣣a5\\C9H\0e6f\rx|=s\ZO>8V]]6oEu5zzz>c<^/keLqQTWW{!!!:uXYAAÐS]JM4)p%֤&FxU1Jq~׈Yuu5;f`+)\'XYZ7jjjy\00񮭭C.mѺ\04m{fY,<<Ȋ*\0s#\\])&<}Gp8\nInn1s5Jrr$$$Ho@+S/o޽ѡC&cV^(i_ѱ؟)))s5ϫ?n,rrrcF\Z\0x\\Ah\Z_VLkŽw+Wbw\r+WƬY%\01 @y*fZ3G*`VV{|fffhڬ)6o͕z2FfaHiK,OAw,[S&OFbbL->`(wc3RUU̙3ԫ7chƦMP^^.޽;ځC`Ȑԩ͛6͛7RYӧOiiȑYMMMǽpi\\n52ormۢ	?xp_;.3\"&&,fpFElƑ>u=$,2֚$	;tB.]v	?TUUm;вeKXYYAOO_\"t\"b>f66Mmm]Vf.Mp\Z\r-nC,2s`E9s&c-++p9p\\ٵ\r&pWur+++cݺu\rAII	(§H\\|g;I&x	JKKѬY38x`?C[nRtn`kk0j1\r8Ҟ[k.tuuannkkkL8\'O)Sb6&FM۪\'kELLz)sûu,SNNݻѣ1` _Af\'ŋF$O.ӋbaX`!`ee+V`ٲ3g.Ə/w8yC:bw>|pucȑ#zΟ]]]TWWύ0~8|b5FCIIII%e*޿\'c	ׯ/^zYo6m1#1jjjǑc=aѣGRp0}t\ZEʕ\rDECC+WSAFNN^|x$&#))ItуF4o8t-.Ñ\00jwޓ9!\Z\ZO>%%%022,,,\":Č oW^ג~\rmێ={JMyy9&M/L{Y1|W^#rfב(p#,--abb\"??~bbc((,3\r\rFkeX8}i\\.߾}CLL}<5AII	ӧS-Zsgɮ,-qEGؼe+JJJp-޽iii6ARAee%w1!C&kKnn.bcbKx{\"ol,\\X.6~޻w_o^4&\'\')J<xH*5\0hfffPSS\0_T߿9iӤ~j<QQQhݺݻw#00Νy{{#c-0yd-11BGGeeeb=<|p4M}=ZlSm}\r;bZXXBH4Hy 	B0LRuuucƆѡCך6m\Z^<P/{.~7BII	x9Ν;Jp8VXEESMÆuk\rRB׸q\Z,\\̛\0={DVm6xyzbĉ\Z)MMM:׼@Qrs\"RP?	Bj\"kRG]/OOA	@K[GjlAQv܉x899޽{k>rNNN֭Ԣtd6#4Ob(**&ϛ+fyDRxxpWtVVVltbi^	 \'\'џ?CH<yD81D*}֯VXm8lٺ\r...^6l܈ٳf2|vlLhm֬2-؏+W))tJsڜ|\\t	SLkGqq1bcc\\tl%%vډ\'3%#4׮1ӧOu+6EQx.!{N Y,L4IB\rGXh(nܼ	3fŋ?o.<}&3VxX,7\n\n\npY\\pyprr¶;`aa|\Z\Z\\*f@4c/ϫ	>EMvibг<xeK \'Oсs/7ËϱnjDEFbBu\rF[7ҥKXz5޾y8|ܛ.&o\nN?Ƹ2ؿq1,@2mkk???hF@@\0ƍ\'\\o|}Ts.\nFJq\rE,^Æ1#I4hlmYY\0(W˚6xǏ9cN8rXo܄h>:w, (MHj\\f?l63gƊ+Xc!3dIEElm`ff\00oa˗`0iHv55R+KaekO	Bq~;?X]vzzz6w}|J\Z#ze⩩LIprvnpƔxDGG3q}ТE׮1&uM8@,VZMnݺ	\0UO,]\\\"n?` \n G!I[hպ\rMKBl6V^#>>i\n{۷/-3g.߸:Ǐ:e2\\\"MLLl\nq.\\3۷qU9}\ZΟXшj\Z={2522BjQPTUUlܸDkKQQ\"##q 77߾}k3urvfBJ$ŚL$;&&\'Qo#F,ٳ\':w޽q}?7KR_>O0^>\\]]e6֢\'N{(tvv6EQ8vLMMqY0?x-o>79з_?͖i888o̞زy֬^4X777h0;l|-7!44**\rCXX\rm$H߯N<iiix6\'z9;a8?j~IK JWl&i.*R^^*8K \nǱ޽v0uK^*Vap\"nSpp0Ə˗.ACSGî{)J5kr㵟%--\ra``;v`\n\rou4-[p)㍎OI4TTTM8s<\r\rqu:oktttp\"ƫi\Z^^^rqq͛tr1c \'\'L(\0:vȄEr?kELF`ͪ}LC/pIgrgDpwm:2$$$ +3qG#л3>/_`СsQ?cD<zF0`;<M80\0wňnK(o~\rȢi\Zg\\Mf~)B} qYXXX0\0|UUݧO 0\rcǎbO 9Yzǈ#pyrvB&Ybdd$\Z,Ap\\x7oSOL:֬]^K._&P\0|]R333 ]vOXbn0(9z7vzt#!!Af{$1s,Vrr2/_[6(lٺ_\\/\0\rrS߻u8~Odf{`6q<\\xikUdRW@Znci!;={g{vWǏdd|Kǌp\"X,٢ٯo_1w<Ç:7\"\"kV­70yT<7<}\'N`ܸqh߾\rtԩR@P!ץk\ZpFII؆@\0R~+A\Z?}T\r888`ƍxwALLƌ%;??/]dNII	g˗p>wn7n3ļE*侉T~~1]=s7\0\0 \0IDATwGn beV̛7O\" p۷B\0A#Ю)_hrpኅ`ٌC4M\"fYkk1wuza8wcٲepvvq%<$LE4,	ʗ/_pe7ڢJOOg;IСä6\nddd`M̋сs^صk7^ZX,Ld8x\0xFYy9_[oFn+-t>Q/ϫB֭q	6zU$IBYYgΞcBiHyj}4-\0vV\\.PD*eURRoL:U^ڶm+622A{1N\Z666\nUUNECKĞ.όeTVVFl۶w3^QTbcc] =111033CrrDՖfUUU#11s{all/`u\rM>}BSKKF55U\ZP(ؼy3<%b`kg[Ȭ>EDDF\ZAKUOn\Zyyy\"/{wJvڡ&M/G 8;; $1ߞ)Dh%pBT +/++CDx8fΚݨ,44TLVnXX(TTU>\r]:w={\Z\"ڒ 4BpPP\rѣ=ɯkVV\rr)وl۾Fl6G#Gd\0gOt*i]ֻ[Si\Z~~̦UUUmx6~1nx<zN,\r(FXX迮ڰP\nHJ؀P]ذ@HtXVPP\06]/C\"RZZ\n_LCF3.u~~><^ś~ jv\0x̞]^(i\Z>GPP tutmv7QZx лOo*Qo;!V-q1͝j1dXd	&L({oHZyy9{1khh`_;س\'󠬬>mNص{7\r\rbYjjFM0\Z___,ZQ=Ԇ|+K\rEQ())FAA;\';-Z(߾ilݲk֬իW_A7\ZKz%%*++3Ӄ.w%KܵKmhhh;;{b݆\rbj2{ՖΝ;o&ۏ)S֩Ե1\nE~܉Jcaa!P4}Dfۻwo&5!毖-[¾\02jݠ, KA4\rpٽ́Wt\rK.燤$׻E߄fҤf***R\ra\0~`\0c_0¢A[EkE8|0GV($\"IMUO<4x@Ь\Z-ZDǎǨ(p\\4 \nr	:x..8?^|!vLڋ Kj{ge+ѣiZ4Q *((;a˖-x(**Bvv6RSS\0z,fa8:Zj>}Hj}{vCнGXYYnxtgK tԉ~\rVZ6ݨ-lջ7l|	;wX]]][fffzYMY7l{CCxXhQyy94nW/4bbby<.\\\0\Zm$ܴ޾֭[3e8t{\0q\04q[M݃@~e^BYQQƺ@$8`dd0ʞ4!88\'ö;?~Ce?ÇǷow׎+W%C gaaMMMYwҿ\0<qB{L!z[\rMSSSXLfI1G!2gϞ5X,0-d@UUyo>Şc6nƨByy9TTT,166|>h§ϟ@Q?^,$*::4\ZxHJNb[-x***@D`,--1x`,X\0/^[?Hb\"ԇҳX,hiicƌP겲21@ifLcOGTTT훷#٢u6\rb(\noR(4h.]==}wL,֮[K)rR@jɤOjy\"䏎7oJA__ǎCѷOo\r7nܨCt`+DȌCyhݺ\r㭤$ぬ@Jr2P[l#iYYC}-D\0UULgee-z1z\r{;:ׯ_ÑvYݧ7YYY׸oN=P`SB{NW==ѭ{X,3qAyfB7[ʵV[|BI-VUMilۺpe<}^װm1^VV H9RUUOOO{\nZl<obb\"*rACPִYSnTx2N>۷o˗bbbW25y$;;H\\+i(Z۷oUO/,Z׼p!$66bAtgFuR^طoFB3Sܺ}G*<٭B#BpDx8ڴmÆŵinn.||߇a\0cccXYYa_|#MZjŬMF2ۻ[fxnZ;+**.//aF\nDII	@ӈ/\"As4([y`ҤI\"bBMe:Xv3!;vD>1klxrݧ߻wI5t-[DzzB<O>S̀7yEKKk׮EYYܵȵ%>>>oPGzcƌœǏE,t	64\rMM-^cYFYSш)/>*ɬ]\0\r62k[Xg \\x	5;FPVVb;8!888$Z+&_~E\0555mg!bR\ZIpt\'_d񩪪o~8y-?~bAȆ\\S(ϟ?oo\n/Ep$`ee3ߚiDС<==8,_y\r}1o+3#A(G^~>233kz#b@*.joeee`pOy\nAQ	#iUbgd|#|R|,Z\0`imڂЬiSbAkqm$jCAA\Z-.PkpEQq\Zf̘64nhaaaxz٨DACMM҂=\"#\"jh\"QVV\0$Ib͘1c:ˬ6W2-ad4@?(ؠU˖ѽ;\r\r-7P-åi*!uuz-h7[]]tEғ${\"+3YYYH$}w1);	ZhE\"33޿!C\ZUϞ=];wD$c1bAjBjj*7q\"/Y6rhhh2%	߿e\0LMMq|$IYfc5556o4[or2+AUUUXb9<̅TTT%%%18%5x\Zb:\\RRv6KU-IVV6Zj]ocZZ\Zw_ee%\0K}\\.%%%hۮڊP$S%ժ!MKui\0;ƷQ cu񆖖OEڵkpqu)Z?4\r555p\\l߾\r!k.&{\n\\.:2Vfff\"ߜDQQX^j墊\n̑^SԕUUU2Oƒ%K(|KOǤIU)..b\".>R|ajb&M]]]@SSXd1N!sbXlRS2wx=/!CTWWŵb Э[7<{r\0;Y\Z?=NTI &&\Z\\>8W44<ض}`M|\Zz(B&FkFT>}3Zb?b㪧TfX022bhrQQQ!@UU׼<QRR-[\"3#bzzz IUUU֕W}yE6ffHKKûwg?،0cƌz),x⺺z2ᬯhV+a++Kp8$%!*2]\ZPL!T#}(\0e>Gŋ~N===b7o>XC_UUU؈\\C_k6mۇ}/\\l߱AbiӺjq7ƌrL,*<+f\\\rVJ}+<a\\䪪*LZZuӲ>h|%Q9gii)Z\n}RQQb033*W!wff&֮Y\'OC[[żƐI0ۍ\"Ǐ54\rUUU|쯡\0޹k+roPRReeefo\\{\rLٳqf,&ZZ8&\\9M6x	Ǒh蠰CIII,[\\dqq	cjAC\n/}}}4om۶[d!xnݺׯ^!11_|ARRt0AN[Tvc\'gA;뺅Ǽz#S7zCKKK\Z\rX,G2o|Ν1n(\no߾Őq۷oɦ\"&	\nLLLp7FqmGuu56ȓ`p8[RR3;BPS\nTWWI(gD`` Zl	;wwn$\r6H_ZZ*VK.]\"!!^OoݻǎjTYkX,L<LЦiݺ5nܸׯ8]]]c6O!7%UFF>~u558::MM(--̟@Td,X\0eMuĠ;YkR./_@PQQEQA\'CUU%(-+EyY9JPTT,$)W?IPQQeT@EEEEa&x@.Yhc6mĈ\\.4\0P@ºmD:t\0I(..LZT^\n_.X,/Qj6Xl/m͙3=z8e6k.:q8\"\"#{nkgQk<\ZZ$Z2UVTJ(pé׸q8)u1dl(\nPSW[?AG[\02kjiqhhh\";+~\ndPGRQ^vUUn*j~nݺؘX@EE**PVQT:q8PVQ%%%$	fڮG]PVVжm[\Z\Zbӧ.]\"QfffeeepSN@mذa=rrr~ـ!trtw<GŃc_bIR		\rQq[3IRr}\r$(	j.eeeƒUIlP$q9<|eeelXfEu/$6!zOU`sEVQl(Q`䋡4ME Y,\'dy$	p<<yL eO^^\\Cuu5ڴi{vg%%K]na߾p=DFF\";;[%>}\Z5V͆sޘ;wAcܹ3N:OFee%/^l\'ՙb@]]ݻX	\0a7Sך--m¶|s\rs`Xb\0>XǡU022e+s<:1c0f8}#WC}K׮x1rss777fӋê+Ȥ%\Z[Y$	\Z֭0hE{ׯ6nX>p8x\"\"##k1fCWW={Ju2H[;bR}s\Z%/x\\\0\'%Hތ>&Oڂ?&L+\ZҔLo܌aW77YF掦qoBzں$& ̿u&lބ\"\Z\ZzQ`ԩh޼9f1x`ʕ+z|Q	A000@tt4Ə5k\0}(4(v/k)KII	p	555CEE2[	0KRZ!G	lUEx\\[f0\"9|cǍ3)((ٳg1sL\\EH3l\"\"\"PUUmJXmeef-//w\'o޼9455QQQpdffc8{ԠVB&XaA]6m+VwBbBB[o---TWWcU+\ZUUUPRk/ZT5aa99f2[L +RBLH\\vUUU54EP\n\'賬C!&&Zb\'\'\'&E\0t10vh4732G>>PRb*f%ѫw<;f4~\nY̍$A I+F_ݻܹs<Ш0[7o}p0JKJ\n\'gg7VSS}Á\Zuŵ$G	HIIσyJ(Ыě(=\'[KSK+ӲX,p8NӦM\nI\r\"66#Go~&}S{&moPMM-&yhtG!\'\'痠l6vXd?REGGӦMCnp+ekltC;,bZڝШ2c`PUUuȁdggx$idHQ\\-(q	hjjXTWW+TUUqGC,VZ1e_ƊKUO>A\\\Zb`PgF\r\0 }\"BaAX`5UT^,apuuUxB]4CO?ƍE(OB>>\ri\r=*vn=BXX(SNCCC5}frx<f#Ib\"CUUUNNNƶm	¡C$ ;;A2s-K\n~Ųa>~1;/_0iK*v2SyhgZnM0Yl6Kᔠ4f1xoR~ˑ!FtwG$,H~FxE*	H5ij%MUU\r,	TTTp	.x&fH--h5\rXd)wP\\8gϜaSF%6͛###/TTTv1ׁ1nx&qww	6oބwcny%1bbɒ5|x!\n+$obmw?\"s&[lFA~!P	з7\0\0 \0IDATFDnо}zgN5z;11mbϫ7TϺC{\\x\'aann.DQ%ZZ`,bDGGcƤ뇾a9e\Z544XRA72HP̬,,kݺ523,V z¬Y0|\n?\r$$,ĄIĉ*UX,kkkxyyܙE.YXܹ3Zjco\\k8p\0E>}p:\n=ڬ&`\\!Ik[%1idYfr!ZZ`n=>y6k&HN^<\ZRVZݺIܸ\n6GF\r\"y]baȐ!z*̙%%%>Jbp;bHKKǏz$IhfLo1w_2\Z\Zb4hΝ;Ǐ(9޽\nDJJJw^mW\\YY8h0ta)2dJ$3ojRS#fx<rskk묦&ؚZZbMd砪\nb;Wbb\"ށ(,YgΞcoq-L0A*Jljj0TЉʔ)Sv\Z8tdc\r4˗f\n\'1gȶmۢm۶9r$233H\\DEETU???_8L1Ca_XOIPUUqaaaGǞСܖ>\"޺u$::\Z:tgN`y2<;6br#ۉ갦&\Z\Z\Zbvyҭ{wĉ?~<HDHHܸ^׮ŋ8ufΘfìysB_ORĄq-HRU%=Q[[/[V*+(BB|\n\n\n\Z-6@GG7_R~\no}_rK>\\aNNNƆukk>i[lE$IVŋ8x`?ʰwn	GL񋢓i}(ѧOr073|:!Plq` _>|8?~˗.s~Em-[vΞ\0t˗>՚F+ólNϟ?#))	\r۷%%n\\\\<fb\nE#mŧ\n+Jzz:x5Dcǰ}ǎFddd-%KM6066~pP]?X`!QTX7o|\"]VVIXsYuuubϜFSFׯ70@f1a\Z4yyPSWXjԎ/83fؿo/\"\"\"n:ͣM6b}			\r\"ޯKpa\rIJJz!(~\nw\r]@T333ٳWa7:fLmC;==SLƺ1zhTUUa1XI=:\'\'GKPSSuuݍƷo.$1mtIu\r\r\rѾCĘ/e+DD3:u3\ZL޼ysBi6\"-))ukрwh8M#6&F||lD|>w}|p̙F;ghh\Z\rѸ\\.̟Çĉ\r\rK%			bbO._MMm>Oϟ?b&%	*5\0||.B)h^!UTTж]ۚ^0#.<z>k(^iFTd̚4)ajŵ[4iL۷o$\Z*\\.{5f60 #\"<_Ey<N?o;_}d%Ĭ_zz:\\.V\\T̘>\r+Aycs3GU[,۷/ZnٳfcXd1\\\\Sy*** ╶2Hs)(|>N>}SQT444БԱ*ʕ+5mڈS\Zq88ŸHNNnyYcTi27\'G!$77_\rD{MR+E$IٹX1PDD\r\Z~cȐ!0q\"?xXֹa}(vǎ+@JkepipLQÑהּY=0\rQZƌz(ߑ \\~Zjme%vOlm<1p@ܼq/^b:v(g7;}\'*P\Z\0M^7ys0u\r5R~ 88m\n\0W;w0p CMMӷo@B6˗/$\08cȐ4i:t\0CC#ݓY\r3j@QĺCsX^^B --			GxXXM0\09kB6mۊ]R<3п\0CGG-Z\0łzu-,,TcL4l???l޴Q;~jHIILR\'zozzJ=b!$i&:bA:B.Z>O\"/7VV077ǤM$\nD?*2\nVrٵsoliȞ;x\07H@dT=}R-&&xpsкu+P&8q˼-Z0<N±GsW6L泓Ȅ1\'_nx/,,+q1ۤ$$\'\'1kڿttu7oaslR	\rp)$$Yhm 33)))hҤDU]yy9bb]M6J/ܘ.zÉrx\rx<_cmaĉh302j===#bcc@Qޏ\\XX!8(/]ʬѷ_?<}Bu|Yf*O*FDDD5g(\n>}Ď۱u6=*$i?.2:Q肂y\0r6uڵk7o\"??鈍Aȇܿw=}{A$FZn\rSSSfwr=ob-^h(ـ12{A+++㍧O֎Kƍ\rsə,))ׯ\"s]qq_Q^^:;99+V,C`eeԔIE]7n(>YTTU+WXdMPXXXo5//x	L`E\ZR\\~|~]lXN0kW̚5]v7MMM䜜zٝ\'+lܹ3&N\"dff\"11;A\0raԤ	&GE1)ғ = \n]TT#99{%K0tP;tDvv6tuu*28}4|쨨(牋(رƎ]eeer&M>j4.Qk̭[ӧ/Zm$Uqin5>˫ސ\'\"\">vx<wa:\\x	7nނ3<fb^YWٓtieɖTDV(.K,KdR\"QBiofSo|~z{~;qqGg?A*amm\r6^r\n\"\"w/uE<L,Do߼\'uD͇Brرc;vZܥ_~\'tXzz:N8BW=&A*)))hi鰵ƂK-7,VVy%b;LaAu=&	6JEEE(..FII	P^^^/PXM44\rӧO;&?\rq8l֢\Z`X(--EII	JJJ(f.Xϊ\niEc8vѫW/8;`T`Sfw_$МÇPt邡Ct:Fb=o2@\rBFmڭ[70ӧOҭ[WHII/CÍTTT`t9{ɱcȐHJJEZ	%F믿rjkk)R:TVV@__\Z\rܸqnn6SciprrFiI	JJKPZR22Wb\nUUUQNói<2N%\0^g7~ͥ1|6lV٠~!%%ECNNJJPTRTTTVкukDDD 90ydo߾[Tم ;;[`ݵM񹹹H\r_ai${{h={cǎM999`K<jFF3ckjj/_u\ZMhFd̤Bϟ#=9TT1g\\`t<-,,|/	z0$ٳ&O1yyy`6j)**\n˖-kFFFԘwќ50`VUUbee(SR\\%(+-U=\\.AFFP\nYzBZZ\Zʔ2UUU(++CUE***PTR\n\099yʊSϝ;KETʿZdψAe&Z`0pvqzOO?pZC7ae5MK>}t\ZZ\"ӗ 2*\Z999x1Μ9H\0*&N1vہ`W\'%Dc\rָm۵k%\'\'%VRSSj=z􀆆&$kn|w.((((Hu\"ccj4K߸kIڿ}UUUv>lݺO<S6;Hwd]vmA\ZAv$zBCdb[ii())iXTToߴȱkk_u^z/_B^^C?gL...(((022SJ\nSRpCD$שMFAQ\nၼz\ni))p\\b1Err2v.Vyee%\Zi\ZLh>	 ##xJKKWܹ;wM}&gLǎQPX#	\\\Z-pf}bkjjЈʵCnnرc%n۶-,pB<\Z0!ſ\Ze,L&JKK񸾁_Ԣm\0011jZUt:ہ3UUU67ۘ|X,0=FF~e{0uu޽-&$\n)@}H\"//=z;wDB=<u\Z+WwaHJLq$}_\Z<،{Z?4\ZM WTTġhۮw`9r$]\\`0x\\\Z̞=ܹ3CJJ\nLz(L&hxċmǏAPQ6###~J@\'.]Э[L6f\\k٣gO*-Sd2%DdG<~!XBB0~-n޼	\r\r\rںYqFbtXcvUUUGf-,[e^^j#,,C/!2*\Z!!~QI*ȟ\r\Z\r\r\r͓A0o444T޹sg!<zSNpuwj9sZH33<>}ʧ;d:##;vѷoZԠ_~!͌琗`33\'ӧ0G`00@ޯ_?DEGe&<׮!bcc)},QإP>߭KNѾ}{HK%B,5z=~{7]***ѣ\'vԡ}}	9|p:ҝ;wQsΛxDx9ҟ=Jf|vŋֵ&ZYAVV>EF;Ф荁Lf\"d00`ӑ5222=ztag~_ItҤI|)--ϟ48tOĚի(>^|S--Jܻ.njLĚBxpp-FPy$k/23&~7oh4ڎ~`.!^|q̇[;ӡCZS9m\Zܿ-tCCCn-qMOjVTRRTڵkq8r?ںǸIDnJdbz2T||<\r0\r:޽;&4W{l$\'\'c˖-puuŦMqeŋx5lllĊrss97ʯG\Z-Wt?%=uu@ё-{p,^\'Ml҉ZQĥЋ\"ǲ2,]3AWW7nUUUk9F\0?~<:tTi\Z^,o`\0Y<|֩S\'SbwBʄn-A޽%\rCy:\\x\rXJ˸w!%%%uDm۵]5`Æ\rCtT	lw 5uX52:C׿÷0%zҥuyŋ8t\r+#+3[ePRR3aj:W]:t\0a%%%%x_Ol6^6L& //&UGG_~-˳i4ׅے-Ά,--U>|-``\'_fJJ\n]A=#}z\nÇ\rEiI	EOԔݼq4stt͓+Ѹq3fffppp@gMMhhhޕz&=ŖHE\\B΅8ov-Fl>(px)CdD8AG2\'NB+\"ÝQFzeee1e\nxp8\\t.`ffq`4:||v331Bihqќo%.l\0Rc{1A3`,h>v5:/WajjOrq)\n		طi\"!MOW^!2\"׬033Ǜ7B`ԨQb]G$\\plXZNF,	Ν[_ؿCxymزe3Zns]r9\rS\0D\r\0pI!\"2\nAAA,\rQ~c˗/Ptt@ѐ|-x=}ޘzJ\0pȾEuJ\nt:\rᡡHIG-l.wwwHVV22طo/ҨCGGG)[n>a0>Q$2/ 0\nl:p ***p)|EEEylPXaI<t:FڽG~\nPa\Z$%%Jn\Z.x!G!X0.c!B.\\D@@\0/X=`=i=\Zw.G-[={6*++!--g\'\'xxxݻ|UWWnF!9;wl~_MJJ\nRSQWWG6mڠvOdY,J|bWWW	oЍK{y\ZiiiE\03ٻ={FƩg0IF.JKKqA\nixb\0LܿmBT_bqƎaC38iؚd?_\ndݻu۶Ԏx	W~\0\0 \0IDAT%:Zb61`8tco$K9sѫW/qw)ݻ7QBPXnnM}BvlߎukL5455QFa${\\.V,_d	dd{K$ͳM4{o|ꢅ`Xl6ZH\"|>~4۷oXd1pLȑ#cԿ1edؿhݺ5\0/Mbi߼qe%%Tk?u.za\Z!%ń>&L/\"<2\ns]`͊pJ4t쨎]\n\"lllqMJ={FgVSmD\"@mc3nܸN{w¢~j31~())ANNIJJ¡CuV*hXp!ܿO-[\'0h_A[[%ToϳUt:>|@:߿\'1pFO.N=Ah*++iqj݃rrrؼy܉Î`0ל8{6\ZGGG_!&\ZRSԩSX|)G]Iеk׮h׮\\^xFd66MMz9_8.n.xw\Z9r$?Oo\n`_*j5ujX,jz) cǎPTTǏؼy3-ZmժvY;r4HKKj8 %%->::رH0OX(*+	\Z\"n8q\\߇,Qy#Łp~\nt:vC3`iiYfp@\00^k6O@EEuZ؎TEE#pqĉx\"۽^	rʱl?v#F]:u/7<\\T۶}{*xA<ӑ r^\"UjAp8ѣG>fG|}.*p88w,Ν;\'uYYYddd6?\rsG9vkD({uu5y\0\n\n	YYY]\0Μ>Td2뷛᪫n-#ХKfrssosh4\Z\\\\\\$۷/6oނ͛3OaT,_>J=;Jk;u@/lIT	9{Af8tPMnn.7oĖ\rx}gpf#00nsp	L6\rai9h\\l`\\ڵ+zoMmLg8rT(jggw`2hp8?υO\0zTtXXC}_&yڿFdC0t0MO;vlq*Be0prv{Ժwwwwܸ5kVM,?3fLGTT6n\033sq6\'O&M.L+DEEJDK䄲J1[k>˖7IД9::rq9\"Uh~p5ҥKpXsk1BOYfil6^^Zedd`cc)nˤ	=5L&m!9s&\'˅\"ǾWr}\n3RRRz\n_\n)pnURR;aݚŶm[ީIRΟN?g	3~СL)EElܰprvKa#22E*:T8̧$@N8<|˖.t?W77^\'\'\':VYKxs\\ڵS$9`\0hhh\'ׯ_0zHX[[B)oL&/_-sZ@VV|D٫6:w,g2Xtue˖aa\"ZZZ͆-ͯl6R<A֭ajj;wӓb(,[/}x%n݊[$\\r2Eرc\'_sD⚲2Fz-7oCp	FC߾7MĒDӟaҤX0\r%az܌4{l	ڕ\Z\\~%YBBBh\0^F˘2e\n޿ooo̝;|!6oI|νsx\r,=z@=ߦ	&o2f7T8Qcѣgj@JJo߾Żw8,]ϩ4ŦMӍØ5\'OdI8zbT\0<FLݺD\r Wu+5.tLoiv\n`)Xsg%i<?=\0{{{r֭k(ivE]#-pǉ\'лwo<~&hk\'O۷{nGUUvo~|νu<yҘ1eee|]<F%\ZPSS=PVQzB&h=zeee|`10;w$܎`^ÇgyۿY,n:_Off&.\\\0MիV	8}4tO飨Ξ	kd_]vF}iŒxDQII	nSDF7[׷ܾ[$zܯ	̙aYظk׮ѣw^\\\0Zn\r?04Ϲ݃ÇK.hFh4o`}ߦCӡ&tll8z(t:gq\\R#M;$\'dPl\rNffn]v	teٳuԣgO}{QZZ#G\nU\0il\"QQScgggcvoDD#^_&߽{;qpus{$99uYbĪwX[[#9j8{,F,(F=3f]\r7@Qp\\?}a9;733\Z51a4ȸP1@555ooo޸v=W\0hiiAA^aѢPVV䠤i,!@IJIIA^^27:yA[zꅗ/_BNN4\Z\rmڴD:W.y)VUU~᯿݃E^[[KD]]***PSS*ee,T\nyyEtj51Z\'OuijjR-={өZ֘={vNF\Zu!)17lkBBr1~[SS3O󵷊[˱{<DE?Oıs=>\'n\Z۷}l631ih,^R\")gϞT^///iρfR5F8\n8CiE`0@!--\r:^O+\riAJJ\nJ< /:0Z4ˮ*nڴ{;6edJ,Vy*G]]-X娫FUU\\.jkkp@\\Աr9r	 d,+礥!//666pvq$;;hu&d\"$$VƉu=|۷ٯ\\|\"cg\'ĭF,nF`Z+\'\'/c\"ӧxSΓ2KGlf2ppǏ	App0\';ӧNQ˗/GK\"y6___#7,^wވ^q3:X|9;חpC;&΅\n~(w2TTT2|%Y	\"p4oAaa!EEE6j2)j@@@h4(++fj\n5PSkuNHĪk0uTצPQQ!Cp8ΘomY]4sf#s̜%|\\/_xظK 8s8\\._T\\\\:mD4\"&YYY)\'Y~ȅb[b0_t:,,F`܊\nƙӧuammk׮a:9{N0ݻwh4,p[QBW6\r6\Zա:*++QUU	\'*+eee(-)KKa{EDD8ڴn6m@YE%EE(++C^A|ddd(1\0iiiHIIQNvv6B;+jE=yss硫ׯ_dO>͢555XbS0}b)))ظa0c#OG{L;rX^~iS`%bwedd`tp8h4!!\'D D6!7l \n,ǻO>@OurR]]M!͛Ȁ<{5n\"?x7og}=]r	R\\\\[?ϗfRQQA畔\'N}=]Ӈz>zٙ}V=i3ŋ$.6yO>I|$~}=]bdh@tI||<y-ٶm+-k}=]?cڵDOW~uI2dJ0-}0H```C~:~׏!Fɓ\'8u,162$YYYBWVV[@zƚܽ{\r֒;w8++\rOW1#b\'77W^/DOWO\"_~%!!!dQ˗/bիWeff摾ƆdBDVV162$Ν&]>dذ96!v==]_](,V9z(טڵSk-&}=]gԐիW$OKK#F{nk1cF]K,&O>\'i\\.ŋ	ƍv2axpr%)++l0^?z$[gMM\rr\n1#$$$ڨl6Yb91ӕ(Z\ZPKboҏnK8\ZC6*++ɂ󩇤Ӈ7oވ0kjjȩS\'Iyy9124 W\\^s,(/h\ZD_OIzz:agfgϞ=R޳>E233Imm-qpFmF=G}=]K47\';;WRUU[w^^پ};162$ےTr,(\Zk׮Iփ(<k`s8\Z7;vc굵-A@x;%3\\^m8yTuuu8s4_6SaԩԿ@[[WytE{|yC3˱hg}1xWG[b)=p2nnnS|?͛u6epUcplظ&Ν;ر};Xy>ggJF]ԩ>iB۷pwsFW\\[7rd2vzGPZZʫ=28uEh,F`٠BK?~޽{6WZ	Ė}\r&Q4Cb̀߸q֬pqq1ZG^ݻ7Νg(--Ph@d>|4\Zut`o?X\\<|.\"U\\Aڭ=`ffWp8Ê˰g>k&()+cڵČ8`^ΦPh4\Z\"\"l87LoVpr؈{jj*fϚIiQQ-kiFz:dΜ-Ν;GB[n}=bGbbbHXXkiI\rȰaÄ\"Mٓ\'OY=]H\nzjj*߄|ޘѣ	&\'FDW\'?~ Bs蒒AƌMb]>Tӓ;7ׯs:*{뒱c-ITTHѣ\"^]]MI?c#OzGq_\nKF\r\r]n\n܋l=nN6߽:v!Xh!Õ1@AAvMaŊT׮]fa__?XУ}Xٷoߠ999?ve0336XZԩSѪU+=zG&[RRd9s\Zٯ^\Z~ipgmSSS:u]V^^<dee\\NQyѐ, ;˗<L<zOOMC=:w.#\"ѭ[7SNb\r`ŊxJb2<\033?0m*Oƍ~_ll,V\\A=z`d\n=ox,]N4zġCnn.lr|Ra5XrEڹM64\0ˈq_=mr1ϠީyS/>|p8u;v˗/ѡCxb^EL\0?KN4`:h---oodϯ߫%%%Ǉ{a37tB`ccq044a|7߰	T֭[1|0ׯ_a5+WD!+<uL&~wcQ&T{x=]RRI(,dbj1fX`1,^f͒Zoʕ+@&bɒ%\">+**0lP6;]v\r֮Ng^߳LԠCJJ\n>|x\'.D.x1<99917]z<HII+xU/:E:O۫sh߮ZLH*++bPGnn.޼~/_u>::)DYa޼Kyy95a5WaǏx\"sꝻv|_Z`Q:]2t(b\rӧM9J#2:a/!q)0oʹ[iÇblu.&$bߏ0STUU۷HM}x<MKF9:nYAƯ]4q}\Zu}ðѷo_tMpqn?<AN\\^eeBvBNpua޽bm\r桸S`C[cΝ=K8#Gعob6~wS;ׯq!jcBWWp6\rGE\"uuuMa%Bݰ5`n6GbРApvrQk\'&RSS/_ ;;Ϟ=Ã]4\ZHsа)4Dqu!zuuuFvb(G_ڭ<Κ?> %%%Q^ܨM!سw,,,fcҥTz@ҥKcz*++oBc\'i6_˖		Xd1lhjvAIq1ƌڵ뚼Vxx8!BOnsFAk0AP7n\\.ϟ\'k3lǏo`2ɕ(((@^^>~w#[~tb+++g^ֽ;u\n.]ЩS\'mVzcFѦÇ<:ssÎ;%&8  <<[7{跣8r4PׯcF+Wcb1c@LL<׭nR^^WcI`qi\Zb#F@ee%_۶BQYQMFGEa͘6}:-[.󃫫+~g\'jvaaĜs%Fl6F))s\0\0 \0IDATi\\zUT٫WpUdd<Zk1FaQIee%맾X,QYY\ZՂîHIICVV\nPTTyyy~^NgBgzXxqSN 9}/RTT hop\\\Z4a۷og\Z01c6fXd1bd Ƨ;ҟ>tG\',[ѪU&`j5V\\)rdj6\n߿ǚ5k*+Sskݺuc߇\r\r|Ǐ1w,``	XγEa?3\n\n]Ϟp8 @h\ZRVVyyywavo<~tu})|ٲPx&dddp%TVVbbImlذW#G[n0///q!:޽q*~^{KRRR۷B/BYI	C;E:t PxL\'Nǁ1e4\\Im#\Z(ĠAЪU+1?\n \'-Å֖{tYdNRқ7oЫW&___<MK#Xr(..+8.㋬lǏǖ[DdXFRRt􁴌0m\ZZjA[[ݺu?y[naW}Fþ~]j#kp8UVVYńZ:x\'N9sWT\\2e\n\0ۈ# #+\rMlMTUWW^-n\Zhl	>ߤ\0\\Omm-BCCbйsgn|<444{{_]BJJ\nHMMţ<9}˧\0\\t5k׎z!&4)**5~B>})SnQx`?~@@@\0|}va!L&K-X`ӧO8x`?>~Ɛ!C7ѽ{w<}h۶-u~>n13(mr&7I$x;6NOOǗ<	ᠠ\0#$444cAGѾC&*++Ћp̞=G(\"_ZZ4jՊrcGc\n}k_9tܽ{ݺuH5**R(MѠEIfj̚V<x0n޸Ku:fdd`\r0\r22{d$\'CQQ	9998s0j((++#++^6`K\n -##b̙MFEpt3hl>ҥKApp\0lmmŮthkkCsg?b>ylٲRL&?\'*2p\'.]$:\Zd\Z5t:ͱhb+H~`uE͛)o;[6ƍBs5///Da\'D\0PPPg0t0dee}^\n\0O(U:Owp;mR/[M)xN@dY@QQWWS\'OŋIաS<ٻAAs:jqwc9|ŋ(**B|c5J7ih4ڢ߿c:kaތMSfeeMv	:Gŋq}8;$\ZTر55eaaas/YjR~c<ۼlBff!+VSgM[|!ڪU+w+[c$fqwr\"Ji TNKKXrQvqOBllb\0u5ۈڴi˱wKqizO}*l4H:u\'\'gDGEN(ÆcU* --%KyCY$jjjpMLhS\'O捹ŕVcX\r,>|MpIMvxx\0\ZdJd`s>˱V3h\\\\6{m\r6n$цm\\ܹ˧E`\0`mckkrXf*\"\0O#((aEHO,g/ƊRRRPSS./Y#طo/8eddЦM*\'\'3f004)9j\n\\ϟ?{M6\r7M}NG1\Z\'N(c9С֯߀\Z۶k:j;\\\r---ӧ*F]00\'EjX|9VZҒF48w>ӧOO]]jjj8|\0.^(&chشi#mۆ;w 44Vc-1v֭[Zo-**ʕ+&LkͶԘt:K.Ń>`lܸI✢}ضK,hߡJqh okΝ,X\0=z˭\0DDD`/wlݻp>b2cԨQdddбc!߿.Za*VUUQޯN\0/#}E~~>h4\Z:t v^[\\t	BL\Z_V\\&HKKKمm\nLN6\ruuuK9u={|014Ċ8/Q]/c$@S0tKFEF\"44Ũ={xax=ssNݻwЖ_+))	.c1`2)A0`e***ڵأ公Sձ^gnLs\\$&&@[[c/]\"N<Yd\"66{t\"S$	P/nPg2kK0}ƌ2,]MMrr2NNNXpOsl߱# %%L̞={cO.Z>ƅg.\\KRRRZtx|22~<ٞ|מ?}=]2m4bG/^D֯_/}Ց8bccGCŵ={B9~8!555>!f>ɑĐHbrbdh@?~L!Ç#y5klDHmm-!555Ǉ\ZMNєzH\Z(1~-sgVXXH&OuIN[wȐ<qp\\-rW?3))I\no/w	3mmmu6O\0z\nXZUV+W,ǉ`ff#>F% {۶lYkW\r7oġCvځ` ::\ZjjjHtMMMQt:Ǝz\'$%&`9#44PTT?\Zk޽~:::Enn.\0`1`0ܹ3PRi2[~>qN=}\n\ZXz\rգ]TTBٳg2Ռ6mo訮.1uSuu5>}G`-xH*֬Ċ+ѻw\"//SSS#)1	cƌCi4\ZPfH!-[\0@CCC{\rS\rZJREVf&нG齺\Zvvv8p`?w	|3;gسg#?ys`ȐéSSSSӟBuhjjBUUrW^!::\Z_ٷopu\Z25䊆FF8qLLLVc\\nvE,lq5\\PU\0a!\\.bnP_|gD\r\\.+VX+QT\\JHKKCUUكpqv\0\Z/Za`h7I9YPP3]JF]i?w솜j\r;JHH@dDO>Lgt쨎ok=z 00jjjD׮])u؛	ѯ_?>\ZnnnxANN\\GŜXN&\ZAC:Æ\rϷe+**BVf&Es`JIaE5jD]~~>\"\"q!B0\Z:tr!%-\r---2|ݻXl)llm~(*!!y|0lٲE5K\\IF)++frl\0x\\0+WoN,D(++Ӧ@U+htҀ/>sG\0\\.B?+00GÇǷop06yy~8u$>mLNN\'={[kܿac,m\\.077q**k3\r|,h۶H\0/eرsżh=׭a%1Pfc\\7rnOc6olܰl6BѦukUUCptħOHJLCr\"*ܱӧOz\0LHQ.)++G(**ܮ];cx)DG֭X*\r=s\Zϝ޽{C]]]\"//^£Gs\n:tnGk($ŦMQQ^+Bĺ${{|AATyƌ:Oǂv_;uO\0lmmQ;O)M<x\0ʘ9!{o]˱ֈ,22QQt2kN=B50۷o(//ҥKPQQ	ŋЭ[w/\0:t(|ܻp|/5vr\0sׯԗT1d[nر#Zj%q+?\n˗/x/^ 1)%S\0袥I&a`3tb|˖p꒒dCb}μQba\rpttWldϟǑ#|eåK?xՎ₂B/l6o<m^?l0ҥjZ\n<7n`@AAף}8tR#::\Z;w;v\\ cEmM\ry{::jKѽ{wtDGG{~>7XqqpJ4@ZZZ裣---hhhm۶PUU%a+--$Kl6\"7BII1/@#22#\'	;vT\r\r\Z={6diii*Kĉ8,zNP[WyC___X,ӱh8;\"\"\"볫S3G\',s_M6|ዏɦҺr\0}Ztv[Bu5}3I+ ւ*k+UQT,\"Mv}U,kwUD*(H&-dQ\0s/_LfywK!YJř3g\nGGBq)lٲ\\Ajj*\"##S&m~v~ҊD\"ԭ[͛2\Z5nźP[rrrKHGJTJ23#\'GRR>BNNN*F@\'iУgOFϞ=Ѯ]\nD\",Zٳ\r[۵\rEf3goߣGp\">ka\0@AA^n^~QL>c3ڪ=j\Z<| f-[tR7Ν;0ISG022*]XXfcnB͸c|S\\vL ;;/c.,ɒkU8ܹ3zh߾=5kV)/?~Ѹqods΢6nwʕ+pt^iW|\n\0|B^\'O董004vWU11w,--^~Vk<^ԁu/$CB]=<G⦦bƌHOKsb׮@Xh(\\V`_hK4>F~DEhhh#kiZ܍0KK.shjjm6hѢe^DHH-DvV`ƍ\naӷ,A{x\0\0Ha5u=wJTk׮ښQUFW76oBFܹ\nbE}+<rpe?\n0˗/\\s=%<d+(1gfvv6RSSD#>>			HLL@B|\"Gnee(++C*TTT\n555BUEQ~*5+r襧CMM\rA \'\'ϟUT@CZZ\ZΞ۷A]_NQ޿?~@Fh˗aovJlٲ\\Fk^O\r\reoRHtpss;A\"8x)))Z\Z+VĤP|%4ڵCĻwxXlyˢVrsst9Qtc! \'\'G?+}[3v,.]X%3̝3gtPٳga::j=y+l7j̙vΌy??BWׯ)SyT(](+5nJP?QԣGiSRǏԈ#ݴSB.11ڹsճGwЀzOICI]PsLLx֝bQ?ݴR;w3~5;ǇM25GEFFѣTݩOҟ+=Sς}zS=w|||~eeeQ۷m+@ŋͨDVVHNN:ggܹ/CIcɰ,Ga|SZ~i̘hԨ|1GaqذaOׯ#{EACCzzz֮6C(-$ames nݺcGѡc\'E.]~SRRy&\\p!>r$XZbpM<qߟз_?899#]\Zѣ8u89xxnÇAz\n8YfxVV8{KTKF%KCTRRRG9\ZՃvn8p 455?}cǀdY[`T#::\Zx	c)v򔩰\ZClx=8x\0aѴi3lݶ;w)y%v؁\'O$1}X[۔ypwwǙӧ\n(H!0xxxz\\Qx5lb \nV6>}O\'0vx̝;離˗-+PsEX`!띍\"+Cƍ0(8w,45ʥb:F:\"44#3Z*uO`` 6o,Ԁx]8**\n-[VNzMBTT&N0BRR;/-KQaFe7n`|Sz9AQQ	Æ\r%3ڵkX،.2)jǜ9s]V[jv55)iu&r{_V\'Q{v1?(UVŎ\"^^^c!E!(L86\'$$Ǐ\0js\n+D\"b)ꤥۘo:w#\reV]Æ/sŖ?~g?<h[\Z}7FSm=ML$+dXjuF}	~~~8,TUU{\"dпTkӉݽ+W@$\"[;;6			v\Zcx&eHaMa햒F\ZUU\'7Pn+VԴa2{6b1p`̆vcGEEaӦMw!<(m+2+,6\nhkk\\]7\"}IB[(8^[[eao\0\0 \0IDATdX6m`ooCCClDzzz2EEQӱ|2L1+V@VVs\ZZhMMM?DP`(\n4d)yJڦ}|>\nAmUUUxxz\"#=zzųf£G{.Z~-b>\nWFrFFF:94j\Z	W91G#!!T&޹[hR\\\\FϞ\\-[\"++iii ޿\";8B__&BEE,c7|Yfj}Þ{iRxBC)oݺՖZN\0Ao-U|I\'h߾}&c~س{7=!K`bbR.PRR²eˠ5WP(_.%]`%z00J4=+VRRIdrxHa&%\nCQFbqf͊t5VV)\"K5)+ԣAбzKPbC1Lo\0ڲ@a9FϞC:B$?ziSʪL2T-ܹsJJJmb7o^AyB\"g!f\")tۦ>X,/EX*S9ƉH\'N`)CLwoPI]#\r\0ZZZرcW۷o+\Z\Z\Z$UHg&rlڢ{ւ HNNPRRs-R\Z4h\0kΊ#uѧ|#wŋv3ֳaanN{e,]۶m/uy&$ԯ_K,E=`ccɴRpk1~\nv6002v܉!@{(-_;\Z5%.]xW/r&i­[2t7oL\Z5z4][(-UxxxRԩTTT ?[%TeE՛b5	0gΜq	\0<=pEXZZV腔ƄGFFׯDhִ)jhɡLpEGGd/KVVN8o퀤j-zoeXr%:t޽{ߧOb=%-Yall\\.u=Sb\"\"1֦|>g͂v[r.\Z갱A߾}$I\"<,,`ll\\my@AA;#ٿHMMūWtss U%l̟o@<@oŋA$/^#F@Yd\0kkk2ѣ($\'\'C^^-Z(7BǇ{3\"ޤ#\nAM=0 0x`,;ÇU9$ӧNXz\rƌ\ZeKj\0r2y/A:u0|lBn8JDQP(Ļwoѯ\0ZH_u$hWntA||<.^Ģy%y	.Yfiy2FO^Z͘<y._\\l\0JUY۽;f>}qU\\zW^7kR/ٳgcEݭ;: vݺuѽGtUo955?n,o9׻=e˖xR;?tttk.\\~Nyy{;[hjia\"3ׯ\\9A	]6@HVe#-B\\\\2\'FFX-kFz:b]c[NNNN>|D\r6F\'05OKM7_c*K,\\oFFF+=i$v-\",$\r`޽2dB=ctܸqLj\r>PHWXdq*Rת[͛7Ǌ+ahhvo˔|;dW咲cƌѣM}nݺ¤IF,\0̝gk׮\Z^HJJBPP<#ᄉ1}:k	4]xq 	۵6hc\\WP$)D(\r6\'0쏡PUUexLŋ_~uBB8R坢!9)$Y,#0ݻwS|gΜAt֭?x(|>\n)\n]`0b8m݊b*͚5!C|@4oѢpQ555\\\n.Y(ƈncc0bߍ!\'\'WT_Enn.^|	///24!2upQ{xG@5*`Cf}酧OӸy#RIbqѩ\0&%%AAAT8ԫWqqqPUUex⠬E۷ox).^\0ζtDz={VX{8bWP{{\\xH>	n}\'Iaaap>}\nğ9\0I0g<cǎU^\"--\r_ݻw{dBT6EQ>c^xPPsK̙;;<KW]/$Edd$n߾|pH\'۴ر㠧vq$/߿G11_XH<\r\Z69s1dmϟ?ǜٳ\\o>skLGLӦNPL@\0GRyc\\\0cݺM@WWL-)SӐ#ˈZy8HƍC^\nM<R@<۶mb;н{)pnn.\"\"\"SN\"9)\"s5j4tСC4oޜ50t|o޼?ynZ~ˇGhSa,rqc --I{x#vm\"w0e$Fr߱e\Zt8,:(\nm5ڡڵ+ih@iRKwXDFF˗xp>>\0	r2u\Z\r;|ܸqVkVC( ԯ_/]a!NnX|9܇H$ǜ`aaQnpg@\nZR^YYEN͛CYY\r\ZNOonn.Ґ/_\"22ah\"*]w[WF&رO\naaiw댙ư]իXkcM++B}sɧOΝ;x\'Qp)6\n\nSZZZeK7m\nUUU4lJJJPTTD:u*lV$!\'\'?~@zz:RRRXwP匊:6A@DQUAvJ#^\"##1h<CG\n;]1Gѕ6o°+333}Ϟ=ݻwO\'ːGAAmۊGv&MиQ#4hՃ!_rry\0sX(\"77999BFF22ґ$#&+\"?|@nnn6\05ҢEK4=z􀖖7oN1\'>[ $I:ȑƗQ+c~y!C-[{DFF\"<<!!!x9M/eFv:@!ۊ%QW\nUYߊGy]==t:uB۶mѬYJYYƈT7Xme\rccc5!!!k2yB*/dggQсv00Wr27\"7oZڵk-[iӦhܸq{a|Ӽ>/^06FeffݍG\\*R0555?x?#99bcc1_\"gH(m¶qhպ5ZlxH(+`hڴi逗zbi8uxMQގM6׺\ZMl})noڵ8}T^M,\0K.Ef\n8Es㬬,dff2R\\ $m|ԩ:uP.S^n]ԕ<RSSal<##AQbb۷a<kpYz۷q\ZΙ׍\Z3zT$ݻ7\ZÇѤѣGO>鼹q\n0?]K4l/]U52m(ڵ~1qdV(ܹNpF9Ul9IKQ*JY0rHן>iii8|p\Zk$pUzNH(,Xm{.._ode\nܹsޔ;w}K\0LGŋ+RRRŅ6ťpp	[fmܸ1Q[(\r>|`][bJ\"VZKǎ۷XڬQFEZj*V]==72u*$Y~ӦZFx+sĮnx\r(zBTV5e$mfe[cEPRR	/_f];ׯ;{{C\\rss嵙)=BVzmSRRĈm^z\r455ŹnҤ	6ldN$L߾}1aD:*}~\Z10kDGAׯ	޹sWvu!C`8j42*۶mß0(J$kp5v|\rNN}d7BBBpg?_kk[y</_Jr\"o͛7Xf͚a+@$9#99#68|\Z4uȀd2tҥZ͛͝6sIbccYVCCCkIV<ygN,]\'Ǉwtk6m0sj}\r0H0MܹlhS,-W1ֶ}CXX(GlǏpsscfe6ׯ_yYf<@ U$)¥pکS\'-^XDvv6Gl6ܹs]{MLdY)@\\Օᱟ=g.ttzՈNԺuk;82vvH:3f0^<ʥZKO>a#zڵT8w^|A{՛bn\r722B^y٩a];6lG\'\'R:g\'|#vUC$apiՋ}#ȊrrvfWV֌9(8um߿?ƌK/\0vލX-}=ܼyC2rrr05Ϻvb\'--1yT߿F:lj\Zd֭Cjj*I/YBL\"._@Ud_NfZ\0guPWWg][/_	E&cԹXZK49ºvhNN݄j\rH?d	ecWh(**̕.+=um3v,uNb~űc8bW6#jkժU&WH78Jph2]vbe%H\r6 ##U픗/g.y#ve!\'\'7mb8cǎk͛7|\0ϖ/_*ῊLccnӆV9\'Od];;wk^^2p<{d4Q[pusGQP~}8:8-+$oׯYYfAYE^Ǹv\ZG =c\r6dU;eqꏽtu1ĄƺHƍщmogʘ\ZE} Q0`\0p.][g~YeayhDuYֵS__#\r$%q$}8bW?~sgf.]uD8::2keuH/w77DFF<.]F\'I`T{bge,kmo>>>=6{҅8\0S\n8ئ֪U+3׶7l@zz:Gę>I~dyN?X[ceU-*fffPPPMpֵ~SNq./DFFb/*5FRSSnsUrjtЁc4iѬjlll8rR͏ IX1=z`][9/Ѵ	ީsj_VY:\Z2tҼN\'[=Yd֭Gĝŝ׬Xs	gkkWkx<,_vuܺuum51\r\ZMƍIIIذa=w^u1օ闙-F׮]9-Z`C\'߾}cU;UTT켎uΈiӶo>|8NܩS-CeeCCC8N]X=d:TYx:0m-,,Xkl߶UFGGԯ_cm) I[-S<߿Ϫv|X\'IO\'O8bؼy-lrhiieggݍ؛5tu9Ɩm۶cIIIkj+kxFeؗ/]!M-Zbڴ?YwΝ;!!cOYErL	C뛍:i&Mfv8{,-A`bWASعk7$\"##1h<#n][.x-N̨co鱪O>鼹DEa݌$1cƢ_~:Q,7qdԿ:r+$ttt0}L6Kk>E(\0Xd	Mtʕ+|X[733Y2u*:tD_Dחu7o#,6]ܾ}#v~a3-Z`Icm}+8Vaggܷw^xv6i֯gm;;90B%/KWm7U\'$Ix{o/i>Сp,Ghkkc\"<SW$t҆\rX9bK}oׂy5ktmܸ~Q(UgooqiVQ ܂!{!!!B!mƬee2ݺucl0]X7U)hР:i۶najhanaM[n!}9sXv/0p \r\r9V tuual<}pwgNڔ)SFCv}ϟNHHzei\n.\\@@\03VZ]*LM!!XE\Z\0WlmI>>|222Qp }:U-))	NNL2[{mۖc]%@YY֭gu#>~Ȫv1$\0`_11ϟ?QF9FA2B=ut8JƠA0a:il;Xp!h{n!vVV<==!q4@vXu?~ǘe6V03[yp>ڨ|yNURiľp^m`*$RSS/˪4\\62Lr{{;700@>}qњOhlt\00afgkz,_:aiêFɈΊyrrrdm:x\0/_Ħ(\nvCƳлOVu/^`=Ξ/bHD$kСXY3\"<==l½VeKQc>@\0@ϧ?xx<d~/}]#++72-26,e˖pqGGB$	{@ƍ!Jx ɼ$IBD e>$P(HDB(F\n E\\q;$)NĄ(\n^:uj\nNMMIgEx<@3d(U`R(&_ֺ\r8\r\Zpb	B!p.ـe-X~UD\"Q6+We˖5?燸o(.YևPQܽ)yG6ٙ#5 I[)?׌\0=EQگx6y}U\0\0IDATFQ%y6b}S&O1GG🺻2zˎRR46ƚ5VX\'OURx!򾬘$o\n!\nc.8;331BJ_,}-Пˌؖ(\n38#	9ṕGl8pG첀OA cSi\'X}3J?ߪ\'bAWBD6A1A$b^9v@sjX\\âp5MdfP๹Gԩ\n|_5<D]+ҰAo\Z:u0zn	C6&#GA8h٥^M~	 EDQ `\rA4\0p͟hb3ԷG*>j7WD%uFqh\r@$vx\0uۘlQߞ&\'o\0NA	>(ܳQ^#g$!D6`6*y(\"n>\0\'sK\0(ișUoyxR\ns|\"AmjZPREW(Pp59bk/Aoۚ.2Jn6J\ZHn\0c	\\]e\"y(r-!w%X=aC\n^ɳ#EQF9 |	\"\" d ^ ~Uxـu:s\\Qsd:ut).W)3Z{CEQʡu$+\0\"M+9bRW- ti2h-\"乴z?/HWX&L+7nxee#Gls\0fKBH+EQ\r`+\0~j+JlMJ:F,I4(Z8Z4LJ_||z\0(ʩn((dUCG(@_@Qԧ<FL$cGr~MG	I~Gi2󛫒}\02AQ\Z\0ag^Qc\0eq~Z6bzJt;\0uZI\\n/\r׿U1rĮc!ʎlY+?*zP	.b?K9bWA^)=N9EW!:#GR+љZHjPuy)D@W6S$m(E!hP滟hK3:KޒBм#vd:|^ɾ& ήA\"\0`[Eq 	XHAmekCL X#bج;ƪ5\"mRʒYf/J	34\'\'0K\Z$\'\'\0PR\0XI\r>r\Z5: &jU7\0*M8!W\\Ix A,e&:Kj)\0>\0xg(Fێ*+ÁCGlj G7:+\0\0\0\0IENDB`',NULL),
('nabl_symbol_old',NULL,'PNG\r\n\Z\n\0\0\0\rIHDR\0\0\0\0\0J\0\0\0.mr\0\0DQzTXtRaw profile type exif\0\0xڭm与m_!5Cf=~E̺73뗑\'qD{\0]_rzrmrӟ_~?W]_緑__Pb_5\\%(BυREsXw#e}}???[ow?J/{MOjOt]]ܕn)__g߷}tSXz;~p鼬_j;u{k\"\'/u->qgL{-L>=\n_\Z{6wv34x~2.4^4[\'̂\Z!~\r	_vgwҎf|-,؁C	w:6B-\' w\nӢkj8?s}b#2Tٚ^ذ4l)?9kn緤\\JE{kO͵Z[m=-jkW\'1koM_xG\Zȣ:㝘|feٮJXeV_Sλ0/}ϗկ}{޵pv-߻KkA8;Ww\0˭s̥1}׾ſvro/;??杮Cz\'܏zc_bҿ|`Sm~Tj\nӸ4%19M}C,[Y\nߍk\nov+<_\Zţo/	},r.,7+[Xy]\0M$F\')dcsadU*_jp6ۼ^qb/|^uJk/f}xYrvXx.ڵr_X8x7qO6;~weowe2o}wMaf`	3K]r<[Mi~[W~woWn#k6ʛ{/SAd<355y-HR3\Z|V,ybk%KW.\r[kܻw[mϳ\"7x螧U_Qy]=9\\0+F}9>җ_ϸY	oc>O}+%]zR_%\Z`5Xl[+KZhe^&>c;WWq]aI/˗B	!7p7h+|n㹠vQƬ+?nO\ZGݏ윶}#OW9MEYQCϕUʁ1ŷ	ݼ0J^X/{WY[a(7ޏgpyl<bq#ńUww??\\@ٻ*U;\\}Bu/\nF&;_quqR1XuC<	A3]\0V\r|lRtw.V\"k\0n-ȑg#	ZP!VݼWI\0>+W&y/]:Y@Gxyڹ޽\0k c[t	ာ07\\2xGJ\rWxj[r9#Zzk<+nIg@\'½	#n׾Yύ!\\|8\\aQx狐jhJh	<y6wc!&a/~	.oPg7r<Tġbnx	2cI+>3/w#OO\'] yxV\Z\n0r26z^x\Z^[ZG\"dH0L1x;k[\")?_1ͻ.Ag#8XR!0\'.0m\0)%k a=zx&\ZU;ٞ/ldB,\n\'a,uhC0h&4׾7*D^?n?$8R\'(.>,3ak~|հ;~aA`!hKaW70C_ pW@YO%c)a0cb5cyZ	ە\0{^apFiNXJ\rsޱN\rf=5ea7\"	3\ZXӂw`kO\'a>E\\\0MX<;x.!8ĉ\'{bf`t4+JU\"ټ\ZN63M7s\\E3g`l0R `Ǻe&0jU<yxnQ\"EDM3q|ە0csKDΫ\ZXxO\0w\"1\"i@$\"\'!]2{]ByO6e RG/taOa$rm`ce配냤7^gᝠxbV\"I J%AmQ\"(|B+֔=MvWzI/ax斡*D>(avc_{KfA--\nw\r=xأDiȤa/w\r	:7DG+\\O$\\5m ܀-4_#5Lw\r|\rd7Z`n~I`x8$WXZwn4XZ0\03$/>\Z:O~[s||%bLL_G/{D4-Dxt}\0yǇs{~>w#{\0?,(>\\Ha#	jBjfbJv_Oln]p:[({gnqP(~-G5ߐh#hjM@$\0TE==}\\l9<;A-!۸YM~PN^;\ZR|s.>=಻dJ:CfY>>l1>Pᢇ?tĢ+X׀&I>f4ɺ4)n;X$Xj)\\ťGDb׍x7bjG\nc VJK@1\rUvo $\0hڛ@;b] #_yXBAEz0vI{!1n5#qf@¸YFC_5x4XhsZ+@Ο|G߂j,_P?\';F8m=˨H\rٰ?$\Z1DT*\0<%2_E;N`P@>54TYpCܯI[m!4Jj>-@(dއZwf)BMϜ\rNK -`qnk\rƀd-꠴\rh4/\"Ca\Z0Ucʥ?񭠃@TΫbps\ZIU_Jh3L\Z]Īg8w_+s?<$\\EtQx-ᜈ]PQP\"h1ƂFKmo\\RVfF5E.P#8k)sFA8P߲$~2&ӑl6SV| x)D\"@*{ErQn+b,(B(r\r!rL@Z9d]oIZ  L9r1\0`K:-wFE)̭6A_8֟6:Z	w[Ê^r6&)a+FyƨP80m?صz\"X 2~HNfĄyc(;x#1o`][D\reپ݆#ũo?/\r䚙n}c{55ċ0VuJÕd.	ʗ1g$MTƼx{sGH1|&~[#/	2FMvR-j@wFઘCPԳhgd¶B/4Iͨh5a?Bg2I;d$PlHӰ/CpXBXZA;Y^sʞMaa\"tQ`5BjXоwa\";C\']D$8eQA\07G]c9\rB!;A\09B=h])Π_>%]#w]}sBn҃9vE0~Sl^PE3U;mQc\"* IE?&\'M2:h0_${5#vuRo\Zs\r$|3y\0Dӣ\"x0ߧqiH\'rs!c1+e!`8G(Kxf1>.9\0c}!oI?in^ׯb!O}_ז\n3Bqs=䃿f31S#|ւ{Pr(aDn5>/\"\"s\r?b{xcߨub9@\n^G֑Ӽ:	\rn1az\rAfG3nˌ6l\nҵ>.Ex@8$LeP1wWʅȃ]40m8!Фmȣ<<`ޗǆPXM8&ZX.8A\r$Ao..0`\n%T<H5ފIbRpsS\rձde4 Wl>fԧdXlT1wuafuƆ\\ 9oQ=E,\n Rsd$߈ҋDU	`R5I2\r`vlʡ>(E{\Z=|7^@On̗YL- O\0ya,`9A4PyfϲeV0E\"q7;?K>q|#+=Onl*Â\"zf\rIȳ,t,[D|10x8nP\"9jwp7L#1	?bA#HpA)Xp=Iw|ʵ	VHa,9!?FN\\ܯǘf2`*I|[vĎ0F; !lt_^}[5Ea7p`쁦K	e	\n+	G.׉N9q֓R<^b\'OѰ|/&	%.\0l[`#\0\ryi?ϕee\r(sJ	S\".ytt~V(7~!ʺ#zQ~h[u\"Uf}ovsյr5X^̑BۣST\r`uj	0_qu	$/6޸\ndAL!i{7bx\nawX\nE)P__c`wG/L%8`U Qs\'߿Ӏl6u۬c3B 3~?.EoOj\"~0<Cj<~5ه>+I+l8↑\0ƎL=\Z>hzn%x\Zfiś$mvn_\"R&_#΄z|s.;QKF$N3U`q!EUNӕ봷\"aY*FUr??@@qxV4#&0.ȎOYN6z~VfcC$dI1?͢#5dZ\n`yXiƆћ-\ZFN4\n}sYI&1Î2L7\'^5uCvm,xܘlq2_:}\n!brC;fґ]yqx	vz0{l]\ZC_u@0$McAJFqzIt{JcTD7=c!KTѰGr`?=P0Sw`+KGD!r`@d4rs3sH}5fP\nxVX(P;[y<q+*y\Zj1zuB\095zxHw+-$FT(i?B<EyX=JyWuqe5R17%ыau|;<DFF0=ufgJ\rCRfm@ݗ#t:ШDo2^{R?bкf\\1ciJ-z:\0fR,i\"ty\n8a:,\0f;OU$IT㤩b|`8xQ\"r*\rO3(Ae%p0Q@m>khc6	8YylP.6\nXؒqq佹j\"@s6)5f=l .\nHo\0ԭ_hX\r6ni]*\"ĄBtg`AMw?7kM8HP&WjCbC<1k@t{{\r\\`@N_ɥnM}bႨz!@!1V@5׳~f+x7D(9W(	u̑-AYMǙVɸM]PxERՒuP,0(ukI\'$EʼM.A:XX^Id\0COvC?o\'\0\0`m?}YCT$\"r.fp*z%`\0{;(\"pʍ	;Ƌ2}\0C!Jn@nvpAX=L%jj`6\Znfk	Sb(rۜ6zXQⱶ},O%#_[a\rd@@CH¼v:\n.Ĭ\'e:@z.X\"~YK~:i9(1]#^QֆB09L,dlg%/yNX6n#tUg%?AZ`l,Miq`\\\\wttjYܦzaǦ5PtǾ߂E)`S~KFnN8W{b֬mc.UzL\\ths՚[@67U\"|HAKI1**`\"M}$fzޮ?\rSb؞W%.jeff+vvW7$30)j\n{VZ?[$΋cώ5/\rÛهǌP1;XIW̟&Գ$ۦn (SAVPP`灼,\r7>Ò\'\\YX%Н\"\0ICq½QjtlḬ%ց\nc-XF`Wis\Z݌!<TD?ڒݼKehgu&\nno-1*\rGZ\Z\r,\'#BmH-1r>QΩ!L+\0d$`v_yJ\\\n?VcAXA\r\0)dIZ8$+Ī\\^+ߵ!\0m7F<Ӌ+5d}p	<F~7}Ə@X~᳀`\"x`\\!xFWLibWSĄ4Mp6XU jTœ?t1[!V?|j IsAL7^YY(-EGqDYÜ%x6;~ǳ؆]y\':8|[~X	=\\U2N!+XU`ܩej@\"kTє$ݳ{]~ZzvBaB`]<Z}{b肘0\ZY{YLg=q?z6=1,~܁eOC-0!eoio)\"h!j,q팆7w?Zⵀ(]X\'7\0>w\'Y\nL#7\'\rV%Jœ\"}ʵh><ZqG/6^\'1#\Z{Ws%)k. c{*+0ݎ@c/?eX\r60ZjRV?$b[@Ezݸ~ż@%(=#쳘afQt=єR=}<YMgӌ an\rܜV?)5oLCe<	(Հؔ!8\'؆X6a2{na=Jg%M<hߟ{]0w\"mݿ-<K|&?fjc= {!ڿyA16R `<e-b֊cH	ݖ\0/OeZ٫yfh2ST}\r7$\0Ɋc\"Xpp>YsMd)7RaXL\ZK\'҅_	%	@enϜ<&6dW\riovR&/#|BMCԾ6)bNn@PAf{޳`cVlX]ĩK#bQԼD!V 7Ae?x\"u0{0dٴaM(Pb_.f=6f87Ujť7M3?\ZFbg\rY\rԽ`*`\na~N>b=n	`	C.puc&|1j\rK5NW\'sH\0ͱ_&sp;\'Puۆ\ZJ̥ Rby{OZρ{ͳ~2)A\Z\r;nM]G?1DCllH@KD~lzb&\n]\'@~s>9`y0bo)_C\rMA_1ijv=׼RlhMh&&Fwf[YQIh`Z{]c<w us9&=hz\"J\Zi#<m~0\ZfAދldN/OV_	:-3|_keJò6\ZPhj\ZOdsue:j>ʋ!`Ie9@[1=+@!2jb<A#>14x@]k~[qCWvN*|=O 2}[3Wy7+Vsm^}6(a«X[\"3@r\rC>{,^asߣltkB|1Z_ܧWf5/>^)Fl5s6<H0b_8SP>Y~A70Kt9wX3[~Zjߺw[uue#3!Z=c;SuE}b)<wUCFzYgSXm_{#0y&kܐ,2B^߯o\\Pq	ki@=}hGDqGŧƚ+֖,RFKȶX4T]blpXzUevB1(3=ڈ󳧙Y#ۨB8ۑv|]0ʑ~%[񇅨6eeBCŭ\"dD-;KXjD MsDUav e1X8 x2?Y!,av.0Mi}B@VI5#eí0wY3,^4AaA|{Mj,W uX{Yqf]\'r!Y1cy@xI\'_ѡ*NqbilR@5yуD@D;֪ o%n)}rQk\rQ o7\n]TuVy41L|Շ>l\ZxL\0yin+)UX\0b$4\0/Pg¿,Bcx˸05:\'$mR\r8x%S\nOё 8]0Lײ]kʕp\Z-kc/ AyVC;GT`7mEi\Z1mWTks6jPL0yfYB]!\" L)4&xW_xѳ\\\'PG<=c\nA_qAD@DgЈx_nsdg8)tiv+h\'%\ruMźce<bkNC[y?؊Ykqi$4PfJt(5lna*kAbknVȰhu+h-5M8iIvD2uX2ڤLR&kՍ,yLvA{rDSR`֏أgӓy^.b87</| nmt\"\'py$l5uj8 &<-~Ժbj=~gFBJՓٰ}*\Zgo-AE(AYpC97t[QãXN]IXEh|\r\rs~(|\Z1y@Cϧ^K9NhSݬݞu5<Cëْlˌkv@,&Lf%˘އ4wM\"籑/ZIⰪP.h7PmY`٫:v184cT5D[Z8+2,M$x&7<)Bj_mҍf?qydw~=dVCx*X=,99x] }lm\'!kAv4+!NL׾n!I`QevdeysilJKa[aX~\0r¤ʁ{J|R	ur).!<6!IhM1K(mKV\"G5d^m;7rGoɣW<Eb+9	#l\"b2qm1eO}G+Ze\ro:f$)-_,G{kĪ[,?K	C\'A/+X$!,KXl=:{K|wrw<BL=d|h9%lId\\㱓~1ORd,auXJ6{$\rbhUy~GbFB ;J2\"+6[!BЀ\\ЉelYM-wbբ7#d\"5ϡ*R\\jm̠dF\"%PmIԫA[95E\\A	%65\Z%BZ#3Ɵ>D\\C[L`a	T \';f,}AM{dCxG+]_@͟&^L>hOp\r`9(N7/RgmciZ3PeZ?y&uvA.DcnEɷ؝2N<nxXr\\Nc8fWVŖB#/4	P!}C_lqM[#ci%Yɚy\Zsp`k1(Yi%O=fSGVse\n;`z[m]ǩ<E82|K}f(NGG\\32bjs}Ef`ki\'6zl\"<=Ŭxt؞*MB~0E>#{\ZP~#Pqg~·6k-tQ(NfmmgW_+&&&y u(<D}Ι7$\r;2$%kbbPIbӪx\\\\c,H=ÿ0Qhل )s;|N+d{8\'{(h3uJih00ú`=1VgBkbBlQLJZeGv `,|ϾM&+0p^V<GGY\nkm<0c751vTOe5ۖITPZvU+Ze#9B	*%VO\' ؐh}<\",M!٢߃R(#°&)f#^\"c<QgYK\rwy &s֟X?e+ܦKy	^\\෼\ZA.!G:$u;`	8{OGQ\\~)80;ՊX$ivV򼞚;hoWv|T/8IT6B\n:R$٭X|#V0T\\*$N(sƗ8Au6pZ`kF(1gՊZ`%K{qO6E%WutJ0UJLz\"OP;x2öJ&6+BFmӍbcD<)p*+?YR`|YOTYt3\rspLgճ\Z]7H!n+dsv}vrPwaUn2@ّGඵ8Ί\'>B6JtT׍P{pf{*:RqG ,[!kPaa/£\rHt\'e,5l\r:ǄȢi4PN8Qy=r*m$ӊEc(]Y;\0Z.+~\Z>uIiCm8r5ܨ^\nX\0ogc93%1y9O\"Lbq59^j:vhE1:hawaDq_05ݺ[:a߯XT/\"w xU7rǑ%V7Y̻^с<fKH/:\nF,Ӵ%&1~l!7yG3s`i0m+ˉMژ=񴁀,jlVד#?9dq?$l:G	A&Vπ\rwO1?A?tB-;Ӛ{fzWjȓ]Q-#緅@{\"B\0v	$d{Lbbi:gB{@CX#!UJ[ݞf4@n\n3o9m©FaFzYE7=lFg^ll[lCUi,&My݂CթMaѶ3yz-y&@\0m=Q9luӮd\0j=O61ʏӀljTO=&p8ӝLgjjHbF<q%gýN{	$n72i³:NLpިge؍xTJ.tY{O*u{6$bD#a~ǌnxH=Yb@\"7bЎ9ư&5Zct<;Sc\\~q:Dw|s)XڬL\ZXie\r?8Yqq&49蜻.&T͜:F^oyl(#|̆q٫S!ID>Ŋ(ԭzAfr>a\Z\'x\r\n{8VX[t}akkOoJq.>g\Zc??XsXzprFrkI\ZtmP:ϑ	dQhim?\'ooc	Ho0\rolK^j8,~êTiE9&j&ߔrKٝߎt*{\nv&Bc38촿 )Z\'-<#>ѱW s*#}엿@}q>\n4W>{!Ru?u8G6[<MS]g\r-8YokDv3<	7h[sw=c YI<[\rmX>!ǕOe$](:I~v\"W<`hkfg`WiP@@Srlhm-)PӸWCiޠRl;Ʊ^5ܣ\rzhxXdyL+|yrRQX&TN=GJX(Gu䉯owQv6ȃCLvxOm(8EQknCOЁ-2z-˱9ԑFDD#-Hy1WK;<b[bM+\04Ǒ4CۑDWTVi<F=6\'),9Ӥ)V|bCݼ2 C/7st+7Q]/FzC?|byZ7ot`\rUMXYle>T/Ǩu=~=? F\rܣI7ng2waHeд)bC\0r9@X[:g$6ܿ=pcz\0ub?ɩ8C|>E˵\Zˁ>)hgdT{ڜdSbI6}^%*@?8;1e\"`CYq\0MΡW{.i+}za;qqo\\&	}5ng0ۍ[)?:/_Kz֐lgx)ɎMade{S@˥DZ+!֙%\Z8GTá[! Iۖ~RlG-րW8\"U&9;^yFMGb\ZLɰ:YQ{wm\rexjӅ̓k\0ۼx	?I`;Бz:\rq{gn&wy>d+u]ebEׯP\"vypIpdvfԽi#EH7մ,iSPRyXɾ\'^&[d;~nLy {T9(Io8$7p	t5eTIX@\"q=d7{Zo{PN2z=%~fj DDhhD3[t皩VtϏ@gq-Ql<ub\\ek3	F~PMYD(v)ώ{x6eˎs{Du]s$xR(gVJ7srBMSGIm)#Xg$Aq&( Ei9RSIL@\Z;٥JL?	07BA9lۦ&8\rȮZa?hܩ\ZgQ	[0kS=XϽ67< h^޽5\'S9Jj=/iNDG9nHsK\Zw|2irU9&a˒.\'m۬]<2TjZ3t?ޠT5w`9,0Z!K9<SBS11%6Xl$vf\'8Q;欘j-q`byYIc°ejg0gP6\'g\"Ȟv1OZ8	b ktK\Z,}g~_:Erl\\}	;>D?a5LDDPWiHE~T5iKO5H,[,~WsS̼(jU\Z`>AU;	ݶu%ivS${kt\\/bf]gU5Xô2)h)v4+R7}U3ĞQ<а+@@ס\\/0FB\Z[kΉvwlZ`xޏ)w+EFeJP$̂˦y#[lPu11zNGfͭdb#~Kz\n!42\' sD:w*NL{t$r4BY\0w`}~^sg6E=m(5#`iN7`mzo-\'OF|\nK>P(2+RVq!c_5FI=gzä~\'ɨL&F	@sgRCo3<u|1~K\'`mqY!P:	i.s#©rt˙x\\sT\'&^N/\'~GY$L8W%S=bS;m9|$\ndzL:[9Im[x C(V !3oh)P=9/.d5bn9L=-t;܊PZJ<A9b唪{\0|Hz\0#B,f i;%Pr&CvQö\\O\0n[VxY]jlqf1wn\nwv~VX݂aM5CF1_?\'Bp΄3#B@D<zq7ϊ| d7ixGNcJGE>	0Mv{ռsqgϴWMS@\0*>`^Y쾴>fRs5Y)9{o:pN+cti\Zjǎ*;!~&׉NH\0#ުSV4~@&N(kƒyfU\0ayX\'kGRWs)*U{NAL(_8GbL˽,\Zӥ 鴣\\p]o=\rMݦS(G1\'9v5lA+-+c}lD[s)X%<*|@g:ccx*#y,^f:T#5`pE\\sX@q\Z<E<MXOfJ~EgȀ߀}{ĸGxƢܖ)|cXyJ 9LaoDnH!HFMj<#db,Z4Q#·Xg`K?81Dtipi3\0\0iCCPICC profile\0\0x}=H@_ST ␡:Yq*BZu0GbYWWA\0quqRtZxp܏ww\0Qe5hmfRI1_C$eJR\Z%x?GZgaSy8ʲJ|N<jxƹ3cf63G#Kt0+\Z$q\\tr8k\Zkݓ0ZЗNs),`D(*lO]D.\\0rc\Zd^R4	t80u>v	|L^ok#onkp<)RP,gMyzq\0d\rpp({=77rN9\0\0iTXtXML:com.adobe.xmp\0\0\0\0\0<?xpacket begin=\"﻿\" id=\"W5M0MpCehiHzreSzNTczkc9d\"?>\n<x:xmpmeta xmlns:x=\"adobe:ns:meta/\" x:xmptk=\"XMP Core 4.4.0-Exiv2\">\n <rdf:RDF xmlns:rdf=\"http://www.w3.org/1999/02/22-rdf-syntax-ns#\">\n  <rdf:Description rdf:about=\"\"\n    xmlns:iptcExt=\"http://iptc.org/std/Iptc4xmpExt/2008-02-29/\"\n    xmlns:xmpMM=\"http://ns.adobe.com/xap/1.0/mm/\"\n    xmlns:stEvt=\"http://ns.adobe.com/xap/1.0/sType/ResourceEvent#\"\n    xmlns:plus=\"http://ns.useplus.org/ldf/xmp/1.0/\"\n    xmlns:GIMP=\"http://www.gimp.org/xmp/\"\n    xmlns:dc=\"http://purl.org/dc/elements/1.1/\"\n    xmlns:tiff=\"http://ns.adobe.com/tiff/1.0/\"\n    xmlns:xmp=\"http://ns.adobe.com/xap/1.0/\"\n   xmpMM:DocumentID=\"gimp:docid:gimp:62b9c2c5-63b0-4042-ae44-38deb0c4db21\"\n   xmpMM:InstanceID=\"xmp.iid:764239dc-1631-456c-bf35-7390e91b8b80\"\n   xmpMM:OriginalDocumentID=\"xmp.did:44c3c0f6-69eb-4ed3-901f-baf1f93b67e8\"\n   GIMP:API=\"2.0\"\n   GIMP:Platform=\"Linux\"\n   GIMP:TimeStamp=\"1688899848462183\"\n   GIMP:Version=\"2.10.22\"\n   dc:Format=\"image/png\"\n   tiff:Orientation=\"1\"\n   xmp:CreatorTool=\"GIMP 2.10\">\n   <iptcExt:LocationCreated>\n    <rdf:Bag/>\n   </iptcExt:LocationCreated>\n   <iptcExt:LocationShown>\n    <rdf:Bag/>\n   </iptcExt:LocationShown>\n   <iptcExt:ArtworkOrObject>\n    <rdf:Bag/>\n   </iptcExt:ArtworkOrObject>\n   <iptcExt:RegistryId>\n    <rdf:Bag/>\n   </iptcExt:RegistryId>\n   <xmpMM:History>\n    <rdf:Seq>\n     <rdf:li\n      stEvt:action=\"saved\"\n      stEvt:changed=\"/\"\n      stEvt:instanceID=\"xmp.iid:8ef5fa44-aaa4-4d83-ac73-d9ebc2762956\"\n      stEvt:softwareAgent=\"Gimp 2.10 (Linux)\"\n      stEvt:when=\"+05:30\"/>\n    </rdf:Seq>\n   </xmpMM:History>\n   <plus:ImageSupplier>\n    <rdf:Seq/>\n   </plus:ImageSupplier>\n   <plus:ImageCreator>\n    <rdf:Seq/>\n   </plus:ImageCreator>\n   <plus:CopyrightOwner>\n    <rdf:Seq/>\n   </plus:CopyrightOwner>\n   <plus:Licensor>\n    <rdf:Seq/>\n   </plus:Licensor>\n  </rdf:Description>\n </rdf:RDF>\n</x:xmpmeta>\n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                                                                                                    \n                           \n<?xpacket end=\"w\"?>t)\0\0\0bKGD\0\0\0\0\0\0	pHYs\0\0\0\0od\0\0\0tIME	\n20΃\0\0 \0IDATx]gXTI=3bĈ	52PQŰYv\rs&0k\n3*% 9g&Ѱ;}S]]]uED\"Baa!b1\n\n\n\\\"\'\'yyA^^rssBEEɤ\0\0G\r5kBV-ԭ[Cݺuz~uAڵQV-bO󑙙T$&&\"!!qqqFtTbbTTJ\'%gRZm?uhѢZhMaÆSΏA΄cg%//))Edd$B니0l\0P)U\nUmD<\\.Gݹ3ڵk֭[CSSu1?#ChH|s|R\0a`eSjժ\0dϯV{4DM٫B\r~`wD,#66AAAx<ݑ\0O4XJD.Yh߾=ZiyhҤ	\Z6jK5j@\Z5pffbrrd2H$H$fdfd 55ɈCXh(RSSĊ4lB__]vjժcr\0K/_gVO)r9t\n;tO?f͚G\0׮]jj5\"JQPPddd ))	>|@Dx86]*yD˅\0cǎ1i~\053!%%꧓fDh߾zk׮h׮-7oF\ZkVdff\"11QQQDDf(4>(V>|zΝ;0\00CBBc\\t	ii rŉ\\ܥ\r@ ]h޼y^eLT4i䛯ҟ#HJJBDD|߿S/@.++:M61ah?<ׯ_wJ+sb 1={K.hժj׮]bߠ\rt__G`` ||6[ikRz%\nEmHu?&`o`XJfvܸI>={66mZ{&Mr\\\ZǏejj*?*k̄\\JaI011ǃ؟/x9.99WJGM\r\'[Ob3aÆ_QQQ\rq!?Ɠ\'Op	f%Wz0nxQF?&`W]p}!#=\r2\\d$\"4i=OZZ\Zm݊\0f͚>OMMpܺyS*bXp8hTf͂QhѢŏKll,n߾f+LU֘4y2\r\rѶmoCF-[S-HTT?~瑘W*˱xl7nN/޹c5\nzzz٫N<=֕R_˝ׯ_Ws8\\CѪUܼy{\0]9~D>]v.`hh3R)d2XJII-nݼ\Z\ZظqDϞA*AMM\rchР\Z6lu~w\\Rpuu\04VDeVajjZm`%\'\'س{TN9sǐ!CСCypxC,#88AAȀ%hhh`ʔ)6m\Z\nf*<d&M`%<yD98l6$v292z;@K57oMMMf͚hڴ)444%<<7nq{;ʸ~}\rX-_^z? 2Ϟ=LK\0Ǽy:tڴi͟HKMEBb\"\"\"[7o2@󮩦&x<>ڴidffbyx9c:y?i 33			x͚A&i[0[qD^\rѡChkkM6ܹ7Qtt4p8ٺ`իs>A	\r\r\'p\r@Lܙ3g᷑#?SEpz\nwnfKc\'m\r\rsgaohkkv\ngΞŞݻ7֭̝;B͛7f*x޻ƍ|B!++HMM7\r98ԬY[ӧ#\Zk8yÆǴiѱc`O-dggڵkkGaK\0m6z&Nmmo<鈎~~~`XH17L67cq455իW耆\r<+б#8jl۶\r۵óg`hz\n䃈 H|NuuuQF駟W!B߶mb%bj\nGG\\z8R.ׯX\0]|||`gL53w.3\"66x%_5kB&OZ\Z\\.?mgYصsB.5\0ԫWsvUHOOCY-]%c[Um\r\Z4@\rмy[(R)sذa#\rcǎsdrFٽ..׆;--\rϟǉ:p8[.֮[cc㯒h Px{{ィjԨ1.Z~FF1c&ڷo_fO?F||5\r\Z4\\.GJJJիQXXcǐ6>}((0T\nT;77jjj*&//ѩޏ̙3UhFBnr-7A,C&A*!f9s1iҤ2!?76mڈXUfc?~|VD\"pX,R)N=z]vXb9׀b1TFl >>NDՃL&C\\\\r?wo߂fx\0BݕDI2VBrr2ڶ-[B-LSM55vUl6.իs)022Bǎqbڵ1l0t\rq	&H*޽u)`g9lSSzzz_)))x\r._ \"lݶ\n\"w^~8mǍW5i2JcNT1118lk.¸OWfy)WZ8ڴiǏ\"0bR.Wz|V()0~8dda[;\n@\'@__)-Z`%/ރ@He2d2DFcOL8?u4vpp0oߎo^3tsl2=\\AAq]\\pt\0͆@ -[ѽ{wlRakk.ܽsC[[l...ػ\Z^^^cm\0~ة޽}<ސH$QDL	\'I(	ww4MMMp,Zjݻ)))HJJ7q񱱱HOÞA(ptt5!1qdSN_dagg+W.c_6⩗V^_]_.rH%NWt%G/~|w><.;ƌM>Õ/((Q#GHHO<!T|M֯\']~k.qu(77WGǥL{I$1c=}Ts#G);;[;nݺz\ZP?qc*Cud$A\"P`` %K7o7oސD\"b;4q\"	<fy\\tMvXпzʂΟ;7&NE6\ns:xx8u>|hQA\"55X\Zu]1eT\\WWW3Y;u555ddd(-[\0AnnIMM\r۶mRKKxyy &:\Z.]BJJ29?{cL0RRRp3fΚjjjҥtN:a|	׮^PWٳgǾ=vϟ#G +ٳg\Z),,,,̕/}\\>Gb1=~&LO\"0a<=~bu>SAAA\"WByyy^\"=^zp銄_ft22GB|-^߻Gta@y	tڵOQ@@@׬Yz4hrwKF$=]\Z5}\"\"CJ޴iS)\"\"_b+ŘN%!iŊ_%I&tQQ={ΙL(D߻G\"ze\'>>|\\d)001+iiiΝ;ӕ+/_Th\"x2ftuXX銄t%ڷoѦMTn{LFIW$h8Zl)	ʦ^$e0ߙ2555XY-͛VeI@@\0&OڋBRx{?ܹs0ox)m߁K._~eA\"յg(.0|gVF J\Z[\r\r\r*qJi\ncȉЬYjaHHBC0m29;HA)nXr^1fp1$%%UwCVZamXl9}\\\\)߃k]PP`J \"}QL674?#T*˗/ʆX,\Z4hLܻwnnnxR8f\r0}L8;_-3$,,[nšCpeHccck֭>}ŋ\nL}BddTsĉP݊p8ԑV%III8w&M6WyՠA7nsp-0ƕ+W]ձrJ^|\0VuuuXXXCT*Ö͛q!;--HXj?-h^ɓ\'sRKK	WO}6W<yG/-t+$],YB\nm\\]]T{銄qI(-[J)))*߿?銄`RΝ;LJnnn͇mmiџ5999MO}ٳgIO$Jbr\n+R߾}ӓ\n6FY滇+yͅ|XBaglܸqx`e^O0\ZF\Z-[TT֭6mڠuHOOQQQu	8P555฽=|X.s`j:Exܽ`\Z41+5j{#GR2u555XWoCab2XYܦMԮS[fX,ѽ{wp8j\"ԬYJH$5kBOO˖ZBY3lْ	]MNNҥ04I&Uj;{n̛\0saaa8{4>|@.]Tzl6{{CCCCUnFпddd ,4ax\"61$+W+WVd?>ݽ{WAHH˗/YfH䥽~\Z(00P}(##9/ݼy3-\\@4%&Qhi&ڸq\r8D>xBo^zE!!Cyyyte2ѝBׯttΚ5\\R3ґ#GH(+8Ն\\eGݻ1quH(iݻ$\nW/zJ+dj:lCOWH>OLL$OԳД)Sh)D+k24M\"!:q\\NKK#G\"x\\quH_OݕodD|tEB5k)(	)x++WP\'WwPQ!o߾sJD3cC022l\'ܩS\'aŋɏo#1hIey1b$aԩ:ԪUذa_<@cc;999Xr,,,d 4$,#GBFfFFAFF:._t̞=&>-uDGƙʊ\Z6l%1Jsrr0~X;\0@Ycc&ٰ*y ]|ڵsvv&=]={L/|.ݻwJu	\r_{RPPfjcػ툣#:tܶ>}Jz\"z*OE$OOjU_FzfLƜ!Y,ԙrv~~>/^>8fgLZVW`	UrQŋWW7[2{*D\"X,V+**BQQQq[	]\r5kf͚UҟkN2++Liv5bUhƎA:upy/^`խֳb򤉟X,:]6|77oAfCA8qdԩSfg.tС܂KlXl<uZeXڵ\Z_r9$$$ >.񈍋Ç1H+]U/y$mּ9~\rZkiAKKs5CƍQ~B\nXBDhl<kB6m܀*%WSSC\n6c4,]F*K|>.]ƌӐ0u={Bwba	chԨ1N<Կyyy`X*;??ÛWpmhiiNdd$ƘD*B:u\ZӦOǯŋ!))			?^zlRj;%~\Z\Z\Z֭;t\\hwꄟ۶EfͪH$*W)ڵ/8`u֭㻈1qd,_\\w>|زe+90uW444ӧOCvV&rb%t0qxŌiӠaC>}@\\r^OCsp\\L4I4663g@6?eJpuuWѹsg\Z45kĺu된kׁV;멨		7o	\"f@\0 R\r^E@\"8>rvY`\0ȉо}64H$6[RCfQ^=Püy\\mۂꂍ6lmW6,,S,,>:uE̸)`a)HNNbkRj\'r;{{;tbhڴ)p.nJQ)Sx*oO>cG0zҾ?22_Y,ѪUzn׮~\r455ѨqchhhnݺUաƘrR+6ҐpOYS=ztuЮ]RZ?԰z/~W ׯ1}T\0SŮcF+Xp?t̟?~~Y,.\\t6Q\\.3gp~m\'Ob}SRR0ׁ0ҥ&Ecp8l۾U7:w\\aܢ\"yBg/=X.g^骃ڡUhT\r\Z4@:uٕ9Jd/	x{?g*N*C-(ҡWY###a>y2uþ}7n<ղe\r\r;1xj9&}#γl޴	bGTuA\r/{\0-RJVx	]E]\Zڵ>3`.Ij-[/}hѢ\Z6lU%ԩMMMD\"AVV___<y		r9(^zc޽%tttD~~,--@aRC\0\0 \0IDAT077/\'Nukz*\'y^x<8y\n3gL\\^L-[`_	[r9 -}\r~/bC[[[a]]]n\Zhn\rsss͛אIeVm07X>K.#((wVB.3łL.C:::rrr\0xyy*׳X,g͚A&&ܹgy?z%KabK[X(|qcǂaWjSSS?jjjoXĲʴ<Ev)Xl7/ṕݻv2jjjؼe+FU77W=rl6Ӧπ\"\"\"`{1;s}HH&#رcG݅x\r^;o1fзot-Z|W.\"DDɓǸrG!U\0\0\"Z}\n{pm|QQV\\=qC9Xp!޼~VЕÎ;*TFij\Z?7*|jH$mVϣ;w(\0늄JH+ŋt?XL=YfrE8T֭[E5//(99\"\"\"(--͛kz1	(rӫĤRIHH7nЂ}싒xk!GsQI3Udff>~8ҍne&$HRڸq#\n	*B\r{W+MѣJtȳP\Z88Fau_u(IZѯWtYؽZ 33cI֊R)|||p)x{?\\&c3ѯ_?tС,JUѣ>VZiaܹ000H\0HZH͛cHKKÞ={DFQQ^x---hjjnݺն$d2=ą\n66zaiֽ{XXbi򚴴47_#))	YU1vX%oqca2x6lP%D\"Mr2q^͎	0}42%`E=浞8q6q0z]6|}}q)xx+A.]`nn^zU{VVkz\Zq6m\Z\r4aCV0ppum*_!capqu&n\Zt2SSSS9{!!JOlԩSBdbDFEL fddoC=LZprr®1t(֮[W%\'Xvv6wg|.]\'	W\'Zؽ{zy1puuuWY,K+B\0eK!ati\\q=֯[Ijjja`+Vb޼yxj_\" 992yf1w!j%~mR,f!\'\'9-,,իW!o߾ųg JѶm[#h6m`޼hԨjժѲh3gNz^4im۶Ŏۑ!++N:uc0>_ԴT$%%1V\\^LfpoҤ	^nL7o ?/FFjjpI ,,ӫBSWWGp@qto߾_ߗmW|}}lU$\"\"lmmSEN...LnݻUG@S/Χ)S,ÇU3иqhq|*3hy\\U5  <nTJdl^ArrrG ޽{O666\nfׯ_3f(;C/^0<󛜜*wAA=x,Kx\\ruur_\'rfΘA(55y$ϗܹC\"*ٳgJI-+F	J_[r9҅hŊd8,oV Z`IUa2ܹSi\'Tff&smhh(	|\\#P0L8/\"sss	Uf7nܠӦ1DPXXHvs(!!DB{fmdkcIH,Sn$(...]Jnݪѭ[dJepB\nMYbBCC	<˗.>\\={V>LvYYY4jH>V\\SbɩR\ZXL/^P*#T=}J{OԩS4hЯKDDvvrJ%ԩSŋ($8ilӓ<.~$hٴvZڸq#ؐT*%K9{<==H(QLLGIwKY4wtCSۈ4yd\"XL|W$>>bcc+]2\'--Μ9_B$EVﲞ\'00)}oggGz*+/DBVVH<.3\\*AaalK~Uxe>UqDEE᯿£6r$M^R!CpY&\nF\ZUG8b\0tƒ%KpmNRZ;u;v0ׯ_.\0rl[nõk`oo:us۬,DFF0)\0+\Zd\0qN??_s.hӦ\ro>\\-Zs.\Z7n\Z\ZpuuQ(m<}/VFUNPɨ[Ν;M^ZZZ_	soA.#$8Xdɿgc}EuPy4OOCQ߾}{UvZZd1c~޿R)H(`LZ28Q(3V\\.2_BrrrŅ]璗CqqqBcFy`vEcǌdtPULX*\'\ZVY<*4ɛׯI$ӀUU1bpchX8\nm*|q`ao\"踽}ڒdm6ꦯDZ5%77lll:%;vTp0::<.9rL۷og˷lBz\Z;cR\')++hquHQJJ\neddPW/YzTEi۶m*ȑ\nΪ#/||H$СÇ2\\TT޽zќٳs1<ҷH]{˖-4eEԕȅH_WDNNNlҼy\\%<<<*}||<]|ܹrҭ\\)i{XLWʊ<]2+9ٳi`\"\"%Wr9ݻח\n\n\n]zW.r6>,X`TE>}J\"!3M_,X@!!!;quHW$$k=Ug~~>M<yG;v	.,(޽l¾}~SɉӖ-[h)͙=[۷o^\\~(%`{)|:^iHpp099]8###i޼?Y>KU>+$sj.d2h	|x\":p\0\n+Uwk_L\"gΙ/*KKNK{vvv2OB呉	=zTi{tĉo<LFRRg\\|\r{͛7JGG>Z\"!=]]x.]Z,^c1Gz*=RwXv-$\"M6^TΜ9Tquh\nV)ݱd!\"]W95333g@VVfϙ۶vڰ?wUK.a-Lc	޿cj#..C+u/0\0\0󒨾\\dee!==HOGVv23BqH5PK]jFÆ\r@\Z5n&Qhܸ1\Z4hz}VZ۷oꆨHW ))	Xx.]-̔bwww,[j䴗T[G			p8eVd*+2220bp1˗@NNΙ\0?ݬt6XAAfΜ	!1+	1*O\\T8y4B!1<dfc1\\^X/~IchѢ%8P󇇇ÐXfeVZḽ=<yܹp8(((AqVGtt4Bwo 33\"Ri>P隆h_\Z6lv:m۶hٲ=\'O(33<y:t1bĈ*-~~~Xx#1555,sO^-$Jaog@XR%a[[hٲ%bbb0b0p<=vɓ&*etJXnb?|`̝[fӸx6oeH4551q8`x}.H`kc;c9zefH$ܺu˖-q\r:kNBhiiʕ+HOdsj=D\"s\\x;vl/N8{/_DTd\n.EWW^^n.kJV,#:2^ݻprr\r7\"//5j@ݺuMdg~HfkL0Uf͚a\n\nBRb\"He2W			\\h|AJmDDF\'b:TݺԩD^*7͚5D\"۷o#1!&&&Mw\'O`Ӛ5k[U>nٌigFuQ&9Tի.**piP:l)39w^k/{@(i0hg,]߼AnNlVlLС޳E^nnq\\cil68l6XY\0yjĄ_~ \"šaÆh|2^r\\/\n\nQVm4hРJQ	!ɪɭ###$&&!\"<oQ 3I+\ro.Ϊĉkb1ll!C,f̜Ō5k{cׯ_&\rkTqqҵk)\rQT-԰}0`@)((k@vvv9tl6W:WX\"`߾}p8&NƢEʤfo`)r*υ03CE׮]pgzURRRKܼy>`TL&Co>ԩZBf҆\r\";;Ǐ,Ĵ5{F\\Ą$%\'ÇXӧ ~Fajj\n}}JgݿgϞAXԪ]vvJYYiii{.ЧOѣ9o>8]pTܲ2-\"ュ1;{f#>jtsu`ӡغuB#\"L:͛5Ǯݻ+޽VVJ`XjK/ׯ#5%af44죲h^\\\\!ѬY34mThի!&\"\\zmmX(*,_Gݺ\\\rmj>}͟_);.VZqcb(3>L67=V^]>\r	;>jvڣ!~$P9iñ\Z|QZq8:8`Ϟ\03f(R)ą͌GiPSSY믃бcr߻ׯ`mmYBK?#ׯԩS,Tvm,[kӧ J!JqiԨQ,4z聉\'~͚^A*b0h	*U\00Ϟ~TpuuT/b\'&&bЯÁ&ApuqÁLVL._Cڵ1yD3k׮Uy\\oq\\-Z~PWWGQ^=hhh^z5kVuvvv8lk\0Y?PiIR`lll/$	f͚^z1|iiiiHHH6j֬YQ/|}}쌫W.3JՐ0A۷/\\.*QXXgggڹKa1e3DQDEEa-u&\r2ּ<?X,UQ1caȑxb3ݺ\nl6l27n*bT*a[[88/sfΜYiKtYXjq\'Ѷm[7 A&hܸ}===sdCMM\r7oݮIɓ<<Uյdc|m۶UL22G\"?>zR)==(44WO\Z=ڌ233+\04ɡH$pR}ʍfғ\'OcccIW$$OO*]F)S|͝3_F111U:w)\"\"\\!rKsz4\n|JՍdM׮]ٳg3LѺkUa\'߿\'>TPP@fff\nxH$w^K.Uy\nqEEFFhҥt=ya*͛0Wau/<@ }\Z7IR>|@\'O˭{1s	\rJq;vT\nٳ3\Z1|8͛7޼yCDDwܡׯWvޭ\nWlmm߿12n޼I\"Ν=[!U;,,NV-[\r7J?:tH]>uͿ|I4}STTD[nUHU|P,ի$I(|.\\ }==|{Ν\nmߺutE22LP	4|Pf=<<O\\^hybŊJǯ?}&ODb6lXOR4\'\'wT$ɠATDڰa͚9,UI瑕ղJD4p@~v\ň)((<y2/7c,??~/a-/4fh(h9\'իV)X,ӧQ##ήt<xP[{v6PLPiիI(3rhџRbb\"EDD0f*O:z4`&ǥӧ>dlܟƎCG\"Tׯi\nBɀ:p ]~	TQlP*tV <i\"jٜܪzHzz:9;;\0cc%](9c%IIIb\nF(<z1͟?>YXff&M2x\\24M*$77Ο?O\"|HHNr4M2\rsǏ7RT+PH,Rfk>3gP_,3G,Ӂuk۶xJ;;;UK>+U/##<HgϢR9VGCVVV՚\\iiityt>ɖaNeVoTJ			Hcǌ9gM<Ξ9SsǓQ??\Z)߿	ƓmVrb|^)Nc{U%`(,iȐ4eʕ \"\"-[Jz\"s2)*	V<T̗Ȟݻi͚ՔL4o<\Z7nbz-yJҔ)S7%	%w\08q]\n4~Xjբ9V*&&vܩDX(hԩ:Jf͚I|BCB(%%<nd	^	WϣTz#]땻H$C\Z`lL\"!-nzq*m>zU$vvǪ<ȏ>$=]\r#H֭[LSݻw<9MJ:g>??5׮X,&OO\n\'u3B\0\0 \0IDATjJ63lf|:s͝3[5@)r9:H:]T{.޿>QF*x\\*-E.3>oҘ1iΜtNHHH5ww9!K+ٔAvɒ%+qƒ7d2rtt$=]=y}ua;v\0;%%t<S,N<~۷RrqFѴiS+ulI|WرP\\\\	<%#YZZV\ntR4%α#GTxW\n	ӥR_ЪVwhQ3VQr	| =]*D/0\'WGQ||鄄:x 銄$Ed#7\'Lz\ZPn%	ccc}=rʧRXq7WW<xI6}\r\ZT37o฽\npw@\rYf]q3Rx<(BZqbʕ֫W!!x}E\Z5@D8zK.冂nڴ	W.;1Ul6\Z7nbԨQ.*J3gNc͚ٳ̭o\'-ZѨQv؎֮&xiUwPǏd{5bbbWn+W@Y33EEE9Cxb%t|>|}$^DEEaP99\Z\Z\Z*pM̜1޽ŜscN)Ϛ5k⧟\r7t]aT^=sr}x|deCf4ϫW&тd zYZZ<.9:8TxܓDO\'O={Ty{BruuGhh3\Z`lL\'OWGFF*B>ZZV޺u+9;_GVVׯ^јfԥ6TK/V:;fL(88rssiRK\ZlbR=h4)CHAd2=}~mJ%])S,haPV.V-i#ʪZNnztefі-[HWTǏW+((H),&KLF631/_Poٲ\\\\\\\024	;VmE\"vl]SpgeeqYj9K߾%==&N@֭VGURHHH̤5kVUF񤾞n+ordP/XD-h8z%z(,,L	)S,H$H(={vSHb1M6M nme^	ڸq#h릯GӦMTأ/atss\"m~qcǐwғt)iwH|ϟY\\Rv9hqlGK/.sJJ\n]x\\yfYfVhyHH.]ӹ.ia4eEӧO%KW*B`)fff_RѸq$HW$k۷o+t\\tyyWyMzCbƌC7owTڼ}z/ Q:v]{ek/k`tM:$9#䘐}s]{33~5mgkS/ (Mm\ZNV&ET袢Bzuts3ܬ9mmeI[[Y3fL)/޽KKKKi7ݻ>ޡ5p:I#%mn2(y!!!\rÆk֬=C-]TTTn#FVgjJҊ6bbb褤$w.//ummeIwhO$!UO߿:thBڧf@Z~~>mkc]g^>&&FRλj ?aѮ-mĐv>\nǭh:mĈB,0a?UP$ޱ\\wNNݵKg:33r+Wh{;;*)]+0EѧO;:3CvҽtuׅM\rʴfR4NN\nݿw\'\rnXp!RRRĈ޾񅫫\08ѣG]@ vڃI	3LIpqqeFJ===,^SL۷Byy9,Y[lKMMŴS87oֶQgA l6[TtWXxfΘ4H\"WTT6Tp\r=s|UxCCC<{Xx1N:	k1j(`EXh1kK>}0dPyt׮]#Gp!yg_``x`Bŗ/_:	(\n^^^(++7d}=Lhquw|	lܸ{ѣpybuMŋ@@UU?`\0X[[KMEDEEbcΜz;A7n8ŋe8lmm1MyyyXd1JKK&\\3P΢i\ZZZZp88vFW[֭ׯCKKjjjR ?\\.Qmii)܅Xl\n\n\n$FDD3XXXhٲ%TC9w<M*>=\'%%aοp-8===͛1$\0пx<xyzuf͚m;ӣQՙǾp>$]$/Y*6>¦MbՌm֬3!  \0vv Yl=7m۶rx7mڄbaŪpR011C`J[{IŐJ4⚗T\"IΆ72Щ&\n.T,_\\.N6M49{iرgOx3[aAзo_oվ}{زe3N?cO	ӦNH=PSW fdNvB[nԩQC-::\Z&&ة˗/a!rуh\Z kʼ뼼<f!\\ϟ=EQ\nЬ	DZWlڴ	8p\0t통kV#33s!8(f&9rc}||.Zj˗˜y	O1u_q.EWWW:.]WWܿw吝ϟW<yPQQ(iT7uˏ8	Vr|~NᕗaAPWWǫ׾	8sL\rhʼ;5cXa޽L~aäpջ؟64Mr]\Zx{K^UHj>I;f,eʢA@lw---œ\'И?P6Ȉz9,Ǽt2|i4Maعs\'~GsLE$RH0g͛o\n㣣a5\\C9H\0e6f\rx|=s\ZO>8V]]6oEu5zzz>c<^/keLqQTWW{!!!:uXYAAÐS]JM4)p%֤&FxU1Jq~׈Yuu5;f`+)\'XYZ7jjjy\00񮭭C.mѺ\04m{fY,<<Ȋ*\0s#\\])&<}Gp8\nInn1s5Jrr$$$Ho@+S/o޽ѡC&cV^(i_ѱ؟)))s5ϫ?n,rrrcF\Z\0x\\Ah\Z_VLkŽw+Wbw\r+WƬY%\01 @y*fZ3G*`VV{|fffhڬ)6o͕z2FfaHiK,OAw,[S&OFbbL->`(wc3RUU̙3ԫ7chƦMP^^.޽;ځC`Ȑԩ͛6͛7RYӧOiiȑYMMMǽpi\\n52ormۢ	?xp_;.3\"&&,fpFElƑ>u=$,2֚$	;tB.]v	?TUUm;вeKXYYAOO_\"t\"b>f66Mmm]Vf.Mp\Z\r-nC,2s`E9s&c-++p9p\\ٵ\r&pWur+++cݺu\rAII	(§H\\|g;I&x	JKKѬY38x`?C[nRtn`kk0j1\r8Ҟ[k.tuuannkkkL8\'O)Sb6&FM۪\'kELLz)sûu,SNNݻѣ1` _Af\'ŋF$O.ӋbaX`!`ee+V`ٲ3g.Ə/w8yC:bw>|pucȑ#zΟ]]]TWWύ0~8|b5FCIIII%e*޿\'c	ׯ/^zYo6m1#1jjjǑc=aѣGRp0}t\ZEʕ\rDECC+WSAFNN^|x$&#))ItуF4o8t-.Ñ\00jwޓ9!\Z\ZO>%%%022,,,\":Č oW^ג~\rmێ={JMyy9&M/L{Y1|W^#rfב(p#,--abb\"??~bbc((,3\r\rFkeX8}i\\.߾}CLL}<5AII	ӧS-Zsgɮ,-qEGؼe+JJJp-޽iii6ARAee%w1!C&kKnn.bcbKx{\"ol,\\X.6~޻w_o^4&\'\')J<xH*5\0hfffPSS\0_T߿9iӤ~j<QQQhݺݻw#00Νy{{#c-0yd-11BGGeeeb=<|p4M}=ZlSm}\r;bZXXBH4Hy 	B0LRuuucƆѡCך6m\Z^<P/{.~7BII	x9Ν;Jp8VXEESMÆuk\rRB׸q\Z,\\̛\0={DVm6xyzbĉ\Z)MMM:׼@Qrs\"RP?	Bj\"kRG]/OOA	@K[GjlAQv܉x899޽{k>rNNN֭Ԣtd6#4Ob(**&ϛ+fyDRxxpWtVVVltbi^	 \'\'џ?CH<yD81D*}֯VXm8lٺ\r...^6l܈ٳf2|vlLhm֬2-؏+W))tJsڜ|\\t	SLkGqq1bcc\\tl%%vډ\'3%#4׮1ӧOu+6EQx.!{N Y,L4IB\rGXh(nܼ	3fŋ?o.<}&3VxX,7\n\n\npY\\pyprr¶;`aa|\Z\Z\\*f@4c/ϫ	>EMvibг<xeK \'Oсs/7ËϱnjDEFbBu\rF[7ҥKXz5޾y8|ܛ.&o\nN?Ƹ2ؿq1,@2mkk???hF@@\0ƍ\'\\o|}Ts.\nFJq\rE,^Æ1#I4hlmYY\0(W˚6xǏ9cN8rXo܄h>:w, (MHj\\f?l63gƊ+Xc!3dIEElm`ff\00oa˗`0iHv55R+KaekO	Bq~;?X]vzzz6w}|J\Z#ze⩩LIprvnpƔxDGG3q}ТE׮1&uM8@,VZMnݺ	\0UO,]\\\"n?` \n G!I[hպ\rMKBl6V^#>>i\n{۷/-3g.߸:Ǐ:e2\\\"MLLl\nq.\\3۷qU9}\ZΟXшj\Z={2522BjQPTUUlܸDkKQQ\"##q 77߾}k3urvfBJ$ŚL$;&&\'Qo#F,ٳ\':w޽q}?7KR_>O0^>\\]]e6֢\'N{(tvv6EQ8vLMMqY0?x-o>79з_?͖i888o̞زy֬^4X777h0;l|-7!44**\rCXX\rm$H߯N<iiix6\'z9;a8?j~IK JWl&i.*R^^*8K \nǱ޽v0uK^*Vap\"nSpp0Ə˗.ACSGî{)J5kr㵟%--\ra``;v`\n\rou4-[p)㍎OI4TTTM8s<\r\rqu:oktttp\"ƫi\Z^^^rqq͛tr1c \'\'L(\0:vȄEr?kELF`ͪ}LC/pIgrgDpwm:2$$$ +3qG#л3>/_`СsQ?cD<zF0`;<M80\0wňnK(o~\rȢi\Zg\\Mf~)B} qYXXX0\0|UUݧO 0\rcǎbO 9Yzǈ#pyrvB&Ybdd$\Z,Ap\\x7oSOL:֬]^K._&P\0|]R333 ]vOXbn0(9z7vzt#!!Af{$1s,Vrr2/_[6(lٺ_\\/\0\rrS߻u8~Odf{`6q<\\xikUdRW@Znci!;={g{vWǏdd|Kǌp\"X,٢ٯo_1w<Ç:7\"\"kV­70yT<7<}\'N`ܸqh߾\rtԩR@P!ץk\ZpFII؆@\0R~+A\Z?}T\r888`ƍxwALLƌ%;??/]dNII	g˗p>wn7n3ļE*侉T~~1]=s7\0\0 \0IDATwGn beV̛7O\" p۷B\0A#Ю)_hrpኅ`ٌC4M\"fYkk1wuza8wcٲepvvq%<$LE4,	ʗ/_pe7ڢJOOg;IСä6\nddd`M̋сs^صk7^ZX,Ld8x\0xFYy9_[oFn+-t>Q/ϫB֭q	6zU$IBYYgΞcBiHyj}4-\0vV\\.PD*eURRoL:U^ڶm+622A{1N\Z666\nUUNECKĞ.όeTVVFl۶w3^QTbcc] =111033CrrDՖfUUU#11s{all/`u\rM>}BSKKF55U\ZP(ؼy3<%b`kg[Ȭ>EDDF\ZAKUOn\Zyyy\"/{wJvڡ&M/G 8;; $1ߞ)Dh%pBT +/++CDx8fΚݨ,44TLVnXX(TTU>\r]:w={\Z\"ڒ 4BpPP\rѣ=ɯkVV\rr)وl۾Fl6G#Gd\0gOt*i]ֻ[Si\Z~~̦UUUmx6~1nx<zN,\r(FXX迮ڰP\nHJ؀P]ذ@HtXVPP\06]/C\"RZZ\n_LCF3.u~~><^ś~ jv\0x̞]^(i\Z>GPP tutmv7QZx лOo*Qo;!V-q1͝j1dXd	&L({oHZyy9{1khh`_;س\'󠬬>mNص{7\r\rbYjjFM0\Z___,ZQ=Ԇ|+K\rEQ())FAA;\';-Z(߾ilݲk֬իW_A7\ZKz%%*++3Ӄ.w%KܵKmhhh;;{b݆\rbj2{ՖΝ;o&ۏ)S֩Ե1\nE~܉Jcaa!P4}Dfۻwo&5!毖-[¾\02jݠ, KA4\rpٽ́Wt\rK.燤$׻E߄fҤf***R\ra\0~`\0c_0¢A[EkE8|0GV($\"IMUO<4x@Ь\Z-ZDǎǨ(p\\4 \nr	:x..8?^|!vLڋ Kj{ge+ѣiZ4Q *((;a˖-x(**Bvv6RSS\0z,fa8:Zj>}Hj}{vCнGXYYnxtgK tԉ~\rVZ6ݨ-lջ7l|	;wX]]][fffzYMY7l{CCxXhQyy94nW/4bbby<.\\\0\Zm$ܴ޾֭[3e8t{\0q\04q[M݃@~e^BYQQƺ@$8`dd0ʞ4!88\'ö;?~Ce?ÇǷow׎+W%C gaaMMMYwҿ\0<qB{L!z[\rMSSSXLfI1G!2gϞ5X,0-d@UUyo>Şc6nƨByy9TTT,166|>h§ϟ@Q?^,$*::4\ZxHJNb[-x***@D`,--1x`,X\0/^[?Hb\"ԇҳX,hiicƌP겲21@ifLcOGTTT훷#٢u6\rb(\noR(4h.]==}wL,֮[K)rR@jɤOjy\"䏎7oJA__ǎCѷOo\r7nܨCt`+DȌCyhݺ\r㭤$ぬ@Jr2P[l#iYYC}-D\0UULgee-z1z\r{;:ׯ_ÑvYݧ7YYY׸oN=P`SB{NW==ѭ{X,3qAyfB7[ʵV[|BI-VUMilۺpe<}^װm1^VV H9RUUOOO{\nZl<obb\"*rACPִYSnTx2N>۷o˗bbbW25y$;;H\\+i(Z۷oUO/,Z׼p!$66bAtgFuR^طoFB3Sܺ}G*<٭B#BpDx8ڴmÆŵinn.||߇a\0cccXYYa_|#MZjŬMF2ۻ[fxnZ;+**.//aF\nDII	@ӈ/\"As4([y`ҤI\"bBMe:Xv3!;vD>1klxrݧ߻wI5t-[DzzB<O>S̀7yEKKk׮EYYܵȵ%>>>oPGzcƌœǏE,t	64\rMM-^cYFYSш)/>*ɬ]\0\r62k[Xg \\x	5;FPVVb;8!888$Z+&_~E\0555mg!bR\ZIpt\'_d񩪪o~8y-?~bAȆ\\S(ϟ?oo\n/Ep$`ee3ߚiDС<==8,_y\r}1o+3#A(G^~>233kz#b@*.joeee`pOy\nAQ	#iUbgd|#|R|,Z\0`imڂЬiSbAkqm$jCAA\Z-.PkpEQq\Zf̘64nhaaaxz٨DACMM҂=\"#\"jh\"QVV\0$Ib͘1c:ˬ6W2-ad4@?(ؠU˖ѽ;\r\r-7P-åi*!uuz-h7[]]tEғ${\"+3YYYH$}w1);	ZhE\"33޿!C\ZUϞ=];wD$c1bAjBjj*7q\"/Y6rhhh2%	߿e\0LMMq|$IYfc5556o4[or2+AUUUXb9<̅TTT%%%18%5x\Zb:\\RRv6KU-IVV6Zj]ocZZ\Zw_ee%\0K}\\.%%%hۮڊP$S%ժ!MKui\0;ƷQ cu񆖖OEڵkpqu)Z?4\r555p\\l߾\r!k.&{\n\\.:2Vfff\"ߜDQQX^j墊\n̑^SԕUUU2Oƒ%K(|KOǤIU)..b\".>R|ajb&M]]]@SSXd1N!sbXlRS2wx=/!CTWWŵb Э[7<{r\0;Y\Z?=NTI &&\Z\\>8W44<ض}`M|\Zz(B&FkFT>}3Zb?b㪧TfX022bhrQQQ!@UU׼<QRR-[\"3#bzzz IUUU֕W}yE6ffHKKûwg?،0cƌz),x⺺z2ᬯhV+a++Kp8$%!*2]\ZPL!T#}(\0e>Gŋ~N===b7o>XC_UUU؈\\C_k6mۇ}/\\l߱AbiӺjq7ƌrL,*<+f\\\rVJ}+<a\\䪪*LZZuӲ>h|%Q9gii)Z\n}RQQb033*W!wff&֮Y\'OC[[żƐI0ۍ\"Ǐ54\rUUU|쯡\0޹k+roPRReeefo\\{\rLٳqf,&ZZ8&\\9M6x	Ǒh蠰CIII,[\\dqq	cjAC\n/}}}4om۶[d!xnݺׯ^!11_|ARRt0AN[Tvc\'gA;뺅Ǽz#S7zCKKK\Z\rX,G2o|Ν1n(\no߾Őq۷oɦ\"&	\nLLLp7FqmGuu56ȓ`p8[RR3;BPS\nTWWI(gD`` Zl	;wwn$\r6H_ZZ*VK.]\"!!^OoݻǎjTYkX,L<LЦiݺ5nܸׯ8]]]c6O!7%UFF>~u558::MM(--̟@Td,X\0eMuĠ;YkR./_@PQQEQA\'CUU%(-+EyY9JPTT,$)W?IPQQeT@EEEEa&x@.Yhc6mĈ\\.4\0P@ºmD:t\0I(..LZT^\n_.X,/Qj6Xl/m͙3=z8e6k.:q8\"\"#{nkgQk<\ZZ$Z2UVTJ(pé׸q8)u1dl(\nPSW[?AG[\02kjiqhhh\";+~\ndPGRQ^vUUn*j~nݺؘX@EE**PVQT:q8PVQ%%%$	fڮG]PVVжm[\Z\Zbӧ.]\"QfffeeepSN@mذa=rrr~ـ!trtw<GŃc_bIR		\rQq[3IRr}\r$(	j.eeeƒUIlP$q9<|eeelXfEu/$6!zOU`sEVQl(Q`䋡4ME Y,\'dy$	p<<yL eO^^\\Cuu5ڴi{vg%%K]na߾p=DFF\";;[%>}\Z5V͆sޘ;wAcܹ3N:OFee%/^l\'ՙb@]]ݻX	\0a7Sך--m¶|s\rs`Xb\0>XǡU022e+s<:1c0f8}#WC}K׮x1rss777fӋê+Ȥ%\Z[Y$	\Z֭0hE{ׯ6nX>p8x\"\"##k1fCWW={Ju2H[;bR}s\Z%/x\\\0\'%Hތ>&Oڂ?&L+\ZҔLo܌aW77YF掦qoBzں$& ̿u&lބ\"\Z\ZzQ`ԩh޼9f1x`ʕ+z|Q	A000@tt4Ə5k\0}(4(v/k)KII	p	555CEE2[	0KRZ!G	lUEx\\[f0\"9|cǍ3)((ٳg1sL\\EH3l\"\"\"PUUmJXmeef-//w\'o޼9455QQQpdffc8{ԠVB&XaA]6m+VwBbBB[o---TWWcU+\ZUUUPRk/ZT5aa99f2[L +RBLH\\vUUU54EP\n\'賬C!&&Zb\'\'\'&E\0t10vh4732G>>PRb*f%ѫw<;f4~\nY̍$A I+F_ݻܹs<Ш0[7o}p0JKJ\n\'gg7VSS}Á\Zuŵ$G	HIIσyJ(Ыě(=\'[KSK+ӲX,p8NӦM\nI\r\"66#Go~&}S{&moPMM-&yhtG!\'\'痠l6vXd?REGGӦMCnp+ekltC;,bZڝШ2c`PUUuȁdggx$idHQ\\-(q	hjjXTWW+TUUqGC,VZ1e_ƊKUO>A\\\Zb`PgF\r\0 }\"BaAX`5UT^,apuuUxB]4CO?ƍE(OB>>\ri\r=*vn=BXX(SNCCC5}frx<f#Ib\"CUUUNNNƶm	¡C$ ;;A2s-K\n~Ųa>~1;/_0iK*v2SyhgZnM0Yl6Kᔠ4f1xoR~ˑ!FtwG$,H~FxE*	H5ij%MUU\r,	TTTp	.x&fH--h5\rXd)wP\\8gϜaSF%6͛###/TTTv1ׁ1nx&qww	6oބwcny%1bbɒ5|x!\n+$obmw?\"s&[lFA~!P	з7\0\0 \0IDATFDnо}zgN5z;11mbϫ7TϺC{\\x\'aann.DQ%ZZ`,bDGGcƤ뇾a9e\Z544XRA72HP̬,,kݺ523,V z¬Y0|\n?\r$$,ĄIĉ*UX,kkkxyyܙE.YXܹ3Zjco\\k8p\0E>}p:\n=ڬ&`\\!Ik[%1idYfr!ZZ`n=>y6k&HN^<\ZRVZݺIܸ\n6GF\r\"y]baȐ!z*̙%%%>Jbp;bHKKǏz$IhfLo1w_2\Z\Zb4hΝ;Ǐ(9޽\nDJJJw^mW\\YY8h0ta)2dJ$3ojRS#fx<rskk묦&ؚZZbMd砪\nb;Wbb\"ށ(,YgΞcoq-L0A*Jljj0TЉʔ)Sv\Z8tdc\r4˗f\n\'1gȶmۢm۶9r$233H\\DEETU???_8L1Ca_XOIPUUqaaaGǞСܖ>\"޺u$::\Z:tgN`y2<;6br#ۉ갦&\Z\Z\Zbvyҭ{wĉ?~<HDHHܸ^׮ŋ8ufΘfìysB_ORĄq-HRU%=Q[[/[V*+(BB|\n\n\n\Z-6@GG7_R~\no}_rK>\\aNNNƆukk>i[lE$IVŋ8x`?ʰwn	GL񋢓i}(ѧOr073|:!Plq` _>|8?~˗.s~Em-[vΞ\0t˗>՚F+ólNϟ?#))	\r۷%%n\\\\<fb\nE#mŧ\n+Jzz:x5Dcǰ}ǎFddd-%KM6066~pP]?X`!QTX7o|\"]VVIXsYuuubϜFSFׯ70@f1a\Z4yyPSWXjԎ/83fؿo/\"\"\"n:ͣM6b}			\r\"ޯKpa\rIJJz!(~\nw\r]@T333ٳWa7:fLmC;==SLƺ1zhTUUa1XI=:\'\'GKPSSuuݍƷo.$1mtIu\r\r\rѾCĘ/e+DD3:u3\ZL޼ysBi6\"-))ukрwh8M#6&F||lD|>w}|p̙F;ghh\Z\rѸ\\.̟Çĉ\r\rK%			bbO._MMm>Oϟ?b&%	*5\0||.B)h^!UTTж]ۚ^0#.<z>k(^iFTd̚4)ajŵ[4iL۷o$\Z*\\.{5f60 #\"<_Ey<N?o;_}d%Ĭ_zz:\\.V\\T̘>\r+Aycs3GU[,۷/ZnٳfcXd1\\\\Sy*** ╶2Hs)(|>N>}SQT444БԱ*ʕ+5mڈS\Zq88ŸHNNnyYcTi27\'G!$77_\rD{MR+E$IٹX1PDD\r\Z~cȐ!0q\"?xXֹa}(vǎ+@JkepipLQÑהּY=0\rQZƌz(ߑ \\~Zjme%vOlm<1p@ܼq/^b:v(g7;}\'*P\Z\0M^7ys0u\r5R~ 88m\n\0W;w0p CMMӷo@B6˗/$\08cȐ4i:t\0CC#ݓY\r3j@QĺCsX^^B --			GxXXM0\09kB6mۊ]R<3п\0CGG-Z\0łzu-,,TcL4l???l޴Q;~jHIILR\'zozzJ=b!$i&:bA:B.Z>O\"/7VV077ǤM$\nD?*2\nVrٵsoliȞ;x\07H@dT=}R-&&xpsкu+P&8q˼-Z0<N±GsW6L泓Ȅ1\'_nx/,,+q1ۤ$$\'\'1kڿttu7oaslR	\rp)$$Yhm 33)))hҤDU]yy9bb]M6J/ܘ.zÉrx\rx<_cmaĉh302j===#bcc@Qޏ\\XX!8(/]ʬѷ_?<}Bu|Yf*O*FDDD5g(\n>}Ď۱u6=*$i?.2:Q肂y\0r6uڵk7o\"??鈍Aȇܿw=}{A$FZn\rSSSfwr=ob-^h(ـ12{A+++㍧O֎Kƍ\rsə,))ׯ\"s]qq_Q^^:;99+V,C`eeԔIE]7n(>YTTU+WXdMPXXXo5//x	L`E\ZR\\~|~]lXN0kW̚5]v7MMM䜜zٝ\'+lܹ3&N\"dff\"11;A\0raԤ	&GE1)ғ = \n]TT#99{%K0tP;tDvv6tuu*28}4|쨨(牋(رƎ]eeer&M>j4.Qk̭[ӧ/Zm$Uqin5>˫ސ\'\"\">vx<wa:\\x	7nނ3<fb^YWٓtieɖTDV(.K,KdR\"QBiofSo|~z{~;qqGg?A*amm\r6^r\n\"\"w/uE<L,Do߼\'uD͇Brرc;vZܥ_~\'tXzz:N8BW=&A*)))hi鰵ƂK-7,VVy%b;LaAu=&	6JEEE(..FII	P^^^/PXM44\rӧO;&?\rq8l֢\Z`X(--EII	JJJ(f.Xϊ\niEc8vѫW/8;`T`Sfw_$МÇPt邡Ct:Fb=o2@\rBFmڭ[70ӧOҭ[WHII/CÍTTT`t9{ɱcȐHJJEZ	%F믿rjkk)R:TVV@__\Z\rܸqnn6SciprrFiI	JJKPZR22Wb\nUUUQNói<2N%\0^g7~ͥ1|6lV٠~!%%ECNNJJPTRTTTVкukDDD 90ydo߾[Tم ;;[`ݵM񹹹H\r_ai${{h={cǎM999`K<jFF3ckjj/_u\ZMhFd̤Bϟ#=9TT1g\\`t<-,,|/	z0$ٳ&O1yyy`6j)**\n˖-kFFFԘwќ50`VUUbee(SR\\%(+-U=\\.AFFP\nYzBZZ\Zʔ2UUU(++CUE***PTR\n\099yʊSϝ;KETʿZdψAe&Z`0pvqzOO?pZC7ae5MK>}t\ZZ\"ӗ 2*\Z999x1Μ9H\0*&N1vہ`W\'%Dc\rָm۵k%\'\'%VRSSj=z􀆆&$kn|w.((((Hu\"ccj4K߸kIڿ}UUUv>lݺO<S6;Hwd]vmA\ZAv$zBCdb[ii())iXTToߴȱkk_u^z/_B^^C?gL...(((022SJ\nSRpCD$שMFAQ\nၼz\ni))p\\b1Err2v.Vyee%\Zi\ZLh>	 ##xJKKWܹ;wM}&gLǎQPX#	\\\Z-pf}bkjjЈʵCnnرc%n۶-,pB<\Z0!ſ\Ze,L&JKK񸾁_Ԣm\0011jZUt:ہ3UUU67ۘ|X,0=FF~e{0uu޽-&$\n)@}H\"//=z;wDB=<u\Z+WwaHJLq$}_\Z<،{Z?4\ZM WTTġhۮw`9r$]\\`0x\\\Z̞=ܹ3CJJ\nLz(L&hxċmǏAPQ6###~J@\'.]Э[L6f\\k٣gO*-Sd2%DdG<~!XBB0~-n޼	\r\r\rںYqFbtXcvUUUGf-,[e^^j#,,C/!2*\Z!!~QI*ȟ\r\Z\r\r\r͓A0o444T޹sg!<zSNpuwj9sZH33<>}ʧ;d:##;vѷoZԠ_~!͌琗`33\'ӧ0G`00@ޯ_?DEGe&<׮!bcc)},QإP>߭KNѾ}{HK%B,5z=~{7]***ѣ\'vԡ}}	9|p:ҝ;wQsΛxDx9ҟ=Jf|vŋֵ&ZYAVV>EF;Ф荁Lf\"d00`ӑ5222=ztag~_ItҤI|)--ϟ48tOĚի(>^|S--Jܻ.njLĚBxpp-FPy$k/23&~7oh4ڎ~`.!^|q̇[;ӡCZS9m\Zܿ-tCCCn-qMOjVTRRTڵkq8r?ںǸIDnJdbz2T||<\r0\r:޽;&4W{l$\'\'c˖-puuŦMqeŋx5lllĊrss97ʯG\Z-Wt?%=uu@ё-{p,^\'Ml҉ZQĥЋ\"ǲ2,]3AWW7nUUUk9F\0?~<:tTi\Z^,o`\0Y<|֩S\'SbwBʄn-A޽%\rCy:\\x\rXJ˸w!%%%uDm۵]5`Æ\rCtT	lw 5uX52:C׿÷0%zҥuyŋ8t\r+#+3[ePRR3aj:W]:t\0a%%%%x_Ol6^6L& //&UGG_~-˳i4ׅے-Ά,--U>|-``\'_fJJ\n]A=#}z\nÇ\rEiI	EOԔݼq4stt͓+Ѹq3fffppp@gMMhhhޕz&=ŖHE\\B΅8ov-Fl>(px)CdD8AG2\'NB+\"ÝQFzeee1e\nxp8\\t.`ffq`4:||v331Bihqќo%.l\0Rc{1A3`,h>v5:/WajjOrq)\n		طi\"!MOW^!2\"׬033Ǜ7B`ԨQb]G$\\plXZNF,	Ν[_ؿCxymزe3Zns]r9\rS\0D\r\0pI!\"2\nAAA,\rQ~c˗/Ptt@ѐ|-x=}ޘzJ\0pȾEuJ\nt:\rᡡHIG-l.wwwHVV22طo/ҨCGGG)[n>a0>Q$2/ 0\nl:p ***p)|EEEylPXaI<t:FڽG~\nPa\Z$%%Jn\Z.x!G!X0.c!B.\\D@@\0/X=`=i=\Zw.G-[={6*++!--g\'\'xxxݻ|UWWnF!9;wl~_MJJ\nRSQWWG6mڠvOdY,J|bWWW	oЍK{y\ZiiiE\03ٻ={FƩg0IF.JKKqA\nixb\0LܿmBT_bqƎaC38iؚd?_\ndݻu۶Ԏx	W~\0\0 \0IDAT%:Zb61`8tco$K9sѫW/qw)ݻ7QBPXnnM}BvlߎukL5455QFa${\\.V,_d	dd{K$ͳM4{o|ꢅ`Xl6ZH\"|>~4۷oXd1pLȑ#cԿ1edؿhݺ5\0/Mbi߼qe%%Tk?u.za\Z!%ń>&L/\"<2\ns]`͊pJ4t쨎]\n\"lllqMJ={FgVSmD\"@mc3nܸN{w¢~j31~())ANNIJJ¡CuV*hXp!ܿO-[\'0h_A[[%ToϳUt:>|@:߿\'1pFO.N=Ah*++iqj݃rrrؼy܉Î`0ל8{6\ZGGG_!&\ZRSԩSX|)G]Iеk׮h׮\\^xFd66MMz9_8.n.xw\Z9r$?Oo\n`_*j5ujX,jz) cǎPTTǏؼy3-ZmժvY;r4HKKj8 %%->::رH0OX(*+	\Z\"n8q\\߇,Qy#Łp~\nt:vC3`iiYfp@\00^k6O@EEuZ؎TEE#pqĉx\"۽^	rʱl?v#F]:u/7<\\T۶}{*xA<ӑ r^\"UjAp8ѣG>fG|}.*p88w,Ν;\'uYYYddd6?\rsG9vkD({uu5y\0\n\n	YYY]\0Μ>Td2뷛᪫n-#ХKfrssosh4\Z\\\\\\$۷/6oނ͛3OaT,_>J=;Jk;u@/lIT	9{Af8tPMnn.7oĖ\rx}gpf#00nsp	L6\rai9h\\l`\\ڵ+zoMmLg8rT(jggw`2hp8?υO\0zTtXXC}_&yڿFdC0t0MO;vlq*Be0prv{Ժwwwwܸ5kVM,?3fLGTT6n\033sq6\'O&M.L+DEEJDK䄲J1[k>˖7IД9::rq9\"Uh~p5ҥKpXsk1BOYfil6^^Zedd`cc)nˤ	=5L&m!9s&\'˅\"ǾWr}\n3RRRz\n_\n)pnURR;aݚŶm[ީIRΟN?g	3~СL)EElܰprvKa#22E*:T8̧$@N8<|˖.t?W77^\'\'\':VYKxs\\ڵS$9`\0hhh\'ׯ_0zHX[[B)oL&/_-sZ@VV|D٫6:w,g2Xtue˖aa\"ZZZ͆-ͯl6R<A֭ajj;wӓb(,[/}x%n݊[$\\r2Eرc\'_sD⚲2Fz-7oCp	FC߾7MĒDӟaҤX0\r%az܌4{l	ڕ\Z\\~%YBBBh\0^F˘2e\n޿ooo̝;|!6oI|νsx\r,=z@=ߦ	&o2f7T8Qcѣgj@JJo߾Żw8,]ϩ4ŦMӍØ5\'OdI8zbT\0<FLݺD\r Wu+5.tLoiv\n`)Xsg%i<?=\0{{{r֭k(ivE]#-pǉ\'лwo<~&hk\'O۷{nGUUvo~|νu<yҘ1eee|]<F%\ZPSS=PVQzB&h=zeee|`10;w$܎`^ÇgyۿY,n:_Off&.\\\0MիV	8}4tO飨Ξ	kd_]vF}iŒxDQII	nSDF7[׷ܾ[$zܯ	̙aYظk׮ѣw^\\\0Zn\r?04Ϲ݃ÇK.hFh4o`}ߦCӡ&tll8z(t:gq\\R#M;$\'dPl\rNffn]v	teٳuԣgO}{QZZ#G\nU\0il\"QQScgggcvoDD#^_&߽{;qpus{$99uYbĪwX[[#9j8{,F,(F=3f]\r7@Qp\\?}a9;733\Z51a4ȸP1@555ooo޸v=W\0hiiAA^aѢPVV䠤i,!@IJIIA^^27:yA[zꅗ/_BNN4\Z\rmڴD:W.y)VUU~᯿݃E^[[KD]]***PSS*ee,T\nyyEtj51Z\'OuijjR-={өZ֘={vNF\Zu!)17lkBBr1~[SS3O󵷊[˱{<DE?Oıs=>\'n\Z۷}l631ih,^R\")gϞT^///iρfR5F8\n8CiE`0@!--\r:^O+\riAJJ\nJ< /:0Z4ˮ*nڴ{;6edJ,Vy*G]]-X娫FUU\\.jkkp@\\Աr9r	 d,+礥!//666pvq$;;hu&d\"$$VƉu=|۷ٯ\\|\"cg\'ĭF,nF`Z+\'\'/c\"ӧxSΓ2KGlf2ppǏ	App0\';ӧNQ˗/GK\"y6___#7,^wވ^q3:X|9;חpC;&΅\n~(w2TTT2|%Y	\"p4oAaa!EEE6j2)j@@@h4(++fj\n5PSkuNHĪk0uTצPQQ!Cp8ΘomY]4sf#s̜%|\\/_xظK 8s8\\._T\\\\:mD4\"&YYY)\'Y~ȅb[b0_t:,,F`܊\nƙӧuammk׮a:9{N0ݻwh4,p[QBW6\r6\Zա:*++QUU	\'*+eee(-)KKa{EDD8ڴn6m@YE%EE(++C^A|ddd(1\0iiiHIIQNvv6B;+jE=yss硫ׯ_dO>͢555XbS0}b)))ظa0c#OG{L;rX^~iS`%bwedd`tp8h4!!\'D D6!7l \n,ǻO>@OurR]]M!͛Ȁ<{5n\"?x7og}=]r	R\\\\[?ϗfRQQA畔\'N}=]Ӈz>zٙ}V=i3ŋ$.6yO>I|$~}=]bdh@tI||<y-ٶm+-k}=]?cڵDOW~uI2dJ0-}0H```C~:~׏!Fɓ\'8u,162$YYYBWVV[@zƚܽ{\r֒;w8++\rOW1#b\'77W^/DOWO\"_~%!!!dQ˗/bիWeff摾ƆdBDVV162$Ν&]>dذ96!v==]_](,V9z(טڵSk-&}=]gԐիW$OKK#F{nk1cF]K,&O>\'i\\.ŋ	ƍv2axpr%)++l0^?z$[gMM\rr\n1#$$$ڨl6Yb91ӕ(Z\ZPKboҏnK8\ZC6*++ɂ󩇤Ӈ7oވ0kjjȩS\'Iyy9124 W\\^s,(/h\ZD_OIzz:agfgϞ=R޳>E233Imm-qpFmF=G}=]K47\';;WRUU[w^^پ};162$ےTr,(\Zk׮Iփ(<k`s8\Z7;vc굵-A@x;%3\\^m8yTuuu8s4_6SaԩԿ@[[WytE{|yC3˱hg}1xWG[b)=p2nnnS|?͛u6epUcplظ&Ν;ر};Xy>ggJF]ԩ>iB۷pwsFW\\[7rd2vzGPZZʫ=28uEh,F`٠BK?~޽{6WZ	Ė}\r&Q4Cb̀߸q֬pqq1ZG^ݻ7Νg(--Ph@d>|4\Zut`o?X\\<|.\"U\\Aڭ=`ffWp8Ê˰g>k&()+cڵČ8`^ΦPh4\Z\"\"l87LoVpr؈{jj*fϚIiQQ-kiFz:dΜ-Ν;GB[n}=bGbbbHXXkiI\rȰaÄ\"Mٓ\'OY=]H\nzjj*߄|ޘѣ	&\'FDW\'?~ Bs蒒AƌMb]>Tӓ;7ׯs:*{뒱c-ITTHѣ\"^]]MI?c#OzGq_\nKF\r\r]n\n܋l=nN6߽:v!Xh!Õ1@AAvMaŊT׮]fa__?XУ}Xٷoߠ999?ve0336XZԩSѪU+=zG&[RRd9s\Zٯ^\Z~ipgmSSS:u]V^^<dee\\NQyѐ, ;˗<L<zOOMC=:w.#\"ѭ[7SNb\r`ŊxJb2<\033?0m*Oƍ~_ll,V\\A=z`d\n=ox,]N4zġCnn.lr|Ra5XrEڹM64\0ˈq_=mr1ϠީyS/>|p8u;v˗/ѡCxb^EL\0?KN4`:h---oodϯ߫%%%Ǉ{a37tB`ccq044a|7߰	T֭[1|0ׯ_a5+WD!+<uL&~wcQ&T{x=]RRI(,dbj1fX`1,^f͒Zoʕ+@&bɒ%\">+**0lP6;]v\r֮Ng^߳LԠCJJ\n>|x\'.D.x1<99917]z<HII+xU/:E:O۫sh߮ZLH*++bPGnn.޼~/_u>::)DYa޼Kyy95a5WaǏx\"sꝻv|_Z`Q:]2t(b\rӧM9J#2:a/!q)0oʹ[iÇblu.&$bߏ0STUU۷HM}x<MKF9:nYAƯ]4q}\Zu}ðѷo_tMpqn?<AN\\^eeBvBNpua޽bm\r桸S`C[cΝ=K8#Gعob6~wS;ׯq!jcBWWp6\rGE\"uuuMa%Bݰ5`n6GbРApvrQk\'&RSS/_ ;;Ϟ=Ã]4\ZHsа)4Dqu!zuuuFvb(G_ڭ<Κ?> %%%Q^ܨM!سw,,,fcҥTz@ҥKcz*++oBc\'i6_˖		Xd1lhjvAIq1ƌڵ뚼Vxx8!BOnsFAk0AP7n\\.ϟ\'k3lǏo`2ɕ(((@^^>~w#[~tb+++g^ֽ;u\n.]ЩS\'mVzcFѦÇ<:ssÎ;%&8  <<[7{跣8r4PׯcF+Wcb1c@LL<׭nR^^WcI`qi\Zb#F@ee%_۶BQYQMFGEa͘6}:-[.󃫫+~g\'jvaaĜs%Fl6F))s\0\0 \0IDATi\\zUT٫WpUdd<Zk1FaQIee%맾X,QYY\ZՂîHIICVV\nPTTyyy~^NgBgzXxqSN 9}/RTT hop\\\Z4a۷og\Z01c6fXd1bd Ƨ;ҟ>tG\',[ѪU&`j5V\\)rdj6\n߿ǚ5k*+Sskݺuc߇\r\r|Ǐ1w,``	XγEa?3\n\n]Ϟp8 @h\ZRVVyyywavo<~tu})|ٲPx&dddp%TVVbbImlذW#G[n0///q!:޽q*~^{KRRR۷B/BYI	C;E:t PxL\'Nǁ1e4\\Im#\Z(ĠAЪU+1?\n \'-Å֖{tYdNRқ7oЫW&___<MK#Xr(..+8.㋬lǏǖ[DdXFRRt􁴌0m\ZZjA[[ݺu?y[naW}Fþ~]j#kp8UVVYńZ:x\'N9sWT\\2e\n\0ۈ# #+\rMlMTUWW^-n\Zhl	>ߤ\0\\Omm-BCCbйsgn|<444{{_]BJJ\nHMMţ<9}˧\0\\t5k׎z!&4)**5~B>})SnQx`?~@@@\0|}va!L&K-X`ӧO8x`?>~Ɛ!C7ѽ{w<}h۶-u~>n13(mr&7I$x;6NOOǗ<	ᠠ\0#$444cAGѾC&*++Ћp̞=G(\"_ZZ4jՊrcGc\n}k_9tܽ{ݺuH5**R(MѠEIfj̚V<x0n޸Ku:fdd`\r0\r22{d$\'CQQ	9998s0j((++#++^6`K\n -##b̙MFEpt3hl>ҥKApp\0lmmŮthkkCsg?b>ylٲRL&?\'*2p\'.]$:\Zd\Z5t:ͱhb+H~`uE͛)o;[6ƍBs5///Da\'D\0PPPg0t0dee}^\n\0O(U:Owp;mR/[M)xN@dY@QQWWS\'OŋIաS<ٻAAs:jqwc9|ŋ(**B|c5J7ih4ڢ߿c:kaތMSfeeMv	:Gŋq}8;$\ZTر55eaaas/YjR~c<ۼlBff!+VSgM[|!ڪU+w+[c$fqwr\"Ji TNKKXrQvqOBllb\0u5ۈڴi˱wKqizO}*l4H:u\'\'gDGEN(ÆcU* --%KyCY$jjjpMLhS\'O捹ŕVcX\r,>|MpIMvxx\0\ZdJd`s>˱V3h\\\\6{m\r6n$цm\\ܹ˧E`\0`mckkrXf*\"\0O#((aEHO,g/ƊRRRPSS./Y#طo/8eddЦM*\'\'3f004)9j\n\\ϟ?{M6\r7M}NG1\Z\'N(c9С֯߀\Z۶k:j;\\\r---ӧ*F]00\'EjX|9VZҒF48w>ӧOO]]jjj8|\0.^(&chشi#mۆ;w 44Vc-1v֭[Zo-**ʕ+&LkͶԘt:K.Ń>`lܸI✢}ضK,hߡJqh okΝ,X\0=z˭\0DDD`/wlݻp>b2cԨQdddбc!߿.Za*VUUQޯN\0/#}E~~>h4\Z:t v^[\\t	BL\Z_V\\&HKKKمm\nLN6\ruuuK9u={|014Ċ8/Q]/c$@S0tKFEF\"44Ũ={xax=ssNݻwЖ_+))	.c1`2)A0`e***ڵأ公Sձ^gnLs\\$&&@[[c/]\"N<Yd\"66{t\"S$	P/nPg2kK0}ƌ2,]MMrr2NNNXpOsl߱# %%L̞={cO.Z>ƅg.\\KRRRZtx|22~<ٞ|מ?}=]2m4bG/^D֯_/}Ց8bccGCŵ={B9~8!555>!f>ɑĐHbrbdh@?~L!Ç#y5klDHmm-!555Ǉ\ZMNєzH\Z(1~-sgVXXH&OuIN[wȐ<qp\\-rW?3))I\no/w	3mmmu6O\0z\nXZUV+W,ǉ`ff#>F% {۶lYkW\r7oġCvځ` ::\ZjjjHtMMMQt:Ǝz\'$%&`9#44PTT?\Zk޽~:::Enn.\0`1`0ܹ3PRi2[~>qN=}\n\ZXz\rգ]TTBٳg2Ռ6mo訮.1uSuu5>}G`-xH*֬Ċ+ѻw\"//SSS#)1	cƌCi4\ZPfH!-[\0@CCC{\rS\rZJREVf&нG齺\Zvvv8p`?w	|3;gسg#?ys`ȐéSSSSӟBuhjjBUUrW^!::\Z_ٷopu\Z25䊆FF8qLLLVc\\nvE,lq5\\PU\0a!\\.bnP_|gD\r\\.+VX+QT\\JHKKCUUكpqv\0\Z/Za`h7I9YPP3]JF]i?w솜j\r;JHH@dDO>Lgt쨎ok=z 00jjjD׮])u؛	ѯ_?>\ZnnnxANN\\GŜXN&\ZAC:Æ\rϷe+**BVf&Es`JIaE5jD]~~>\"\"q!B0\Z:tr!%-\r---2|ݻXl)llm~(*!!y|0lٲE5K\\IF)++frl\0x\\0+WoN,D(++Ӧ@U+htҀ/>sG\0\\.B?+00GÇǷop06yy~8u$>mLNN\'={[kܿac,m\\.077q**k3\r|,h۶H\0/eرsżh=׭a%1Pfc\\7rnOc6olܰl6BѦukUUCptħOHJLCr\"*ܱӧOz\0LHQ.)++G(**ܮ];cx)DG֭X*\r=s\Zϝ޽{C]]]\"//^£Gs\n:tnGk($ŦMQQ^+Bĺ${{|AATyƌ:Oǂv_;uO\0lmmQ;O)M<x\0ʘ9!{o]˱ֈ,22QQt2kN=B50۷o(//ҥKPQQ	ŋЭ[w/\0:t(|ܻp|/5vr\0sׯԗT1d[nر#Zj%q+?\n˗/x/^ 1)%S\0袥I&a`3tb|˖p꒒dCb}μQba\rpttWldϟǑ#|eåK?xՎ₂B/l6o<m^?l0ҥjZ\n<7n`@AAף}8tR#::\Z;w;v\\ cEmM\ry{::jKѽ{wtDGG{~>7XqqpJ4@ZZZ裣---hhhm۶PUU%a+--$Kl6\"7BII1/@#22#\'	;vT\r\r\Z={6diii*Kĉ8,zNP[WyC___X,ӱh8;\"\"\"볫S3G\',s_M6|ዏɦҺr\0}Ztv[Bu5}3I+ ւ*k+UQT,\"Mv}U,kwUD*(H&-dQ\0s/_LfywK!YJř3g\nGGBq)lٲ\\Ajj*\"##S&m~v~ҊD\"ԭ[͛2\Z5nźP[rrrKHGJTJ23#\'GRR>BNNN*F@\'iУgOFϞ=Ѯ]\nD\",Zٳ\r[۵\rEf3goߣGp\">ka\0@AA^n^~QL>c3ڪ=j\Z<| f-[tR7Ν;0ISG022*]XXfcnB͸c|S\\vL ;;/c.,ɒkU8ܹ3zh߾=5kV)/?~Ѹqods΢6nwʕ+pt^iW|\n\0|B^\'O董004vWU11w,--^~Vk<^ԁu/$CB]=<G⦦bƌHOKsb׮@Xh(\\V`_hK4>F~DEhhh#kiZ܍0KK.shjjm6hѢe^DHH-DvV`ƍ\naӷ,A{x\0\0Ha5u=wJTk׮ښQUFW76oBFܹ\nbE}+<rpe?\n0˗/\\s=%<d+(1gfvv6RSSD#>>			HLL@B|\"Gnee(++C*TTT\n555BUEQ~*5+r襧CMM\rA \'\'ϟUT@CZZ\ZΞ۷A]_NQ޿?~@Fh˗aovJlٲ\\Fk^O\r\reoRHtpss;A\"8x)))Z\Z+VĤP|%4ڵCĻwxXlyˢVrsst9Qtc! \'\'G?+}[3v,.]X%3̝3gtPٳga::j=y+l7j̙vΌy??BWׯ)SyT(](+5nJP?QԣGiSRǏԈ#ݴSB.11ڹsճGwЀzOICI]PsLLx֝bQ?ݴR;w3~5;ǇM25GEFFѣTݩOҟ+=Sς}zS=w|||~eeeQ۷m+@ŋͨDVVHNN:ggܹ/CIcɰ,Ga|SZ~i̘hԨ|1GaqذaOׯ#{EACCzzz֮6C(-$ames nݺcGѡc\'E.]~SRRy&\\p!>r$XZbpM<qߟз_?899#]\Zѣ8u89xxnÇAz\n8YfxVV8{KTKF%KCTRRRG9\ZՃvn8p 455?}cǀdY[`T#::\Zx	c)v򔩰\ZClx=8x\0aѴi3lݶ;w)y%v؁\'O$1}X[۔ypwwǙӧ\n(H!0xxxz\\Qx5lb \nV6>}O\'0vx̝;離˗-+PsEX`!띍\"+Cƍ0(8w,45ʥb:F:\"44#3Z*uO`` 6o,Ԁx]8**\n-[VNzMBTT&N0BRR;/-KQaFe7n`|Sz9AQQ	Æ\r%3ڵkX،.2)jǜ9s]V[jv55)iu&r{_V\'Q{v1?(UVŎ\"^^^c!E!(L86\'$$Ǐ\0js\n+D\"b)ꤥۘo:w#\reV]Æ/sŖ?~g?<h[\Z}7FSm=ML$+dXjuF}	~~~8,TUU{\"dпTkӉݽ+W@$\"[;;6			v\Zcx&eHaMa햒F\ZUU\'7Pn+VԴa2{6b1p`̆vcGEEaӦMw!<(m+2+,6\nhkk\\]7\"}IB[(8^[[eao\0\0 \0IDATdX6m`ooCCClDzzz2EEQӱ|2L1+V@VVs\ZZhMMM?DP`(\n4d)yJڦ}|>\nAmUUUxxz\"#=zzųf£G{.Z~-b>\nWFrFFF:94j\Z	W91G#!!T&޹[hR\\\\FϞ\\-[\"++iii ޿\";8B__&BEE,c7|Yfj}Þ{iRxBC)oݺՖZN\0Ao-U|I\'h߾}&c~س{7=!K`bbR.PRR²eˠ5WP(_.%]`%z00J4=+VRRIdrxHa&%\nCQFbqf͊t5VV)\"K5)+ԣAбzKPbC1Lo\0ڲ@a9FϞC:B$?ziSʪL2T-ܹsJJJmb7o^AyB\"g!f\")tۦ>X,/EX*S9ƉH\'N`)CLwoPI]#\r\0ZZZرcW۷o+\Z\Z\Z$UHg&rlڢ{ւ HNNPRRs-R\Z4h\0kΊ#uѧ|#wŋv3ֳaanN{e,]۶m/uy&$ԯ_K,E=`ccɴRpk1~\nv6002v܉!@{(-_;\Z5%.]xW/r&i­[2t7oL\Z5z4][(-UxxxRԩTTT ?[%TeE՛b5	0gΜq	\0<=pEXZZV腔ƄGFFׯDhִ)jhɡLpEGGd/KVVN8o퀤j-zoeXr%:t޽{ߧOb=%-Yall\\.u=Sb\"\"1֦|>g͂v[r.\Z갱A߾}$I\"<,,`ll\\my@AA;#ٿHMMūWtss U%l̟o@<@oŋA$/^#F@Yd\0kkk2ѣ($\'\'C^^-Z(7BǇ{3\"ޤ#\nAM=0 0x`,;ÇU9$ӧNXz\rƌ\ZeKj\0r2y/A:u0|lBn8JDQP(Ļwoѯ\0ZH_u$hWntA||<.^Ģy%y	.Yfiy2FO^Z͘<y._\\l\0JUY۽;f>}qU\\zW^7kR/ٳgcEݭ;: vݺuѽGtUo955?n,o9׻=e˖xR;?tttk.\\~Nyy{;[hjia\"3ׯ\\9A	]6@HVe#-B\\\\2\'FFX-kFz:b]c[NNNN>|D\r6F\'05OKM7_c*K,\\oFFF+=i$v-\",$\r`޽2dB=ctܸqLj\r>PHWXdq*Rת[͛7Ǌ+ahhvo˔|;dW咲cƌѣM}nݺ¤IF,\0̝gk׮\Z^HJJBPP<#ᄉ1}:k	4]xq 	۵6hc\\WP$)D(\r6\'0쏡PUUexLŋ_~uBB8R坢!9)$Y,#0ݻwS|gΜAt֭?x(|>\n)\n]`0b8m݊b*͚5!C|@4oѢpQ555\\\n.Y(ƈncc0bߍ!\'\'WT_Enn.^|	///24!2upQ{xG@5*`Cf}酧OӸy#RIbqѩ\0&%%AAAT8ԫWqqqPUUex⠬E۷ox).^\0ζtDz={VX{8bWP{{\\xH>	n}\'Iaaap>}\nğ9\0I0g<cǎU^\"--\r_ݻw{dBT6EQ>c^xPPsK̙;;<KW]/$Edd$n߾|pH\'۴ر㠧vq$/߿G11_XH<\r\Z69s1dmϟ?ǜٳ\\o>skLGLӦNPL@\0GRyc\\\0cݺM@WWL-)SӐ#ˈZy8HƍC^\nM<R@<۶mb;н{)pnn.\"\"\"SN\"9)\"s5j4tСC4oޜ50t|o޼?ynZ~ˇGhSa,rqc --I{x#vm\"w0e$Fr߱e\Zt8,:(\nm5ڡڵ+ih@iRKwXDFF˗xp>>\0	r2u\Z\r;|ܸqVkVC( ԯ_/]a!NnX|9܇H$ǜ`aaQnpg@\nZR^YYEN͛CYY\r\ZNOonn.Ґ/_\"22ah\"*]w[WF&رO\naaiw댙ư]իXkcM++B}sɧOΝ;x\'Qp)6\n\nSZZZeK7m\nUUU4lJJJPTTD:u*lV$!\'\'?~@zz:RRRXwP匊:6A@DQUAvJ#^\"##1h<CG\n;]1Gѕ6o°+333}Ϟ=ݻwO\'ːGAAmۊGv&MиQ#4hՃ!_rry\0sX(\"77999BFF22ґ$#&+\"?|@nnn6\05ҢEK4=z􀖖7oN1\'>[ $I:ȑƗQ+c~y!C-[{DFF\"<<!!!x9M/eFv:@!ۊ%QW\nUYߊGy]==t:uB۶mѬYJYYƈT7Xme\rccc5!!!k2yB*/dggQсv00Wr27\"7oZڵk-[iӦhܸq{a|Ӽ>/^06FeffݍG\\*R0555?x?#99bcc1_\"gH(m¶qhպ5ZlxH(+`hڴi逗zbi8uxMQގM6׺\ZMl})noڵ8}T^M,\0K.Ef\n8Es㬬,dff2R\\ $m|ԩ:uP.S^n]ԕ<RSSal<##AQbb۷a<kpYz۷q\ZΙ׍\Z3zT$ݻ7\ZÇѤѣGO>鼹q\n0?]K4l/]U52m(ڵ~1qdV(ܹNpF9Ul9IKQ*JY0rHן>iii8|p\Zk$pUzNH(,Xm{.._ode\nܹsޔ;w}K\0LGŋ+RRRŅ6ťpp	[fmܸ1Q[(\r>|`][bJ\"VZKǎ۷XڬQFEZj*V]==72u*$Y~ӦZFx+sĮnx\r(zBTV5e$mfe[cEPRR	/_f];ׯ;{{C\\rss嵙)=BVzmSRRĈm^z\r455ŹnҤ	6ldN$L߾}1aD:*}~\Z10kDGAׯ	޹sWvu!C`8j42*۶mß0(J$kp5v|\rNN}d7BBBpg?_kk[y</_Jr\"o͛7Xf͚a+@$9#99#68|\Z4uȀd2tҥZ͛͝6sIbccYVCCCkIV<ygN,]\'Ǉwtk6m0sj}\r0H0MܹlhS,-W1ֶ}CXX(GlǏpsscfe6ׯ_yYf<@ U$)¥pکS\'-^XDvv6Gl6ܹs]{MLdY)@\\Օᱟ=g.ttzՈNԺuk;82vvH:3f0^<ʥZKO>a#zڵT8w^|A{՛bn\r722B^y٩a];6lG\'\'R:g\'|#vUC$apiՋ}#ȊrrvfWV֌9(8um߿?ƌK/\0vލX-}=ܼyC2rrr05Ϻvb\'--1yT߿F:lj\Zd֭Cjj*I/YBL\"._@Ud_NfZ\0guPWWg][/_	E&cԹXZK49ºvhNN݄j\rH?d	ecWh(**̕.+=um3v,uNb~űc8bW6#jkժU&WH78Jph2]vbe%H\r6 ##U픗/g.y#ve!\'\'7mb8cǎk͛7|\0ϖ/_*ῊLccnӆV9\'Od];;wk^^2p<{d4Q[pusGQP~}8:8-+$oׯYYfAYE^Ǹv\ZG =c\r6dU;eqꏽtu1ĄƺHƍщmogʘ\ZE} Q0`\0p.][g~YeayhDuYֵS__#\r$%q$}8bW?~sgf.]uD8::2keuH/w77DFF<.]F\'I`T{bge,kmo>>>=6{҅8\0S\n8ئ֪U+3׶7l@zz:Gę>I~dyN?X[ceU-*fffPPPMpֵ~SNq./DFFb/*5FRSSnsUrjtЁc4iѬjlll8rR͏ IX1=z`][9/Ѵ	ީsj_VY:\Z2tҼN\'[=Yd֭Gĝŝ׬Xs	gkkWkx<,_vuܺuum51\r\ZMƍIIIذa=w^u1օ闙-F׮]9-Z`C\'߾}cU;UTT켎uΈiӶo>|8NܩS-CeeCCC8N]X=d:TYx:0m-,,Xkl߶UFGGԯ_cm) I[-S<߿Ϫv|X\'IO\'O8bؼy-lrhiieggݍ؛5tu9Ɩm۶cIIIkj+kxFeؗ/]!M-Zbڴ?YwΝ;!!cOYErL	C뛍:i&Mfv8{,-A`bWASعk7$\"##1h<#n][.x-N̨co鱪O>鼹DEa݌$1cƢ_~:Q,7qdԿ:r+$ttt0}L6Kk>E(\0Xd	Mtʕ+|X[733Y2u*:tD_Dחu7o#,6]ܾ}#v~a3-Z`Icm}+8Vaggܷw^xv6i֯gm;;90B%/KWm7U\'$Ix{o/i>Сp,Ghkkc\"<SW$t҆\rX9bK}oׂy5ktmܸ~Q(UgooqiVQ ܂!{!!!B!mƬee2ݺucl0]X7U)hР:i۶najhanaM[n!}9sXv/0p \r\r9V tuual<}pwgNڔ)SFCv}ϟNHHzei\n.\\@@\03VZ]*LM!!XE\Z\0WlmI>>|222Qp }:U-))	NNL2[{mۖc]%@YY֭gu#>~Ȫv1$\0`_11ϟ?QF9FA2B=ut8JƠA0a:il;Xp!h{n!vVV<==!q4@vXu?~ǘe6V03[yp>ڨ|yNURiľp^m`*$RSS/˪4\\62Lr{{;700@>}qњOhlt\00afgkz,_:aiêFɈΊyrrrdm:x\0/_Ħ(\nvCƳлOVu/^`=Ξ/bHD$kСXY3\"<==l½VeKQc>@\0@ϧ?xx<d~/}]#++72-26,e˖pqGGB$	{@ƍ!Jx ɼ$IBD e>$P(HDB(F\n E\\q;$)NĄ(\n^:uj\nNMMIgEx<@3d(U`R(&_ֺ\r8\r\Zpb	B!p.ـe-X~UD\"Q6+We˖5?燸o(.YևPQܽ)yG6ٙ#5 I[)?׌\0=EQگx6y}U\0\0IDATFQ%y6b}S&O1GG🺻2zˎRR46ƚ5VX\'OURx!򾬘$o\n!\nc.8;331BJ_,}-Пˌؖ(\n38#	9ṕGl8pG첀OA cSi\'X}3J?ߪ\'bAWBD6A1A$b^9v@sjX\\âp5MdfP๹Gԩ\n|_5<D]+ҰAo\Z:u0zn	C6&#GA8h٥^M~	 EDQ `\rA4\0p͟hb3ԷG*>j7WD%uFqh\r@$vx\0uۘlQߞ&\'o\0NA	>(ܳQ^#g$!D6`6*y(\"n>\0\'sK\0(ișUoyxR\ns|\"AmjZPREW(Pp59bk/Aoۚ.2Jn6J\ZHn\0c	\\]e\"y(r-!w%X=aC\n^ɳ#EQF9 |	\"\" d ^ ~Uxـu:s\\Qsd:ut).W)3Z{CEQʡu$+\0\"M+9bRW- ti2h-\"乴z?/HWX&L+7nxee#Gls\0fKBH+EQ\r`+\0~j+JlMJ:F,I4(Z8Z4LJ_||z\0(ʩn((dUCG(@_@Qԧ<FL$cGr~MG	I~Gi2󛫒}\02AQ\Z\0ag^Qc\0eq~Z6bzJt;\0uZI\\n/\r׿U1rĮc!ʎlY+?*zP	.b?K9bWA^)=N9EW!:#GR+љZHjPuy)D@W6S$m(E!hP滟hK3:KޒBм#vd:|^ɾ& ήA\"\0`[Eq 	XHAmekCL X#bج;ƪ5\"mRʒYf/J	34\'\'0K\Z$\'\'\0PR\0XI\r>r\Z5: &jU7\0*M8!W\\Ix A,e&:Kj)\0>\0xg(Fێ*+ÁCGlj G7:+\0\0\0\0IENDB`',NULL),
('prerequisite_examination_for_print','10008,10010',NULL,''),
('qc_analysis_time_examination_id','10006',NULL,NULL),
('qc_equipment_examination_id','9000',NULL,NULL),
('qc_id_examination_id','1048',NULL,NULL),
('qc_lot_examination_id','3001',NULL,NULL),
('qc_result_limit','400',NULL,NULL),
('qr_code_width','100',NULL,''),
('qr_link_prefix','https://gmcsurat.edu.in:12349/clg/',NULL,''),
('report_bottom_margin','15',NULL,''),
('report_header','  <table border=\"1\" style=\"padding:2px;\">\r\n    <tr>\r\n      <td style=\"text-align: center;\">10011|r</td>\r\n      <td colspan=\"4\" style=\"text-align: center;font-size:2em;\">\r\n      10012|r</td>\r\n      <td style=\"text-align: center;\">report_qr_code</td>\r\n    </tr>\r\n    <tr>\r\n      <td style=\"font-weight: bold;\">sample_id</td>\r\n      <td>sample_id_value</td>\r\n      <td>1001|n</td>\r\n      <td>1001|r</td>\r\n      <td>1002|n</td>\r\n      <td>1002|r</td>\r\n    </tr>\r\n    <tr>\r\n      <td>1004|n</td>\r\n      <td>1004|r</td>\r\n      <td>1005|n</td>\r\n      <td>1005|r</td>\r\n      <td>1006|n</td>\r\n      <td>1006|r</td>\r\n    </tr>\r\n    <tr>\r\n      <td>10002|n</td>\r\n      <td>10002|r</td>\r\n      <td>1000|n</td>\r\n      <td>1000|r</td>\r\n      <td>10008|n</td>\r\n      <td>10008|r</td>\r\n    </tr>\r\n  </table>\r\n',NULL,''),
('report_left_margin','20',NULL,''),
('report_right_margin','10',NULL,''),
('report_top_margin','90',NULL,''),
('restrictive_examination_for_edit_delete','10008',NULL,''),
('status_button_info','1001,1002',NULL,''),
('status_column_size','20',NULL,''),
('status_lot_size','200',NULL,''),
('TAT_remark_id','5191',NULL,NULL);
/*!40000 ALTER TABLE `config` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `dashboard`
--

DROP TABLE IF EXISTS `dashboard`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `dashboard` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `topic` varchar(100) NOT NULL,
  `description` varchar(2000) NOT NULL,
  `priority` int(11) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `dashboard`
--

LOCK TABLES `dashboard` WRITE;
/*!40000 ALTER TABLE `dashboard` DISABLE KEYS */;
INSERT INTO `dashboard` VALUES
(1,'Calculated Parameters','Prothrombin Time related calculation of indexes is now available. \nWhen in <b>Edit</b> mode, Click <b>Calculate</b> to refresh calculation.\nModification in database is required to add new calculated tests.\nChanging ISI value in database as required is essential',NULL),
(2,'Suggestions and Feedback','For suggestion for improvement, contact lab in-charge or whatsApp: 9664555812 Dr Shailesh ',NULL),
(3,'Super Profiles','Use Super Profiles to reduce your clicks and prevent lapses in entry',3),
(4,'View Statistics','Click <b>HOME</b>. select Click <span class=\"bg-danger\">red colored number</span> to view data. Provide appropriate input (e.g date). Export Data in spreadsheet if required',4),
(5,'Bold','use (((xyz)) to bold a word',NULL),
(6,'New Software','New Software have 7 digit sample ID (REMEMBER)',5),
(7,'Dokuwiki and Docs Old LIS Started',' Click ---> <a href=\"\\dokuwiki\">Dokuwiki</a> <a href=\"\\docs\">Docs</a>  <a href=\"http://12.207.3.250\">Old LIS</a>',6),
(8,'Worklist Print','See number 6 (get examination id from 7)',8);
/*!40000 ALTER TABLE `dashboard` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `dementia`
--

DROP TABLE IF EXISTS `dementia`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `dementia` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `Minutes` varchar(10) DEFAULT NULL,
  `Hours` varchar(10) DEFAULT NULL,
  `DayM` varchar(10) DEFAULT NULL,
  `Month` varchar(10) DEFAULT NULL,
  `DayW` varchar(10) DEFAULT NULL,
  `Text` varchar(200) DEFAULT NULL,
  `recording_time` datetime DEFAULT NULL ON UPDATE current_timestamp(),
  `recorded_by` varchar(100) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=94 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `dementia`
--

LOCK TABLES `dementia` WRITE;
/*!40000 ALTER TABLE `dementia` DISABLE KEYS */;
INSERT INTO `dementia` VALUES
(28,'0','8','*','*','*','Pepsin wash in ISE module','2020-09-15 09:45:42','3'),
(29,'0','8','26','*','*','Print Erba640/1000 maintanance sheet, DI Plant(big+small) sheet','2020-08-12 13:49:45','3'),
(40,'0','8','1','8','*','Tejal - External calibration, 7 items','2021-02-15 11:24:41','9099514805'),
(41,'0','8','1','8,02','*','Inhouse Calibration pipettes, wMachine, Glassware, Centri, incubat, refi','2021-05-13 11:37:27','9099514805'),
(43,'0','8','*','*','0','640+1000 Autowash With 0.1N HCL and 0.1N NaOH','2020-08-13 12:36:23','3'),
(44,'0','8','1','*','*','Change saturated KCL solution in PH meter','2020-08-13 12:35:34','3'),
(45,'0','8','1','1','*','Check Expiry Date of drugs in ART kit, Eye wash kit and First aid kit','2020-08-13 12:35:10','3'),
(46,'0','8','1','8','*','Yearly calibration of volumetric flask','2020-12-16 11:08:46','8866580625'),
(47,'0','8','*/5','*','*','Refilling of Std-A and std-B','2020-08-13 12:17:05','3'),
(50,'0','8','1','5','*','Renewal of CMC of Erba XL 640 and 3 semi-auto','2020-08-13 12:14:48','3'),
(52,'0','8','1','4,10','*','PUT REQUEST FOR PRINTER CONSUMABLE','2020-08-13 12:13:08','3'),
(55,'0','8','1','*','*','Back up of volume parameters,programming parameter, reapeat flags from Erba XL-640 to doks','2021-06-30 18:09:58','8866580625'),
(56,'0','8','1','1,5,9','*','quarterly maintenence for 3 semi auto ','2020-08-13 12:09:08','3'),
(58,'0','8','1','7,12','*','refilling of fire extinguisher','2020-08-13 12:03:00','3'),
(59,'0','8','*','*','4','Perform HE and PRE','2020-10-07 16:38:50','9099514805'),
(66,'0','8','1','*','*','Centrifuge Cleaning','2020-09-09 09:06:25','9099514805'),
(69,'0','8','*','*','*','Run IRON and UIBC samples and graph monitoring','2020-09-15 12:36:44','1'),
(72,'0','8','16','7','*','Yearly ealuation of all records before internal audit','2021-07-15 15:13:31','9099514805'),
(73,'0','8','16','*','*','check location and content of eye wash kit and first aid kit','2020-09-26 15:22:52','9099514805'),
(74,'10','8','1,15','*','*','cleaning of barcode printer opd and clinical lab','2021-08-09 16:09:58','9099514805'),
(76,'0','8','1','3','*','calibration certificate of ERBA XL-640 and semiauto from jiteshbhai','2021-02-24 12:38:07','9099514805'),
(77,'50','11','13,28','*','*','Calibration of CRP every 15 day','2021-05-13 11:47:37','9099514805'),
(78,'0','8','1','12','*','Install new electrode_Install before date-1-12-2021','2021-05-17 13:31:59','9099514805'),
(80,'*','*','1','8','*','REMINDER FOR INHOUSE CALIBRATION','2021-08-18 12:24:13','3'),
(81,'10','8','*','*','6','change sediment filter and backwash of DI plant','2021-08-09 16:09:10','9099514805'),
(82,'10','8','*','*','*','IQC of ketone','2021-08-09 16:09:00','9099514805'),
(83,'10','8','*','*','*','Refrigerator temperature and environmental temperature and humidity entry in LIS','2021-08-09 16:08:53','9099514805'),
(84,'10','8','*','*','*','Daily maintenence  and IQC of ERBA XL-640 ,ERBA XL-1000 and VITROS-3600','2021-08-18 12:25:42','9099514805'),
(87,'10','8','2,17','*','*','cleaning of RO water','2021-08-09 16:08:42','9099514805'),
(88,'10','8','*','*','2','weekly maintenence of VITROS-3600','2021-08-18 12:28:35','9099514805'),
(89,'10','8','10','*','*','Hypowash of XL-1000 and XL-640','2021-08-18 12:44:37','9099514805'),
(91,'10','8','1','*','*','Monthly IQC and EQC file of XL-640,XL-1000 and VITROS-3600','2021-08-25 09:46:05','9099514805'),
(92,'10','8','1','*','*','Monthly TAT file','2021-08-25 09:46:43','9099514805'),
(93,'14','0','*','*','*','Its 12 Oclock','2023-09-05 00:12:40',NULL);
/*!40000 ALTER TABLE `dementia` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `examination`
--

DROP TABLE IF EXISTS `examination`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `examination` (
  `examination_id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(50) NOT NULL,
  `sample_requirement` varchar(100) NOT NULL DEFAULT 'NULL',
  `edit_specification` varchar(5000) NOT NULL,
  `description` varchar(300) DEFAULT NULL,
  `request_route` varchar(300) DEFAULT NULL,
  `display_route` varchar(300) DEFAULT NULL,
  `print_route` varchar(300) DEFAULT NULL,
  `request_route_priority` varchar(10) DEFAULT NULL,
  `display_route_priority` varchar(10) DEFAULT NULL,
  `print_route_priority` varchar(10) DEFAULT NULL,
  `display_format` varchar(50) DEFAULT NULL,
  `insert_minimum_authorization_level` int(11) DEFAULT NULL,
  `update_minimum_authorization_level` int(11) DEFAULT NULL,
  `select_minimum_authorization_level` int(11) DEFAULT NULL,
  `delete_minimum_authorization_level` int(11) DEFAULT NULL,
  `append_user` int(11) DEFAULT NULL COMMENT 'if ''yes;, it will add last editor name beside result',
  `default_value` varchar(200) DEFAULT NULL,
  `equipment` varchar(10) DEFAULT NULL,
  `display_help` text DEFAULT NULL COMMENT 'help on screen',
  `print_help` text DEFAULT NULL COMMENT 'help in report',
  `accr_status` varchar(10) DEFAULT NULL COMMENT 'if ''yes'', it report will display symbol',
  PRIMARY KEY (`examination_id`),
  KEY `sample_requirement` (`sample_requirement`)
) ENGINE=InnoDB AUTO_INCREMENT=105039 DEFAULT CHARSET=utf8mb3 COLLATE=utf8mb3_bin;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `examination`
--

LOCK TABLES `examination` WRITE;
/*!40000 ALTER TABLE `examination` DISABLE KEYS */;
INSERT INTO `examination` VALUES
(1000,'Sample_requirement','None','{\"type\":\"text\",\"help\":\"Describe\",\"readonly\":\"readonly\"}','None','Misc/Sample Details','Sample Details','Header','','20','','compact_report',1,1,0,1,NULL,'','','Describe','Describe',''),
(1001,'PID','None','','None','Misc/Patient Details','Header','Header','','30','','compact_report',1,2,0,2,NULL,'SELECT  concat( \'SUR/\', DATE_FORMAT(CURDATE(),\'%y\'),\'/\') as default_value','',NULL,NULL,NULL),
(1002,'Name','None','','None','Misc/Patient Details','Header','Header','','40','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1004,'Department','None','{\"type\":\"select\",\"option\":\",ART,Dentistry,IHBT,EmergencyMedicine,ENT,Medicine,OG,Opthalmology,Orthopaedics,Kidney Hospital,Paediatrics,PlasticSurgery,Psychiatry,Skin,Surgery,TBChest,Samaras,Unspecified\"}','None','Misc/Sample Details','Header','Header','','60','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1005,'Unit','None','{\"type\":\"select\",\"option\":\",-,1,2,3,4,5,6,7,8,A,B\"}','None','Misc/Sample Details','Header','Header','','70','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1006,'Location','None','{\"type\":\"select\",\"option\":\",C2(684),Niramaya_Camp,old building 1st floor,old building 2nd floor,old building 3rd floor,old building ground floor,IHBT,Hemophilia ,C3(685),PICU,Casualty(446),E0(506),E1(507),E2(508),E3(509),E4(510),EMW(485),EOT(591),F0(511),F1(512),F2(513),F3(514),F3N(503),F4(515),FOW,G0(516),G0MICU(500),G1(517),G2(518),G3(519),G4(520),GOT(551),H0(497),H1(522),H2(523),H3(524),H4(525),HemodialysisUNIT(741),Isolation Ward,J0(521),J1(531),J2(527),J3(529),J4(530),LeptoWard(506),MICU(500-2),MOT(567),MOW(310),NEWORTHO(311),NOT(551),NOW(311),O2(539),OB(546),OBICU(546),OLDORTHO(310),OPD,PrisonerWard(310),RI(548),RII(564),RIII(580),SICU-1(478),SICU-2(478),SpecialWard(570-71),SwineFluWard(529),StemGround,StemF1,StemF2,StemF3,StemF4,StemF5,StemF6,StemF7,StemF8,StemF9,StemF10,StemHosp,KidneyOPD,StemOPD,TBICU,TRAUMA1(476),TRAUMA2(485),TraumaCenter(472-87),4A Kidney,4B Kidney,4C Kidney,4D Kidney,5A Kidney,5B Kidney,5C Kidney,5D Kidney,StemTriageSemiCritical,StemTriageICU,Stem Triage,Kidney 6th ICU- B,Kidney 6th ICU-A,,NICU(692),RICU,SAMRAS,6A Kidney,6B Kidney,6C Kidney,6D Kidney,7A Kidney,7B Kidney,7C Kidney,7D Kidney,Unspecified\"}','None','Misc/Sample Details','Header','Header','','80','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1007,'Age(Y)','None','{\"type\":\"number\",\"help\":\"Full Years\"}','','Misc/Patient Details','Patient Details','Patient Details','','','','compact_report',1,1,0,1,NULL,'','','Full Years','Full Years',NULL),
(1008,'Sex','None','{\"type\":\"select\",\"option\":\",M,F,O\"}','','Misc/Patient Details','Patient Details','Patient Details','','','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1009,'Sample_Collection_Time','None','{\"type\":\"datetime-local\", \"pattern\":\"[0-9]{4}-[0-9]{2}-[0-9]{2}T[0-9]{2}:[0-9]{2}\" }','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1010,'Sample_Receipt_Time','None','{\"type\":\"datetime-local\", \"pattern\":\"[0-9]{4}-[0-9]{2}-[0-9]{2}T[0-9]{2}:[0-9]{2}\" }','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1011,'Request_Entry_time','None','{\"type\":\"datetime-local\",\"pattern\":\"[0-9]{4}-[0-9]{2}-[0-9]{2}T[0-9]{2}:[0-9]{2}\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1012,'DOB','None','{\"type\":\"date\"}','','Misc/Patient Details','Patient Details','Patient Details','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1013,'Laboratory Name','None','{\"type\":\"select\",\"option\":\",Haematology and Clinical Pathology OPD-10 New Civil Hospital Surat Ph: 216-2244456 Ext: 424 425 426,Biochemistry Near Blood Bank New Civil Hospital Surat Ph: 0216-2244456 Ext: 317\"}','','','','','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1014,'released_by','None','{\"type\":\"text\",\"readonly\":\"readonly\"}','','','','','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1015,'Collection_Date','None','{\"type\":\"date\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1016,'Collection_Time','None','{\"type\":\"time\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1017,'Received_on','None','{\"type\":\"date\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1018,'Receipt_time','None','{\"type\":\"time\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1019,'(Interim) Released by ','None','{\"type\":\"text\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1020,'Age(M)','None','{\"type\":\"number\",\"help\":\"Full Months\"}','','Misc/Patient Details','Patient Details','','','','','compact_report',1,1,0,1,NULL,'','','Full Months','Full Months',NULL),
(1021,'Age(D)','None','{\"type\":\"number\",\"help\":\"Days\"}','','Misc/Patient Details','Patient Details','','','','','compact_report',1,1,0,1,NULL,'','','Days','Days',NULL),
(1022,'Sample Remark','None','','','Misc/Sample Details','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1023,'Sample Collection Condition','None','{\"type\":\"select\",\"option\":\"Random,Fasting,Postprendial-2HR,PostGlucose-75GM-1HR,PostGlucose-75GM-2HR,PostGlucose-75GM-3HR,PostGlucose-50GM-1HR\"}','','Misc/Sample Details','Sample Details','Sample Details','','10','','compact_report',1,1,0,1,NULL,'','','','',''),
(1024,'email','None','{\"type\":\"select\",\"option\":\",suratcv19@gmail.com\"}','suratcv19@gmail.com','Misc/Patient Details','Patient Details','','','','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1025,'mobile','None','{\"type\":\"realtext\"}','','Misc/Patient Details','Patient Details','','','','','compact_report',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(1026,'sample_volume','None','{\"type\":\"select\",\"option\":\"-,0.5,1.0,1.5,2.0,2.5,3.0,3.5,4.0,4.5\"}','','Misc/Sample Details','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1027,'request_date','None','{\"type\":\"date\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1028,'request_time','None','{\"type\":\"time\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1029,'sample_preparation_date','None','{\"type\":\"date\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1030,'sample_preparation_time','None','{\"type\":\"time\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1031,'analysis_date','None','{\"type\":\"date\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1032,'analysis_time','None','{\"type\":\"time\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1033,'verification_date','None','{\"type\":\"date\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1034,'verification_time','None','{\"type\":\"time\",\"hide\":\"yes\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1035,'release_date','None','{\"type\":\"date\",\"readonly\":\"readonly\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1036,'release_time','None','{\"type\":\"time\",\"readonly\":\"readonly\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1037,'interim_release_date','None','{\"type\":\"date\",\"readonly\":\"readonly\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1038,'interim_release_time','None','{\"type\":\"time\",\"readonly\":\"readonly\"}','','','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1039,'wing','None','{\"type\":\"select\",\"option\":\"-,A,B,C,D\"}','','Misc/Sample Details','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1040,'Transporter','None','{\"type\":\"select\",\"option\":\"-,Manish,Jignesh,Jayaben,Suraj\"}','','Misc/Sample Details','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1041,'ThyroxinRx','None','{\"type\":\"select\",\"option\":\",Yes,No\"}','','Misc/Sample Details','Sample Details','','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(1043,'sms_date','None','{\"type\":\"date\",\"hide\":\"yes\"}','','Misc/Report Details','','','','','','',1,1,0,1,NULL,'','','','',''),
(1044,'sms_time','None','{\"type\":\"time\",\"hide\":\"yes\"}','','Misc/Report Details','','','','','','',1,1,0,1,NULL,'','','','',''),
(1045,'request_id','None','{\"type\":\"id_multi_sample\",\"table\":\"request_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"R\",\"minimum\":\"1000\"}','inserted, never edited, as group of samples','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','10','','compact_report',1,1,0,1,NULL,'','','','',''),
(1046,'opd_id','None','{\"type\":\"id_single_sample\",\"table\":\"opd_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"P\",\"minimum\":\"1000\"}','inserted, never edited, one for each sample','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','20','','compact_report',1,1,0,1,NULL,'','','','',''),
(1047,'ward_id','None','{\"type\":\"id_single_sample\",\"table\":\"ward_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"W\",\"minimum\":\"1000\"}','inserted, never edited, one for each sample','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','30','','compact_report',1,1,0,1,NULL,'','','','',''),
(1048,'qc_id','None','{\"type\":\"id_single_sample\",\"table\":\"qc_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"U\",\"minimum\":\"1000\"}','inserted, never edited, one for each sample','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','30','','compact_report',1,1,0,1,NULL,'','','','',''),
(1049,'niramaya_id','None','{\"type\":\"id_single_sample\",\"table\":\"niramaya_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"N\",\"minimum\":\"1000\"}','inserted, never edited, one for each sample','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','30','','compact_report',1,1,0,1,NULL,'','','','',''),
(1050,'emergency_id','None','{\"type\":\"id_single_sample\",\"table\":\"emergency_id\",\"readonly\":\"readonly\",\"unique_prefix\":\"E\",\"minimum\":\"1000\"}','inserted, never edited, one for each sample','Misc/Sample Details/IDs','IDs','Sample Details/IDs','','35','','compact_report',1,1,0,1,NULL,'','','','',''),
(1099,'LDL Cholesterol','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &lt;130 (Calculated)\",\"calculate\":\"(E/0.948) - (E/0.971) -  (E/8.56 + ( (E-E)/2140 ) - ( (E^2)/16100 )) - 9.44\",\"ex_list\":\" 5015,5016,5018,5015,5016,5018\",\"equipment\":\"C\"}','','Misc/HDL','Clinical chemistry/Lipid profile','Lipid Profile','550','','','',1,1,0,1,NULL,'','C','mg/dL &lt;=130 (Calculated)\r\n<a href=\"https://pubmed.ncbi.nlm.nih.gov/19009762/\" >Maureen Sampson Equation</a>','mg/dL &lt;=130 (Calculated)\r\n<a href=\"https://pubmed.ncbi.nlm.nih.gov/19009762/\" >Maureen Sampson Equation</a>','yes'),
(3001,'Lot','None','{\"type\":\"examination_field_specification\"}','','Misc/QC/Sample Details','Sample Details/QC','','','','','',NULL,NULL,0,NULL,NULL,'','','','',NULL),
(5001,'Creatinine','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dL (&lt;h5&gt;Jaffe two point)&lt;/h5&gt;\\n Male: 0.9-1.3\\n Female: 0.6-1.1\\n&lt;b&gt;(Not in NABL Scope)&lt;/b&gt;\",\"step\":\"0.1\",\"interval_h\":\"1.3\",\"cinterval_h\":\"4.0\",\"ainterval_h\":\"40.0\",\"ainterval_l\":\"0.1\",\"equipment\":\"C\",\"accr_status\":\"no\",\"cost\":\"150\"}','Biochemistry/OPD/RFT,Biochemistry/OPD/Basic,Biochemistry/Basic/RFT','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/RFT','Renal Function Tests','450','','','',1,1,0,1,NULL,'','C','mg/dL <h5>(Jaffe two point)</h5><i>Male: 0.9-1.3 <br>Female: 0.6-1.1<h4></i></h4>','mg/dL <h5>(Jaffe two point)</h5><i>Male: 0.9-1.3 <br>Female: 0.6-1.1<h4></i></h4>','yes'),
(5002,'Urea','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dL 13-43 (Urease  GLDH)\",\"interval_h\":\"43\",\"interval_l\":\"13\",\"cinterval_h\":\"100\",\"ainterval_h\":\"400\",\"equipment\":\"C\",\"cost\":\"200\"}','','BIG1,Misc/Osmolarity-Serum,Misc/QC/clinical chemistry','Clinical chemistry/RFT,Clinical chemistry/ sr.osmolarity','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','mg/dL 13-43 (Urease  GLDH)','mg/dL 13-43 (Urease  GLDH)','yes'),
(5006,'Alanine Transaminase','Plain-Blood','{\"type\":\"text\",\"help\":\"U/L &lt;45 (L-Alanine LDH UV Kinetic)\",\"interval_h\":\"45\",\"cinterval_h\":\"450\",\"ainterval_h\":\"4500\",\"equipment\":\"C\",\"cost\":\"100\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/LFT','Liver Function Tests','440','','','',1,1,0,1,NULL,'','C','U/L &lt;45 (L-Alanine LDH UV Kinetic)','U/L &lt;45 (L-Alanine LDH UV Kinetic)','yes'),
(5007,'Alkaline Phosphatase','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L 42-128 (pNPP with AMP buffer)\",\"interval_h\":\"128\",\"cinterval_h\":\"1000\",\"ainterval_h\":\"3000\",\"equipment\":\"C\",\"cost\":\"70\"}','','AMY-LIP-ALP,Misc/QC/clinical chemistry','Clinical chemistry/AMY-LIP-ALP','Liver Function Tests','','','','',1,1,0,1,NULL,'','C','U/L 42-128 (pNPP with AMP buffer)','U/L 42-128 (pNPP with AMP buffer)','yes'),
(5008,'Amylase','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L 28-100 (CNPG)\",\"interval_h\":\"100\",\"cinterval_h\":\"400\",\"ainterval_h\":\"5000\",\"equipment\":\"C\",\"cost\":\"350\"}','','AMY-LIP-ALP,Misc/QC/clinical chemistry','Clinical chemistry/AMY-LIP-ALP','Pancreatic Function Tests','','','','',1,1,0,1,NULL,'','C','U/L 28-100 (CNPG)','U/L 28-100 (CNPG)','yes'),
(5009,'Total Billirubin','Plain-Blood','{\"type\":\"text\",\"help\":\"mg/dL &lt;1.3 (Diazo Reaction)\",\"step\":\"0.1\",\"cinterval_h\":\"15\",\"interval_h\":\"1.3\",\"ainterval_h\":\"50\",\"equipment\":\"C\",\"cost\":\"50\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/LFT','Liver Function Tests','410','','','',1,1,0,1,NULL,'','C','mg/dL &lt;1.3 (Diazo Reaction)','mg/dL &lt;1.3 (Diazo Reaction)','yes'),
(5010,'Direct Billirubin','Plain-Blood','{\"type\":\"text\",\"help\":\"mg/dL &lt;0.4 (Diazo Reaction)\",\"step\":\"0.1\",\"interval_h\":\"0.4\",\"ainterval_h\":\"50\",\"equipment\":\"C\",\"cost\":\"50\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/LFT','Liver Function Tests','420','','','',1,1,0,1,NULL,'','C','mg/dL &lt;0.4 (Diazo Reaction)','mg/dL &lt;0.4 (Diazo Reaction)','yes'),
(5011,'Albumin','Plain-Blood','{\"type\":\"number\",\"help\":\" g/dL &lt;3.5-5.2 (BCG)\",\"step\":\"0.1\",\"cinterval_l\":\"1\",\"interval_h\":\"5.2\",\"interval_l\":\"3.5\",\"ainterval_h\":\"10\",\"ainterval_l\":\"0.5\",\"equipment\":\"C\",\"cost\":\"130\"}','','LRE-ALBTP-CRPLDH,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/ ALB-TP','Liver Function Tests','','','','',1,1,0,1,NULL,'','C',' g/dL &lt;3.5-5.2 (BCG)',' g/dL &lt;3.5-5.2 (BCG)','yes'),
(5012,'Total Protein','Plain-Blood','{\"type\":\"number\",\"help\":\" g/dL &lt;6.4-8.3 (Biuret)\",\"step\":\"0.1\",\"cinterval_l\":\"3\",\"interval_h\":\"8.3\",\"interval_l\":\"6.4\",\"ainterval_h\":\"15\",\"ainterval_l\":\"1\",\"equipment\":\"C\",\"cost\":\"100\"}','','LRE-ALBTP-CRPLDH,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/ ALB-TP','Liver Function Tests','','','','',1,1,0,1,NULL,'','C',' g/dL &lt;6.4-8.3 (Biuret)',' g/dL &lt;6.4-8.3 (Biuret)','yes'),
(5013,'Aspartate transaminase','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L &lt;35 ( UV Kinetic)\",\"interval_h\":\"35\",\"cinterval_h\":\"450\",\"ainterval_h\":\"4500\",\"equipment\":\"C\"}','','Misc/QC/clinical chemistry,AST-ALP','Clinical chemistry/LFT','Liver Function Tests','','','','',1,1,0,1,NULL,'','C','U/L &lt;35 ( UV Kinetic)','U/L &lt;35 ( UV Kinetic)','yes'),
(5014,'Calcium','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dL 8.6-10.2 (Arsenazo III)\",\"step\":\"0.1\",\"cinterval_l\":\"6.5\",\"cinterval_h\":\"13\",\"interval_l\":\"8.6\",\"interval_h\":\"10.2\",\"ainterval_h\":\"15\",\"ainterval_l\":\"3\",\"equipment\":\"C\"}','','LRE-CALCRP,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/cal-pho-mag','Electrolytes','','','','',1,1,0,1,NULL,'','C','mg/dL 8.6-10.2 (Arsenazo III)','mg/dL 8.6-10.2 (Arsenazo III)','yes'),
(5015,'Total Cholesterol','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &lt;200 (CHOD-POD)\",\"interval_h\":\"200\",\"ainterval_h\":\"1000\",\"ainterval_l\":\"30\",\"equipment\":\"C\"}','','GLU-LIP,Misc/HDL,Misc/QC/clinical chemistry','Clinical chemistry/Lipid Profile','Lipid Profile','510','','','',1,1,0,1,NULL,'','C',' mg/dL &lt;200 (CHOD-POD)',' mg/dL &lt;200 (CHOD-POD)','yes'),
(5016,'HDL Cholesterol','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &gt;40 (Dextransulphate-Mg2+precipitat)\",\"interval_l\":\"40\",\"equipment\":\"C\"}','','Misc/HDL,Misc/QC/clinical chemistry','Clinical chemistry/Lipid Profile','Lipid Profile','530','','','',1,1,0,1,NULL,'','C',' mg/dL &gt;40 (Dextransulphate-Mg2+precipitat)',' mg/dL &gt;40 (Dextransulphate-Mg2+precipitat)','yes'),
(5017,'LDL Cholesterol','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &lt;130 (Calculated)\",\"interval_h\":\"130\",\"calculate\":\"E-E-E\",\"ex_list\":\"5015,5016,5028\",\"equipment\":\"C\"}','','Misc/HDL','Clinical chemistry/Lipid profile','Lipid Profile','540','','','',1,1,0,1,NULL,'','C',' mg/dL &lt;130 (Calculated)\r\nFriedewald\'s formula',' mg/dL &lt;130 (Calculated)\r\nFriedewald\'s formula','yes'),
(5018,'Triglyceride','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dL &lt;150 (LipaseGPOPOD)\",\"interval_h\":\"150\",\"cinterval_h\":\"1000\",\"ainterval_h\":\"1500\",\"equipment\":\"C\"}','','GLU-LIP,Misc/HDL,Misc/QC/clinical chemistry','Clinical chemistry/Lipid profile','Lipid Profile','520','','','',1,1,0,1,NULL,'','C','mg/dL &lt;150 (LipaseGPOPOD)','mg/dL &lt;150 (LipaseGPOPOD)','yes'),
(5019,'Sodium','Plain-Blood','{\"type\":\"number\",\"help\":\" mmol/L 136-145 (Direct ISE)\",\"cinterval_l\":\"129\",\"cinterval_h\":\"160\",\"interval_h\":\"145\",\"interval_l\":\"136\",\"ainterval_h\":\"175\",\"ainterval_l\":\"110\",\"equipment\":\"C\",\"accr_status\":\"yes\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/Osmolarity-Serum,Misc/QC/clinical chemistry','Clinical chemistry/Electrolytes','Electrolytes','460','','','',1,1,0,1,NULL,'','C',' mmol/L 136-145 (Direct ISE)',' mmol/L 136-145 (Direct ISE)','yes'),
(5020,'Potassium','Plain-Blood','{\"type\":\"number\",\"help\":\" mmol/L 3.5-5.1 (Direct ISE)\",\"step\":\"0.1\",\"cinterval_l\":\"3\",\"cinterval_h\":\"7.1\",\"interval_h\":\"5.1\",\"interval_l\":\"3.5\",\"ainterval_h\":\"7.5\",\"ainterval_l\":\"1\",\"equipment\":\"C\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1,Misc/Osmolarity-Serum,Misc/QC/clinical chemistry','Clinical chemistry/Electrolytes','Electrolytes','470','','','',1,1,0,1,NULL,'','C',' mmol/L 3.5-5.1 (Direct ISE)',' mmol/L 3.5-5.1 (Direct ISE)','yes'),
(5021,'Iron','Plain-Blood','{\"type\":\"number\",\"help\":\"microgm/dL 41-141 (Ferrozine)\",\"interval_h\":\"141\",\"interval_l\":\"41\",\"ainterval_h\":\"750\",\"equipment\":\"C\"}','','Misc/Anemia,Misc/QC/IRON-UIBC','Clinical chemistry/Anemia Profile','Anemia Profile','','','','',1,1,0,1,NULL,'','C','microgm/dL 41-141 (Ferrozine)','microgm/dL 41-141 (Ferrozine)','yes'),
(5022,'TIBC','Plain-Blood','{\"type\":\"number\",\"calculate\":\"E+E\",\"ex_list\":\"5023,5021\",\"help\":\"microgm/dL 251-406(calculated)\",\"interval_h\":\"406\",\"interval_l\":\"251\",\"ainterval_h\":\"750\",\"equipment\":\"U\",\"accr_status\":\"yes\"}','','Misc/Anemia','Clinical chemistry/Anemia Profile','Anemia Profile','','','','',1,1,0,1,NULL,'','C','microgm/dL 251-406(calculated)','microgm/dL 251-406(calculated)','yes'),
(5023,'UIBC','Plain-Blood','{\"type\":\"number\",\"help\":\"microgm/dL 120-470((Ferrozine Alkaline PH)\",\"interval_h\":\"470\",\"interval_l\":\"120\",\"ainterval_h\":\"600\",\"equipment\":\"C\"}','','Misc/Anemia,Misc/QC/IRON-UIBC','Clinical chemistry/Anemia Profile','Anemia Profile','','','','',1,1,0,1,NULL,'','C','microgm/dL 120-470((Ferrozine Alkaline PH)','microgm/dL 120-470((Ferrozine Alkaline PH)','yes'),
(5024,'Indirect Billirubin','Plain-Blood','{\"type\":\"text\",\"calculate\":\"E-E\",\"ex_list\":\"5009,5010\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/dL)&lt;1.3\",\"cinterval_h\":\"15\",\"interval_h\":\"1.3\",\"ainterval_h\":\"50\",\"equipment\":\"C\"}','','LREG,LRE,LRE-ALBTP-CRPLDH,LRE-CALCRP,BIG1','Clinical chemistry/LFT','Liver Function Tests','430','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/dL)&lt;1.3','(Calculated)(mg/dL)&lt;1.3','yes'),
(5025,'Lactate Dehydrogenase','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L &lt;360 (L to P UV Kinetic)\",\"interval_h\":\"360\",\"equipment\":\"C\"}','','LRE-ALBTP-CRPLDH,BIG1,Misc/QC/clinical chemistry','Clinical chemistry/LDH','','','','','',1,1,0,1,NULL,'','C','U/L &lt;360 (L to P UV Kinetic)','U/L &lt;360 (L to P UV Kinetic)','yes'),
(5026,'Lipase','Plain-Blood','{\"type\":\"number\",\"help\":\" U/L 0-5 (Turbidimetry )\",\"interval_h\":\"5\",\"equipment\":\"C\"}','','AMY-LIP-ALP,Misc/QC/c c mor','Clinical chemistry/AMY-LIP-ALP','Pancreatic Function Tests','','','','',1,1,0,1,NULL,'','C',' U/L 0-5 (Turbidimetry )',' U/L 0-5 (Turbidimetry )','yes'),
(5027,'Uric Acid','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dL 2.6-7.2 (Uricase POD)\",\"step\":\"0.1\",\"interval_h\":\"7.2\",\"cinterval_h\":\"10\",\"ainterval_h\":\"20\",\"equipment\":\"C\"}','','Misc/QC/clinical chemistry,MG-UA','Clinical chemistry/RFT','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','mg/dL 2.6-7.2 (Uricase POD)','mg/dL 2.6-7.2 (Uricase POD)','yes'),
(5028,'VLDL Cholesterol','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &lt;30 (Calculated)\",\"interval_h\":\"30\",\"calculate\":\"E/5\",\"ex_list\":\"5018\",\"equipment\":\"C\"}','','Misc/HDL','Clinical chemistry/Lipid profile','Lipid Profile','560','','','',1,1,0,1,NULL,'','C',' mg/dL &lt;30 (Calculated)',' mg/dL &lt;30 (Calculated)','yes'),
(5029,'Glucose','Plain-CSF','{\"type\":\"number\",\"help\":\"mg/dl 40-70 (GOD-POD)\",\"interval_l\":\"40\",\"interval_h\":\"70\",\"cinterval_l\":\"30\",\"ainterval_h\":\"1500\",\"equipment\":\"C\"}','','Fluid/csf','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','C','mg/dl 40-70 (GOD-POD)','mg/dl 40-70 (GOD-POD)','yes'),
(5030,'Total Protein','Plain-CSF','{\"type\":\"number\",\"help\":\"mg/dL 15-40 (Pyrogallol red)\",\"interval_l\":\"15\",\"interval_h\":\"40\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Fluid/csf','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','C','mg/dL 15-40 (Pyrogallol red)','mg/dL 15-40 (Pyrogallol red)','yes'),
(5031,'Glucose','Fluoride-Blood','{\"type\":\"number\",\"help\":\"Unit: <b>mg/dl</b><br>Method: GOD-POD endpoint<br><a href=\\\"https://www.diabetes.org.uk/professionals/position-statements-reports/diagnosis-ongoing-management-monitoring/new_diagnostic_criteria_for_diabetes\\\">Criteria</a>\",\"interval_l\":\"70\",\"interval_h\":\"140\",\"cinterval_l\":\"55\",\"cinterval_h\":\"300\",\"ainterval_h\":\"1500\",\"ainterval_l\":\"5\",\"equipment\":\"C\"}','','LREG,GLU-LIP,Misc/Osmolarity-Serum','Clinical chemistry/Glucose','Diabetes Mellitus profile','015','','','horizontal2',1,1,0,1,0,'','C','<i>Unit: mg/dL</i><br>\r\n<i>[mmol/L Glucose] = [mg/dL Glucose] / 18 </i><br>\r\n<p style=\"text-align:center;font-weight:bold;\">Criteria for the diagnosis of diabetes (any one of below)</p>\r\n<ol >\r\n	<li > FPG >=126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h.*  </li>\r\n	<li> 2-h PG >=200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by WHO, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.* </li>\r\n	<li> A1C >=6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay.* </li>\r\n	<li > In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose >=200 mg/dL (11.1 mmol/L). </li>\r\n</ol>\r\n	<p ><i>Note1: DCCT, Diabetes Control and Complications Trial; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; NGSP, National Glycohemoglobin Standardization Program; WHO, World Health Organization; 2-h PG, 2-h plasma glucose.</i></p>\r\n	<p><i>Note2: *In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from the same sample or in two separate test samples.</i></p>','<i>Unit: mg/dL</i><br>\r\n<i>[mmol/L Glucose] = [mg/dL Glucose] / 18 </i><br>\r\n<p style=\"text-align:center;font-weight:bold;\">Criteria for the diagnosis of diabetes (any one of below)</p>\r\n<ol >\r\n	<li > FPG >=126 mg/dL (7.0 mmol/L). Fasting is defined as no caloric intake for at least 8 h.*  </li>\r\n	<li> 2-h PG >=200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by WHO, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.* </li>\r\n	<li> A1C >=6.5% (48 mmol/mol). The test should be performed in a laboratory using a method that is NGSP certified and standardized to the DCCT assay.* </li>\r\n	<li > In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose >=200 mg/dL (11.1 mmol/L). </li>\r\n</ol>\r\n	<p ><i>Note1: DCCT, Diabetes Control and Complications Trial; FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; NGSP, National Glycohemoglobin Standardization Program; WHO, World Health Organization; 2-h PG, 2-h plasma glucose.</i></p>\r\n	<p><i>Note2: *In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results from the same sample or in two separate test samples.</i></p>','yes'),
(5032,'Adenosine Deaminase','Plain-CSF','{\"type\":\"number\",\"help\":\"U/mL &lt;15 (Berthelot)\",\"interval_h\":\"15\"}','','Fluid/csf,Misc/QC/ADA','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','','U/mL &lt;15 (Berthelot)','U/mL &lt;15 (Berthelot)',''),
(5033,'Adenosine Deaminase','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"U/mL N/A (Berthelot)\"}','','Fluid/peritoneal,Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','','U/mL N/A (Berthelot)','U/mL N/A (Berthelot)',''),
(5034,'Adenosine Deaminase','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"U/mL N/A (Berthelot)\"}','','Fluid/pleural,Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','','U/mL N/A (Berthelot)','U/mL N/A (Berthelot)',''),
(5035,'Glucose','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"mg/dl NA(GOD-POD)\",\"equipment\":\"C\"}','','Fluid/peritoneal,Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C','mg/dl NA(GOD-POD)','mg/dl NA(GOD-POD)','yes'),
(5036,'Glucose','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"mg/dl NA(GOD-POD)\",\"equipment\":\"C\"}','','Fluid/pleural,Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','C','mg/dl NA(GOD-POD)','mg/dl NA(GOD-POD)','yes'),
(5037,'Total Protein','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"g/dL NA(Biuret)\",\"step\":\"0.1\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','Fluid/pleural,Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','C','g/dL NA(Biuret)','g/dL NA(Biuret)','yes'),
(5038,'Total Protein','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"g/dL NA(Biuret)\",\"step\":\"0.1\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','Fluid/peritoneal,Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C','g/dL NA(Biuret)','g/dL NA(Biuret)','yes'),
(5039,'Lipase','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"U/L NA (Turbidimetry)\",\"equipment\":\"C\"}','','Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA (Turbidimetry)','U/L NA (Turbidimetry)',''),
(5040,'Amylase','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"U/L NA(CNPG)\",\"equipment\":\"C\"}','','Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(CNPG)','U/L NA(CNPG)',''),
(5041,'Lactate Dehydrogenase','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"U/L NA(L to P UV Kinetic)\",\"equipment\":\"C\"}','','Fluid/peritoneal,Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(L to P UV Kinetic)','U/L NA(L to P UV Kinetic)',''),
(5042,'Cholesterol','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\" mg/dL N/A(CHOD-POD)\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A(CHOD-POD)',' mg/dL N/A(CHOD-POD)',''),
(5043,'Triglyceride','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\" mg/dL N/A(Lipase  GPO - POD)\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A(Lipase  GPO - POD)',' mg/dL N/A(Lipase  GPO - POD)',''),
(5044,'Amylase','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"U/L NA(CNPG)\",\"equipment\":\"C\"}','','Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(CNPG)','U/L NA(CNPG)',''),
(5045,'Lipase','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"U/L NA (Turbidimetry)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA (Turbidimetry)','U/L NA (Turbidimetry)',''),
(5046,'Lactate Dehydrogenase','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"U/L NA(L to P UV Kinetic)\",\"equipment\":\"C\"}','','Fluid/pleural,Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(L to P UV Kinetic)','U/L NA(L to P UV Kinetic)',''),
(5047,'Lactate Dehydrogenase','Plain-CSF','{\"type\":\"number\",\"help\":\"U/L NA(L to P UV Kinetic)\",\"equipment\":\"C\"}','','Fluid/csf','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(L to P UV Kinetic)','U/L NA(L to P UV Kinetic)',''),
(5048,'Sodium','Plain-Urine','{\"type\":\"number\",\"help\":\" mmol/L N/A(Direct ISE)\",\"equipment\":\"C\"}','','Urine/Urine.osm','Clinical chemistry/ Urine osmolarity','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mmol/L N/A(Direct ISE)',' mmol/L N/A(Direct ISE)','yes'),
(5049,'Potassium','Plain-Urine','{\"type\":\"number\",\"help\":\" mmol/L N/A(Direct ISE)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','Urine/Urine.osm','Clinical chemistry/ Urine osmolarity','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mmol/L N/A(Direct ISE)',' mmol/L N/A(Direct ISE)',''),
(5050,'Calcium','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dL N/A (Arsenazo III)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Arsenazo III)',' mg/dL N/A (Arsenazo III)','yes'),
(5051,'Phosphorus','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dL N/A (Ammonium Molybdate)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Ammonium Molybdate)',' mg/dL N/A (Ammonium Molybdate)','yes'),
(5052,'Creatinine','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dL N/A (Jaffe two point)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','Urine/PCR','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Jaffe two point)',' mg/dL N/A (Jaffe two point)','yes'),
(5053,'Total Protein','Plain-Urine','{\"type\":\"number\",\"help\":\"g/dL N/A (Biuret)\",\"step\":\"0.1\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','Urine/PCR','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','g/dL N/A (Biuret)','g/dL N/A (Biuret)','yes'),
(5054,'Ketone body','Plain-Urine','{\"type\":\"select\",\"option\":\", Positive , Negative\",\"help\":\" (Nitropruside)\",\"equipment\":\"K\"}','','Urine/Ketone','ACETONE','Urine Examination','','','','',1,1,0,1,NULL,'','K',' (Nitropruside)',' (Nitropruside)','yes'),
(5055,'Uric Acid','Plain-Urine','{\"type\":\"number\",\"help\":\"mg/dL N/A (Uricase POD)\",\"step\":\"0.1\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','mg/dL N/A (Uricase POD)','mg/dL N/A (Uricase POD)','yes'),
(5056,'Protein:creatinine Ratio','Plain-Urine','{\"type\":\"number\",\"calculate\":\"E/e\",\"ex_list\":\"5085,5052\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/mg)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Urine/PCR','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/mg)','(Calculated)(mg/mg)','yes'),
(5057,'Calcium:creatinine Ratio','Plain-Urine','{\"type\":\"number\",\"calculate\":\"E/e\",\"ex_list\":\"5050,5052\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/mg)\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/mg)','(Calculated)(mg/mg)','yes'),
(5058,'24 hours Urine Volume','Plain-Urine','{\"type\":\"number\",\"help\":\"mL (24 hours urine volume)\",\"equipment\":\"C\"}','','Urine/24 HOUR URINE PROFILE','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','mL (24 hours urine volume)','mL (24 hours urine volume)',''),
(5059,'24 hours Urine  Protein','Plain-Urine','{\"type\":\"number\",\"calculate\":\"E*E/100\",\"ex_list\":\"5058,5085,\",\"step\":\"0.1\", \"decimal\":\"1\",\"help\":\"mg(Calculated)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Urine/24 HOUR URINE PROFILE','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','mg(Calculated)','mg(Calculated)','yes'),
(5060,'eGFR','Plain-Blood','{\"type\":\"number\",\"calculate\":\"175*E^-1.154*E^-.203*E*E\",\"ex_list\":\"5001,5088,5087,5089\",\"step\":\"0.1\", \"decimal\":\"1\",\"help\":\"mL/min/1.73 m²(Calculated)(MDRD)\",\"equipment\":\"C\"}','','','Clinical chemistry','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','mL/min/1.73 m²(Calculated)(MDRD)','mL/min/1.73 m²(Calculated)(MDRD)','yes'),
(5061,'Serum Osmolality','Plain-Blood','{\"type\":\"number\",\"calculate\":\"2*E+(E*0.17)+(E*0.06)+9\",\"ex_list\":\"5019,5002,5031\",\"step\":\"0.1\", \"decimal\":\"1\",\"help\":\"(Calculated)\",\"equipment\":\"C\"}','','Misc/Osmolarity-Serum','Clinical chemistry','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','(Calculated)','(Calculated)','yes'),
(5062,'Protein Electrophoresis','Plain-Blood','{\"zoom\":\"zoom\"}','','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5063,'Electrophoresis Observation','EDTA-Blood','{\"type\":\"subsection\",\"readonly\":\"readonly\",\"equipment\":\"E\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','E','','','yes'),
(5064,'Dithonite Test Observation','EDTA-Blood','{\"type\":\"subsection\",\"readonly\":\"readonl\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5065,'Band at HbA position','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Seen,Light,Dark\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5066,'Band at HbF position','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Seen,Light,Dark\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5067,'Band at HbS position','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Seen,Light,Dark\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5068,'Band at HbA2 position','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Seen,Light,Dark\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5069,'Other Bands','EDTA-Blood','{\"zoom\":\"zoom\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5070,'Dithonite test without Urea','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Done,Turbid,Clear\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5071,'Dithonite test with Urea','EDTA-Blood','{\"type\":\"select\",\"option\":\",Not Done,Turbid,Clear\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5072,'Clinical Laboratory Interpretation','EDTA-Blood','{\"zoom\":\"zoom\"}','For HB Electrophoresis','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5073,'Electrophoresis Image','EDTA-Blood','{\"type\":\"blob\",\"img\":\"png\",\"width\":\"300\",\"height\":\"200\"}','','Reference/hb electro','Electrophoresis ','Hemoglobin Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5074,'Remarks','EDTA-Blood','{\"help\":\"HbA1c is your average blood glucose (sugar) levels for the last two to three months. If you have diabetes, an ideal HbA1c level is 48mmol/mol (6.5%) or below. If you\'re at risk of developing type 2 diabetes, your target HbA1c level should be below 42mmol/mol (6%).\"}','','Reference/HbA1c','Diabetes Mellitus','Diabetes Mellitus profile','','40','','horizontal1',1,1,0,1,NULL,'','','HbA1c is your average blood glucose (sugar) levels for the last two to three months. If you have diabetes, an ideal HbA1c level is 48mmol/mol (6.5%) or below. If you\'re at risk of developing type 2 diabetes, your target HbA1c level should be below 42mmol/mol (6%).','HbA1c is your average blood glucose (sugar) levels for the last two to three months. If you have diabetes, an ideal HbA1c level is 48mmol/mol (6.5%) or below. If you\'re at risk of developing type 2 diabetes, your target HbA1c level should be below 42mmol/mol (6%).','yes'),
(5075,'Remarks','Plain-Blood','','','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5076,'Electrophoresis Image','Plain-Blood','{\"type\":\"blob\",\"img\":\"png\",\"width\":\"300\",\"height\":\"200\"}','','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5077,'Clinical Laboratory Interpretation','Plain-Blood','{\"zoom\":\"zoom\",\"equipment\":\"PR\"}','For HB Electrophoresis','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','PR','','','yes'),
(5078,'Electrophoresis Observation','Plain-Blood','{\"type\":\"subsection\",\"readonly\":\"readonly\"}','','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5079,'Band at M position','Plain-Blood','{\"type\":\"select\",\"option\":\",Not Seen,Light,Dark\"}','','Reference/protein electro','Electrophoresis ','Protein Electrophoresis','','','','',1,1,0,1,NULL,'','','','','yes'),
(5080,'Total Protein','Plain-CSF','{\"type\":\"number\",\"help\":\"g/dL 0.015-0.040 (Biuret)\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','Fluid/csf','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','C','g/dL 0.015-0.040 (Biuret)','g/dL 0.015-0.040 (Biuret)','yes'),
(5081,'Total Protein','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\"mg/dL NA(Pyrogallol Red)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Fluid/pleural,Fluid/pleuralAMY-LIP','Clinical chemistry/Fluid','Pleural Fluid Examination	','','','','',1,1,0,1,NULL,'','C','mg/dL NA(Pyrogallol Red)','mg/dL NA(Pyrogallol Red)','yes'),
(5082,'Total Protein','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\"mg/dL NA(Pyrogallol Red)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Fluid/peritoneal,Fluid/peritonealAMY-LIP','Clinical chemistry/Fluid','Peritoneal Fluid Examination	','','','','',1,1,0,1,NULL,'','C','mg/dL NA(Pyrogallol Red)','mg/dL NA(Pyrogallol Red)','yes'),
(5083,'Sodium','Plain-CSF','{\"type\":\"number\",\"help\":\" mmol/L N/A(Direct ISE)\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','CSF Examination','','','','',1,1,0,1,NULL,'','C',' mmol/L N/A(Direct ISE)',' mmol/L N/A(Direct ISE)',''),
(5084,'Calcium','HCL-Urine-BI','{\"type\":\"number\",\"help\":\" mg/dL N/A (Arsenazo III)(Preservative:30 mL 6 M HCL)\",\"step\":\"0.1\",\"method\":\"24Hr Urine\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Arsenazo III)(Preservative:30 mL 6 M HCL)',' mg/dL N/A (Arsenazo III)(Preservative:30 mL 6 M HCL)','yes'),
(5085,'Total Protein','Plain-Urine','{\"type\":\"number\",\"help\":\"mg/dL NA(Pyrogallol Red)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Urine/24 HOUR URINE PROFILE,Urine/PCR','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','mg/dL NA(Pyrogallol Red)','mg/dL NA(Pyrogallol Red)','yes'),
(5086,'Protein:creatinine Ratio (Not in NABL  Scope)','Plain-Urine','{\"type\":\"number\",\"calculate\":\"(E*1000)/e\", \"ex_list\":\"5053,5052\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/mg)\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','','Clinical chemistry/Urine','Urine Examination','','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/mg)','(Calculated)(mg/mg)',''),
(5087,'Sex for eGFR','Plain-Blood','{\"type\":\"select\",\"option\":\",1,0.742\",\"help\":\" (male:1) (female:0.742)\"}','','','Clinical chemistry','','','','','',1,1,0,1,NULL,'','',' (male:1) (female:0.742)',' (male:1) (female:0.742)','yes'),
(5088,'Age for GFR','Plain-Blood','{\"type\":\"number\"}','','','Clinical chemistry','','','','','',1,1,0,1,NULL,'','','','','yes'),
(5089,'race for eGFR','Plain-Blood','{\"type\":\"select\",\"option\":\",1,1.210\",\"help\":\" (Non african:1) (African:1.210)\"}','','','Clinical chemistry','','','','','',1,1,0,1,NULL,'','',' (Non african:1) (African:1.210)',' (Non african:1) (African:1.210)','yes'),
(5092,'CK','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L 25-125 (phosphocreatine HK G6PD)\",\"interval_h\":\"125\",\"equipment\":\"C\"}','','Misc/Cardiac profile,Misc/QC/c c mor','Clinical chemistry/Cardiac Profile','','','','','',1,1,0,1,NULL,'','C','U/L 25-125 (phosphocreatine HK G6PD)','U/L 25-125 (phosphocreatine HK G6PD)','yes'),
(5093,'CK-MB','Plain-Blood','{\"type\":\"number\",\"help\":\"U/L 0-24 (Immunoinhibition, HK, G6PD)\",\"interval_h\":\"24\",\"equipment\":\"C\"}','','Misc/Cardiac profile,Misc/QC/c c mor','Clinical chemistry/Cardiac Profile','Cardiac Profile','','','','',1,1,0,1,NULL,'','C','U/L 0-24 (Immunoinhibition, HK, G6PD)','U/L 0-24 (Immunoinhibition, HK, G6PD)','yes'),
(5094,'Creatinine','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\" mg/dL N/A (Jaffe two point)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Jaffe two point)',' mg/dL N/A (Jaffe two point)',''),
(5095,'Sample_Rejection','None','{\"type\":\"select\",\"option\":\",not done as sample inadequate\"}','','Misc/Remarks','','Remarks','','','','',1,1,0,1,NULL,'','','','',''),
(5096,'Examination_Rejection','None','{\"type\":\"select\",\"option\":\",not done because instrument is breakdown, some examinations are not done because sample is inadequate,Creatinine is  not done because sample is highly icteric and high bilirubin has negative interference on creatinine level,not done because sample not received, not  done because sample was highly hemolyzed, not done as lab resources are inadequate ,not  done because sample was highly viscous ,examinations are not done because sample is clotted,not done because sample is overfilled\"}','','Misc/Remarks','','Remarks','','','','',1,1,0,1,NULL,'','','','',''),
(5097,'Critical_Alert','None','{\"zoom\":\"zoom\"}','','Misc/Remarks','','Remarks','','','','',1,1,0,1,NULL,'','','','',''),
(5098,'Remark','None','{\"zoom\":\"zoom\"}','','Misc/Remarks','','Remarks','','','','',1,1,0,1,NULL,'','','','',''),
(5099,'Withdrawn_Report','None','{\"zoom\":\"zoom\"}','','Misc/Remarks','','Remarks','','','','',1,1,0,1,NULL,'','','','',''),
(5100,'Phosphorus','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL &lt;2.5-4.5 (Ammonium Molybdate)\",\"step\":\"0.1\",\"cinterval_l\":\"1\",\"cinterval_h\":\"8.9\",\"interval_h\":\"4.5\",\"interval_l\":\"2.5\",\"ainterval_h\":\"12.0\",\"ainterval_l\":\"0.5\",\"equipment\":\"C\"}','','BIG1,Misc/QC/clinical chemistry','Clinical chemistry/cal-pho-mag','Electrolytes','','','','',1,1,0,1,NULL,'','C',' mg/dL &lt;2.5-4.5 (Ammonium Molybdate)',' mg/dL &lt;2.5-4.5 (Ammonium Molybdate)','yes'),
(5101,'Corrected Calcium','Plain-Blood','{\"type\":\"number\",\"calculate\":\"0.8*(4-E)+E\",\"ex_list\":\"5011,5014\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/dL)8.6 - 10.2\",\"equipment\":\"C\"}','','','Clinical chemistry/cal-pho-mag','Electrolytes','','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/dL)8.6 - 10.2','(Calculated)(mg/dL)8.6 - 10.2','yes'),
(5102,'Ketone body','Plain-Blood','{\"type\":\"select\",\"option\":\",Positive,Negative,Not Done(See Remark)\",\"help\":\" (Nitropruside)\",\"equipment\":\"K\"}','','','ACETONE','','','','','',1,1,0,1,NULL,'','K',' (Nitropruside)',' (Nitropruside)','yes'),
(5103,'OPD_Sequence','None','','For Biochemistry OPD Sequence','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5105,'Lactate Dehydrogenase','Plain-Other','{\"type\":\"number\",\"help\":\"U/L NA(L to P UV Kinetic)\",\"equipment\":\"C\"}','','Fluid/otherfluid','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(L to P UV Kinetic)','U/L NA(L to P UV Kinetic)',''),
(5106,'Amylase','Plain-Other','{\"type\":\"number\",\"help\":\"U/L NA(CNPG)\",\"equipment\":\"C\"}','AMY+LIP','Fluid/otherfluid/otherfluidAmy+Lip','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA(CNPG)','U/L NA(CNPG)',''),
(5107,'Lipase','Plain-Other','{\"type\":\"number\",\"help\":\"U/L NA (Turbidimetry)\",\"equipment\":\"C\"}','','Fluid/otherfluid/otherfluidAmy+Lip','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C','U/L NA (Turbidimetry)','U/L NA (Turbidimetry)',NULL),
(5108,'Glucose','Plain-Other','{\"type\":\"number\",\"help\":\"mg/dl NA(GOD-POD)\",\"equipment\":\"C\"}','','Fluid/otherfluid','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C','mg/dl NA(GOD-POD)','mg/dl NA(GOD-POD)','yes'),
(5109,'Cholesterol','Plain-Other','{\"type\":\"number\",\"help\":\" mg/dL N/A(CHOD-POD)\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A(CHOD-POD)',' mg/dL N/A(CHOD-POD)',NULL),
(5110,'Triglyceride','Plain-Other','{\"type\":\"number\",\"help\":\" mg/dL N/A(Lipase  GPO - POD)\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A(Lipase  GPO - POD)',' mg/dL N/A(Lipase  GPO - POD)',''),
(5111,'Micro Protein','Plain-Other','{\"type\":\"number\",\"help\":\"mg/dL NA(Pyrogallol Red)\",\"method\":\"Pyrogallol Red\",\"equipment\":\"C\"}','','Fluid/otherfluid,Misc/QC/c c mor','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C','mg/dL NA(Pyrogallol Red)','mg/dL NA(Pyrogallol Red)',NULL),
(5112,'Total Protein','Plain-Other','{\"type\":\"number\",\"help\":\" g/dL N/A (Biuret)\",\"step\":\"0.1\",\"method\":\"Biuret\",\"equipment\":\"C\"}','','Fluid/otherfluid','Clinical chemistry/Fluid','Other Fluid Examination','','','','',1,1,0,1,NULL,'','C',' g/dL N/A (Biuret)',' g/dL N/A (Biuret)',NULL),
(5113,'Cholinesterase','Plain-Blood','{\"type\":\"number\",\"help\":\" U/L &lt;3000-13000 (Butyrylthiocholine)\",\"cinterval_l\":\"3000\",\"equipment\":\"C\"}','','CHE','Clinical chemistry/CHE','','','','','',1,1,0,1,NULL,'','C',' U/L &lt;3000-13000 (Butyrylthiocholine)',' U/L &lt;3000-13000 (Butyrylthiocholine)','yes'),
(5114,'HCL wash','Plain-Blood','{\"hide\":\"yes\"}','','Misc/QC/clinical chemistry','Clinical chemistry','','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(5115,'Total T4','Plain-Blood','{\"type\":\"number\",\"help\":\"nmol/L , 71.2-141 , (ECIA)\",\"equipment\":\"I\"}','','Reference','Immunochemistry/Thyroid profile ','','','','','',1,1,0,1,NULL,'','I','nmol/L , 71.2-141 , (ECIA)','nmol/L , 71.2-141 , (ECIA)',NULL),
(5116,'Total T3','Plain-Blood','{\"type\":\"number\",\"help\":\"nmol/L , 1.49-2.60 , (ECIA)\",\"equipment\":\"I\"}','','Reference','Immunochemistry/Thyroid profile ','','','','','',1,1,0,1,NULL,'','I','nmol/L , 1.49-2.60 , (ECIA)','nmol/L , 1.49-2.60 , (ECIA)',NULL),
(5117,'TSH','Plain-Blood','{\"type\":\"number\",\"help\":\"mIU/L (CLIA)\\n, 0.465-4.68 \\nNormal ranges for thyroid function tests in infants and children\\n Age             Free T4*(ng/dL)              T4(mcg/dL)        Free T3(pg/mL)     T3(ng/dL)      TSH(mU/L)              TBG(mg/dL)\\n Cord blood      0.9 to 2.2                   7.8 to 13.1       0.2 to 2.4         15 to 75       2.2 to 10.7            1.4 to 9.4\\n 1 to 4 days     2.2 to 5.3                   9.3 to 20.9       1.8 to 7.6         100 to 740     2.7 to 26.5\\n 4 to 30 days    0.9 to 3.4                   8.0 to 21.8       2.93 to 5.08       105 to 387     1.2 to 13.1            1.9 to 4.5\\n 1 to 12 months  0.9 to 2.3                   7.2 to 15.7       2.67 to 5.21       105 to 245     0.6 to 7.3             1.9 to 4.4\\n 1 to 5 years    0.8 to 1.8                   6.4 to 13.5       2.73 to 4.95       105 to 269     0.7 to 6.6             1.6 to 4.2\\n 6 to 10 years   1.0 to 2.1                   6.0 to 12.8       2.73 to 4.69       94 to 241      0.8 to 6.0             1.4 to 3.7\\n 11 to 18 years  0.8 to 1.9                   4.7 to 12.4       2.67 to 4.62       80 to 210      0.6 to 5.8             1.2 to 2.9\\n &gt;18 years       0.9 to 2.5                   5.3 to 10.5       2.10 to 4.40       70 to 204      0.4 to 4.2             1.5 to 3.4\\n T4: thyroxine; T3: triiodothyronine; TSH: thyroid-stimulating hormone; TBG: thyroxine-binding globulin.\\n * Because the normal free T4 reference range varies according to the assay method, clinicians need to determine the range for their specific laboratory, which may differ from the data presented in the table.\\n Data adapted from the following sources:\\n      Nelson JC, Clark SJ, Bonut DL, et al. Age-related changes in serum free thyroxine during childhood and adolescence. J Pediatr 1993; 123:899.\\n     Elmlinger MW, Kühnel W, Lambrecht HG, et al. Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med 2001; 39:973.\\n     Mutlu M, Karagüzel G, Alıyazicioğlu Y, et al. Reference intervals for thyrotropin and thyroid hormones and ultrasonographic thyroid volume during the neonatal period. J Matern Fetal Neonatal Med 2012; 25:120.\\n     Strich D, Edri S, Gillis D. Current normal values for TSH and FT3 in children are too low: evidence from over 11,000 samples. J Pediatr Endocrinol Metab 2012; 25:245.\\n     Lem AJ, de Rijke YB, van Toor H, et al. Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age. J Clin Endocrinol Metab 2012; 97:3170.\\n     Esoterix (Endocrine Sciences). \",\"interval_l\":\"0.465\",\"interval_h\":\"4.68\",\"equipment\":\"I\"}','','TSH,Misc/QC/Immunochemistry','Immunochemistry/Thyroid profile','Thyroid Profile','','','','horizontal3',1,1,0,1,NULL,'','I','mIU/L (CLIA), ref.reg:0.465-4.68 ','mIU/L (CLIA), ref.reg:0.465-4.68 ','yes'),
(5118,'Ferritin','Plain-Blood','{\"type\":\"number\",\"help\":\"microgram/L\\n Male(Adult): 20-250\\n Female(Adult): 10-120\\n Newborn: 25-200 \\n 1 month: 200-600  \\n 2-5 month:50-200  \\n 6 month-15 years:7-140  \\n(ECLIA) \",\"interval_l\":\"6.24\",\"interval_h\":\"464\",\"equipment\":\"I\"}','','Misc/Anemia,Misc/QC/Immunochemistry','Immunochemistry/Anemia profile','Anemia Profile','','','','',1,1,0,1,NULL,'','I','microgram/L\\n Male(Adult): 20-250\\n Female(Adult): 10-120\\n Newborn: 25-200 \\n 1 month: 200-600  \\n 2-5 month:50-200  \\n 6 month-15 years:7-140  \\n(ECLIA) ','microgram/L\\n Male(Adult): 20-250\\n Female(Adult): 10-120\\n Newborn: 25-200 \\n 1 month: 200-600  \\n 2-5 month:50-200  \\n 6 month-15 years:7-140  \\n(ECLIA) ',''),
(5120,'Procalcitonin (PCT)','Plain-Blood','{\"type\":\"number\",\"help\": \"microgram/L \\n # less than 0.5 =&gt; systemic bacterial infection is unlikely \\n # 0.5-2.0 =&gt; systemic bacterial infection is possible \\n # 2.0-10.0 =&gt; systemic bacterial infection is likely \\n # more than 10.0 =&gt; almost exclusively due to systemic bacterial infection\\n(ECIA)\", \"interval_h\":\"0.5\",\"cinterval_h\":\"2\",\"equipment\":\"I\"}','','','','Inflammatory markers','','','','',1,1,0,1,NULL,'','I','microgram/L \\n # less than 0.5 =&gt; systemic bacterial infection is unlikely \\n # 0.5-2.0 =&gt; systemic bacterial infection is possible \\n # 2.0-10.0 =&gt; systemic bacterial infection is likely \\n # more than 10.0 =&gt; almost exclusively due to systemic bacterial infection\\n(ECIA)','microgram/L \\n # less than 0.5 =&gt; systemic bacterial infection is unlikely \\n # 0.5-2.0 =&gt; systemic bacterial infection is possible \\n # 2.0-10.0 =&gt; systemic bacterial infection is likely \\n # more than 10.0 =&gt; almost exclusively due to systemic bacterial infection\\n(ECIA)',''),
(5121,'CRP','Plain-Blood','{\"type\":\"number\",\"help\": \"mg/L \\n less than 10 \\n This is not hsCRP. Donot use this result for interpretation when result is less than 10\\n(Immunoturbidimetry)\",\"interval_h\":\"10\",\"equipment\":\"D\"}','','LRE-ALBTP-CRPLDH,LRE-CALCRP,Misc/CRP,Misc/QC/c c mor','Clinical chemistry/CRP','Inflammatory markers','','','','',1,1,0,1,NULL,'','D','mg/L \r\nless than 10 \r\nThis is not hsCRP. Donot use this result for interpretation when result is less than 10\r\n(Immunoturbidimetry)','mg/L \r\nless than 10 \r\nThis is not hsCRP. Donot use this result for interpretation when result is less than 10\r\n(Immunoturbidimetry)','yes'),
(5122,'D-dimer','Citrate-Blood','{\"type\":\"number\",\"help\":\"microgram/L , &lt;500 , (ECIA)\",\"interval_h\":\"500\",\"equipment\":\"D\"}','','Misc/QC/c c mor,D- dimer','','Inflammatory markers','','','','',1,1,0,1,NULL,'','C','microgram/L , &lt;500 , (ECIA)','microgram/L , &lt;500 , (ECIA)',''),
(5123,'Cardiac Troponin I (cTnI)','Plain-Blood','{\"type\":\"number\",\"help\":\"ng/L\\n Male: 8.8-23.7\\n Female: 4.4-21.4\\n (high sensitivity, ECIA)\",\"interval_h\":\"23.7\",\"equipment\":\"I\"}','','Misc/Cardiac profile','','Cardiac Profile','','','','',1,1,0,1,NULL,'','I','ng/L\\n Male: 8.8-23.7\\n Female: 4.4-21.4\\n (high sensitivity, ECIA)','ng/L\\n Male: 8.8-23.7\\n Female: 4.4-21.4\\n (high sensitivity, ECIA)',''),
(5124,'Interleukin-6','EDTA-Blood','{\"help\":\"pg/mL\\n  &lt;7.0 \\n (upconverting phosphor immunoassay)\",\"interval_h\":\"7\",\"equipment\":\"6\"}','','','','','','','','',1,1,0,1,NULL,'','6','pg/mL\\n  &lt;7.0 \\n (upconverting phosphor immunoassay)','pg/mL\\n  &lt;7.0 \\n (upconverting phosphor immunoassay)',''),
(5125,'NT-ProBNP','Plain-Blood','{\"help\":\"pg/ml (ECIA)\\n===Heart Failure Unlikely===\\n # Any age, &lt;300\\n====Heart Failure Likely====\\n # 20-50 Y, &gt;450 \\n # 50-75 Y, &gt;900\\n # &gt;75Y, &gt;1800\",\"interval_h\":\"300\",\"equipment\":\"I\"}','','Reference,Misc/QC/Immunochemistry','','Cardiac Profile','','','','',1,1,0,1,NULL,'','I','pg/ml (ECIA)\\n===Heart Failure Unlikely===\\n # Any age, &lt;300\\n====Heart Failure Likely====\\n # 20-50 Y, &gt;450 \\n # 50-75 Y, &gt;900\\n # &gt;75Y, &gt;1800','pg/ml (ECIA)\\n===Heart Failure Unlikely===\\n # Any age, &lt;300\\n====Heart Failure Likely====\\n # 20-50 Y, &gt;450 \\n # 50-75 Y, &gt;900\\n # &gt;75Y, &gt;1800',''),
(5126,'Request Form','None','{\"type\":\"blob\"}','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5127,'Free T4','Plain-Blood','{\"type\":\"number\",\"help\": \"pmol/L \\n 10.0-28.2 \\n(ECIA)\",\"interval_l\":\"10.0\",\"interval_h\":\"28.2\",\"equipment\":\"I\"}','','Reference,Misc/QC/Immunochemistry','','Thyroid Profile','','','','',1,1,0,1,NULL,'','I','pmol/L \\n 10.0-28.2 \\n(ECIA)','pmol/L \\n 10.0-28.2 \\n(ECIA)',''),
(5128,'Free T3','Plain-Blood','{\"type\":\"number\",\"help\": \"pmol/L \\n 4.26-8.10 \\n(ECIA)\",\"interval_l\":\"4.26\",\"interval_h\":\"8.10\",\"equipment\":\"I\"}','','Reference,Misc/QC/Immunochemistry','','Thyroid Profile','','','','',1,1,0,1,NULL,'','I','pmol/L \\n 4.26-8.10 \\n(ECIA)','pmol/L \\n 4.26-8.10 \\n(ECIA)',NULL),
(5129,'prolactin','Plain-Blood','{\"type\":\"number\",\"help\": \"ng/mL \\n Normal Nonpregnant Female: 3.0-18.6 \\n Male:3.7-17.9 \\n(ECIA)\",\"interval_h\":\"18.6\",\"equipment\":\"I\"}','','Misc/Fertility','Reproductive Profile','Reproductive Profile','','','','',1,1,0,1,NULL,'','I','ng/mL \\n Normal Nonpregnant Female: 3.0-18.6 \\n Male:3.7-17.9 \\n(ECIA)','ng/mL \\n Normal Nonpregnant Female: 3.0-18.6 \\n Male:3.7-17.9 \\n(ECIA)',NULL),
(5130,'FSH','Plain-Blood','{\"type\":\"number\",\"help\": \"IU/L \\n # normal female follicular phase =&gt; 1.98-11.6 \\n # norma female midcycle peak=&gt;5.14-23.4 \\n # normal female lueal phase =&gt; 1.38-9.58 \\n # post menopausal female =&gt; 21.5- 131 \\n Normal male=&gt; 1.555-9.74 \\n(ECIA)\", \"equipment\":\"I\"}','','Misc/Fertility,Misc/QC/Immunochemistry','Reproductive Profile','Reproductive Profile','','','','',1,1,0,1,NULL,'','I','IU/L \\n # normal female follicular phase =&gt; 1.98-11.6 \\n # norma female midcycle peak=&gt;5.14-23.4 \\n # normal female lueal phase =&gt; 1.38-9.58 \\n # post menopausal female =&gt; 21.5- 131 \\n Normal male=&gt; 1.555-9.74 \\n(ECIA)','IU/L \\n # normal female follicular phase =&gt; 1.98-11.6 \\n # norma female midcycle peak=&gt;5.14-23.4 \\n # normal female lueal phase =&gt; 1.38-9.58 \\n # post menopausal female =&gt; 21.5- 131 \\n Normal male=&gt; 1.555-9.74 \\n(ECIA)',NULL),
(5131,'LH','Plain-Blood','{\"type\":\"number\",\"help\": \"IU/L \\n # normal female follicular phase =&gt; 2.58-12.1 \\n # norma female midcycle peak=&gt;27.3-96.9 \\n # normal female lueal phase =&gt; 0.833-15.5 \\n # post menopausal female =&gt; 13.1- 86.5 \\n(ECIA)\", \"equipment\":\"I\"}','','Misc/Fertility,Misc/QC/Immunochemistry','Reproductive Profile','Reproductive Profile','','','','horizontal2',1,1,0,1,NULL,'','I','IU/L \\n # normal female follicular phase =&gt; 2.58-12.1 \\n # norma female midcycle peak=&gt;27.3-96.9 \\n # normal female lueal phase =&gt; 0.833-15.5 \\n # post menopausal female =&gt; 13.1- 86.5 \\n(ECIA)','IU/L \\n # normal female follicular phase =&gt; 2.58-12.1 \\n # norma female midcycle peak=&gt;27.3-96.9 \\n # normal female lueal phase =&gt; 0.833-15.5 \\n # post menopausal female =&gt; 13.1- 86.5 \\n(ECIA)',NULL),
(5132,'Magnesium','Plain-Blood','{\"type\":\"number\",\"help\":\" mg/dL 1.7-2.7 (Xylidyl blue)\",\"step\":\"0.1\",\"interval_h\":\"2.7\",\"interval_l\":\"1.7\",\"equipment\":\"C\"}','','Misc/QC/clinical chemistry,MG-UA','Clinical chemistry/cal-pho-mag','Electrolytes','','','','',1,1,0,1,NULL,'','C',' mg/dL 1.7-2.7 (Xylidyl blue)',' mg/dL 1.7-2.7 (Xylidyl blue)','yes'),
(5133,'B-hCG','Plain-Blood','{\"type\":\"number\",\"help\":\"IU/L,&lt;=25, (ECIA) , <h4>This Examination is not under NABL SCOPE</h4>\",\"interval_h\":\"25\",\"equipment\":\"I\"}','','Misc/bHCG,Misc/QC/Immunochemistry','Reproductive Profile','Reproductive Profile','','','','',1,1,0,1,NULL,'','I','IU/L,&lt;=25, (ECIA) , <h4>This Examination is not under NABL SCOPE</h4>','IU/L,&lt;=25, (ECIA) , <h4>This Examination is not under NABL SCOPE</h4>',NULL),
(5134,'Urine osmolality','Plain-Urine','{\"type\":\"number\",\"help\":\" mmol/L&lt;1200 (Calculated)\",\"calculate\":\"E/6+E/18+2*E+2*E+E/11.312\",\"ex_list\":\"5135,5136,5048,5049,5052\",\"equipment\":\"C\"}','','Urine/Urine.osm','Clinical chemistry/ Urine osmolarity','Renal Function Tests','','','','',1,1,0,1,NULL,'','C',' mmol/L&lt;1200 (Calculated)',' mmol/L&lt;1200 (Calculated)','yes'),
(5135,'Urea','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dl(urease GLDH)\",\"equipment\":\"C\"}','','Urine/Urine.osm','Clinical chemistry/ Urine osmolarity','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dl(urease GLDH)',' mg/dl(urease GLDH)',NULL),
(5136,'Glucose','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dl(GOD-POD endpoint)\",\"equipment\":\"C\"}','','Urine/Urine.osm','Clinical chemistry/ Urine osmolarity','Urine Examination','','','','',1,1,0,1,NULL,'','C',' mg/dl(GOD-POD endpoint)',' mg/dl(GOD-POD endpoint)',''),
(5137,'Creatinine','Plain-Urine','{\"type\":\"number\",\"help\":\" mg/dL N/A (Jaffe two point)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','','Renal Function Tests','','','','',1,1,0,1,NULL,'','C',' mg/dL N/A (Jaffe two point)',' mg/dL N/A (Jaffe two point)',NULL),
(5138,'HCL wash','Plain-Blood','{\"hide\":\"yes\"}','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5139,'Adenosine Deaminase','Plain-Other','{\"type\":\"number\",\"help\":\"U/mL N/A (Berthelot)\"}','','Fluid/otherfluid','','Other Fluid Examination','','','','',1,1,0,1,NULL,'','','U/mL N/A (Berthelot)','U/mL N/A (Berthelot)',''),
(5140,'Testosterone','Plain-Blood','{\"type\":\"number\",\"help\": \"nmol/L \\n #  Normal male(20-49 years) : 4.56-28.2 \\n # Normal males(&gt;50 years): 2.49-21.6 \\n #  Females with normal  menstrual  cycles : 0.198-2.67  \\n(ECIA)\", \"equipment\":\"I\"}','','','','','','','','',1,1,0,1,NULL,'','I','nmol/L \\n #  Normal male(20-49 years) : 4.56-28.2 \\n # Normal males(&gt;50 years): 2.49-21.6 \\n #  Females with normal  menstrual  cycles : 0.198-2.67  \\n(ECIA)','nmol/L \\n #  Normal male(20-49 years) : 4.56-28.2 \\n # Normal males(&gt;50 years): 2.49-21.6 \\n #  Females with normal  menstrual  cycles : 0.198-2.67  \\n(ECIA)',''),
(5141,'Total 25-OH Vit-D','Plain-Blood','{\"type\":\"number\",\"help\":\"nmol/L\\n Deficient: &lt;50\\n Insufficient: 50-&lt;75\\n Sufficient: 75-250 \\n potential toxicity: &gt;250\\n(ECIA) \\n Multiply The Value with 0.4 to Covert it from nmol/L into ng/ml \",\"interval_l\":\"75\",\"interval_h\":\"250\",\"equipment\":\"I\"}','','Reference,Misc/QC/Immunochemistry','','Vitamins','','','','',1,1,0,1,NULL,'','I','nmol/L\\n Deficient: &lt;50\\n Insufficient: 50-&lt;75\\n Sufficient: 75-250 \\n potential toxicity: &gt;250\\n(ECIA) \\n Multiply The Value with 0.4 to Covert it from nmol/L into ng/ml ','nmol/L\\n Deficient: &lt;50\\n Insufficient: 50-&lt;75\\n Sufficient: 75-250 \\n potential toxicity: &gt;250\\n(ECIA) \\n Multiply The Value with 0.4 to Covert it from nmol/L into ng/ml ',''),
(5142,'Vitamin B12','Plain-Blood','{\"type\":\"number\",\"help\":\"pmol/L 176-687  \\n(ECIA)\",\"interval_h\":\"687\",\"interval_l\":\"176\",\"equipment\":\"I\"}','','Reference,Misc/QC/Immunochemistry','','Vitamins','','','','',1,1,0,1,NULL,'','I','pmol/L 176-687  \\n(ECIA)','pmol/L 176-687  \\n(ECIA)',''),
(5143,'pH','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"7.35-7.45 (Direct ISE)\",\"interval_l\":\"7.35\",\"interval_h\":\"7.45\",\"cinterval_l\":\"7.20\",\"cinterval_h\":\"7.60\",\"ainterval_h\":\"7.8\",\"ainterval_l\":\"6.9\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','7.35-7.45 (Direct ISE)','7.35-7.45 (Direct ISE)',''),
(5144,'PCO2','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmHg 32-48 (Direct ISE)\",\"interval_l\":\"32\",\"interval_h\":\"48\",\"cinterval_l\":\"20\",\"cinterval_h\":\"70\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmHg 32-48 (Direct ISE)','mmHg 32-48 (Direct ISE)',''),
(5145,'PO2','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmHg 83-108 (Direct ISE)\",\"interval_l\":\"83\",\"interval_h\":\"108\",\"cinterval_l\":\"40\",\"cinterval_h\":\"250\",\"ainterval_h\":\"500\",\"ainterval_l\":\"20\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmHg 83-108 (Direct ISE)','mmHg 83-108 (Direct ISE)',''),
(5146,'Hematocrit','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"% (Calculated)\\n Male 20-60\\n Female 30-60\",\"interval_l\":\"20\",\"interval_h\":\"60\",\"equipment\":\"A\"}','','','','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','% (Calculated)\\n Male 20-60\\n Female 30-60','% (Calculated)\\n Male 20-60\\n Female 30-60',''),
(5147,'ct Hct','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5148,'Na+','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 136-145 (Direct ISE)\",\"interval_l\":\"136\",\"interval_h\":\"145\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 136-145 (Direct ISE)','mmol/L 136-145 (Direct ISE)',''),
(5149,'K+','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 3.5-5.1 (Direct ISE)\",\"interval_l\":\"3.5\",\"interval_h\":\"5.1\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 3.5-5.1 (Direct ISE)','mmol/L 3.5-5.1 (Direct ISE)',''),
(5150,'Ionized Calcium(Ca2+)','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 1.15-1.30 (Direct ISE)\",\"interval_l\":\"1.15\",\"interval_h\":\"1.30\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 1.15-1.30 (Direct ISE)','mmol/L 1.15-1.30 (Direct ISE)',''),
(5151,'Cl-','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 101-110 (Direct ISE)\",\"interval_l\":\"101\",\"interval_h\":\"110\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 101-110 (Direct ISE)','mmol/L 101-110 (Direct ISE)',''),
(5152,' Base(B)','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L -3.0-3.0 (Calculated)\",\"interval_l\":\"-3.0\",\"interval_h\":\"3.0\",\"equipment\":\"A\"}','','','','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L -3.0-3.0 (Calculated)','mmol/L -3.0-3.0 (Calculated)',''),
(5153,'Anion Gap','Heparinised-Arterial_Blood','','','','','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5154,'HCO3 ','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 22.0-28.0 (Calculated)\",\"interval_l\":\"22.0\",\"interval_h\":\"28.0\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 22.0-28.0 (Calculated)','mmol/L 22.0-28.0 (Calculated)',''),
(5155,'cHCO3-(P,st)c','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 22.0-28.0 (Calculated)\",\"interval_l\":\"22.0\",\"interval_h\":\"28.0\",\"equipment\":\"A\"}','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5156,'sO2','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L 95.0-99.0 (Calculated)\",\"interval_l\":\"95.0\",\"interval_h\":\"99.0\",\"equipment\":\"A\"}','','','','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','A','mmol/L 95.0-99.0 (Calculated)','mmol/L 95.0-99.0 (Calculated)',''),
(5157,'Bilirubin Reference range','Plain-Blood','{\"zoom\":\"zoom\"}','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5158,'Glucose','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mg/dl  (Amperometry)\",\"equipment\":\"A\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5159,'Lactate','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)\",\"interval_h\":\"1.3\"}','','Misc/ABG,Misc/QC/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)','mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)',''),
(5160,'tHb','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)\",\"interval_h\":\"1.3\"}','','Misc/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5161,'FO2Hb','Heparinised-Arterial_Blood','','','','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5162,'FCOHb','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"% less than 2 (Photometry)\",\"equipment\":\"A\"}','','Misc/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5163,'FMetHb','Heparinised-Arterial_Blood','{\"type\":\"number\",\"help\":\"% less than 2 (Photometry)\",\"equipment\":\"A\"}','','Misc/ABG','Blood Gas Analysis','Arterial Blood Gas Analysis','','','','',1,1,0,1,NULL,'','','','',''),
(5164,'FHHb','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5165,'HCO3-std','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5166,'ctCO2','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5167,'mOSm','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5168,'BO2','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(5169,'ct O2(a)','Heparinised-Arterial_Blood','','','','','','','','','',1,1,0,1,NULL,'','',NULL,NULL,NULL),
(5171,'Anti-SARS-CoV-2 IgG','Plain-Blood','{\"type\":\"number\",\"help\":\"Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)\",\"equipment\":\"I\"}','','','','','','','','',1,1,0,1,NULL,'','I','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)',NULL),
(5172,'Sodium','Plain-Urine','{\"type\":\"number\",\"help\":\" mmol/L N/A(Direct ISE)\",\"equipment\":\"C\"}','','','','','','','','',1,1,0,1,NULL,'','C',' mmol/L N/A(Direct ISE)',' mmol/L N/A(Direct ISE)','yes'),
(5173,'Potassium','Plain-Urine','{\"type\":\"number\",\"help\":\" mmol/L N/A(Direct ISE)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','','','','','','',1,1,0,1,NULL,'','C',' mmol/L N/A(Direct ISE)',' mmol/L N/A(Direct ISE)',NULL),
(5174,'HbA1c','EDTA-Blood','{\"type\":\"number\",\"help\":\" % \\n &lt; 5.7 =normal \\n 5.7-6.4 =prediabetes \\n &gt;6.4 =diabetes \\n (HPLC)\",\"step\":\"0.1\",\"interval_h\":\"6.5\",\"equipment\":\"H\",\"accreditation\":\"yes\"}','','Reference/HbA1c,Misc/QC/HbA1c','Diabetes Mellitus','Diabetes Mellitus profile','','10','','',1,1,0,1,NULL,'','H',' % \\n &lt; 5.7 =normal \\n 5.7-6.4 =prediabetes \\n &gt;6.4 =diabetes \\n (HPLC)',' % \\n &lt; 5.7 =normal \\n 5.7-6.4 =prediabetes \\n &gt;6.4 =diabetes \\n (HPLC)','yes'),
(5175,'SARS-CoV-2 Ag','Plain-Swab','{\"type\":\"number\",\"help\":\"Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)\",\"equipment\":\"I\"}','','','','','','','','',1,1,0,1,NULL,'','I','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)',NULL),
(5176,'SARS-CoV-2 RT-PCR-E','Plain-Swab','{\"type\":\"number\",\"help\":\"Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)\",\"equipment\":\"I\"}','','','','','','','','',1,1,0,1,NULL,'','I','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)',NULL),
(5177,'SARS-CoV-2 RT-PCR-N','Plain-Swab','{\"type\":\"number\",\"help\":\"Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)\",\"equipment\":\"I\"}','','','','','','','','',1,1,0,1,NULL,'','I','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)','Test/Cutoff Ratio \\n &lt;1   = Non reactive\\n &gt;1   = Reactive \\n(ECIA)',NULL),
(5178,'HbA1c Chromatogram','EDTA-Blood','{\"type\":\"blob\",\"img\":\"png\"}','','Reference/HbA1c,Misc/QC/HbA1c','Diabetes Mellitus','','','30','','',1,1,0,1,NULL,'','','','',''),
(5179,'HbF','EDTA-Blood','{\"equipment\":\"H\"}','','Reference/HbA1c,Misc/QC/HbA1c','Diabetes Mellitus','','','20','','',1,1,0,1,NULL,'','H','','',''),
(5180,'Rapid SARS-CoV-2 Ag card test','Plain-Swab','{\"type\":\"select\",\"option\":\", Positive , Negative\"}','','','','','','','','',1,1,0,1,NULL,'','','','',''),
(5181,'Albumin','Plain-Peritoneal_Fluid','{\"type\":\"number\",\"help\":\" g/dL N/A (BCG)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','','Peritoneal Fluid Examination','','','','',1,1,0,1,NULL,'','C',' g/dL N/A (BCG)',' g/dL N/A (BCG)',NULL),
(5182,'Micro albumin','Plain-Urine','{\"type\":\"number\",\"help\":\"mg/L (Turbilatex)\",\"method\":\"Turbilatex\",\"equipment\":\"C\"}','','Misc/QC/c c mor','','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','mg/L (Turbilatex)','mg/L (Turbilatex)',NULL),
(5183,'ACR (Albumin-creatinine ratio)','Plain-Urine','{\"type\":\"number\",\"calculate\":\"(E*100)/e\", \"ex_list\":\"5182,5137\", \"step\":\"0.1\",\"decimal\":\"1\",\"help\":\"(Calculated)(mg/gm) \\n Normal&lt;30 \\n Microalbuminuria 30-300 \\n Macroalbuminuria &gt;300\",\"method\":\"Turbilatex\",\"interval_h\":\"30\",\"equipment\":\"C\"}','','','','Renal Function Tests','','','','',1,1,0,1,NULL,'','C','(Calculated)(mg/gm) \\n Normal&lt;30 \\n Microalbuminuria 30-300 \\n Macroalbuminuria &gt;300','(Calculated)(mg/gm) \\n Normal&lt;30 \\n Microalbuminuria 30-300 \\n Macroalbuminuria &gt;300',NULL),
(5184,'pH','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"7.30-7.43 (Direct ISE)\",\"interval_l\":\"7.30\",\"interval_h\":\"7.43\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','A','7.30-7.43 (Direct ISE)','7.30-7.43 (Direct ISE)',NULL),
(5185,'PCO2','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmHg 38-58 (Direct ISE)\",\"interval_l\":\"38\",\"interval_h\":\"58\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','A','mmHg 38-58 (Direct ISE)','mmHg 38-58 (Direct ISE)',NULL),
(5186,'PO2','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmHg 19-65 (Direct ISE)\",\"interval_l\":\"19\",\"interval_h\":\"65\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','A','mmHg 19-65 (Direct ISE)','mmHg 19-65 (Direct ISE)',NULL),
(5187,'HCO3 ','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 22.0-30.0 (Calculated)\",\"interval_l\":\"22.0\",\"interval_h\":\"30.0\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','A','mmol/L 22.0-30.0 (Calculated)','mmol/L 22.0-30.0 (Calculated)',NULL),
(5188,'Na+','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 136-145 (Direct ISE)\",\"interval_l\":\"136\",\"interval_h\":\"145\",\"equipment\":\"V\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L 136-145 (Direct ISE)','mmol/L 136-145 (Direct ISE)',''),
(5189,'K+','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 3.5-5.1 (Direct ISE)\",\"interval_l\":\"3.5\",\"interval_h\":\"5.1\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L 3.5-5.1 (Direct ISE)','mmol/L 3.5-5.1 (Direct ISE)',''),
(5190,'Lactate','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)\",\"interval_h\":\"1.3\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)','mmol/L\\n &lt;1.39 at Bed Rest\\n (Direct ISE)',''),
(5191,'TAT_Remark','None','{\"type\":\"text\",\"zoom\":\"zoom\"}','','Misc/Remarks','Sample Details/Remarks','Sample Details/Remarks','','','','',2,2,0,2,NULL,'','','','',''),
(5192,'ca+','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 3.5-5.1 (Direct ISE)\",\"interval_l\":\"3.5\",\"interval_h\":\"5.1\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L 3.5-5.1 (Direct ISE)','mmol/L 3.5-5.1 (Direct ISE)',''),
(5211,'Glucose','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mg/dl  (Amperometry)\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,0,'','V','mg/dl  (Amperometry)','mg/dl  (Amperometry)',''),
(5212,'Glucose','Plain-Blood','{\"type\":\"number\",\"help\":\"mg/dl 40-70 (GOD-POD)\",\"interval_l\":\"40\",\"interval_h\":\"70\",\"cinterval_l\":\"30\",\"ainterval_h\":\"1500\",\"equipment\":\"C\"}','','Misc/QC/clinical chemistry','Misc/QC/clinical chemistry','','','','','',1,1,0,1,NULL,'','C','mg/dl 40-70 (GOD-POD)','mg/dl 40-70 (GOD-POD)','yes'),
(5215,'Cl-','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mg/dl  (Amperometry)\",\"equipment\":\"A\"}','','Misc/VBG','Blood Gas Analysis','Venous Blood Examination','','','','',1,1,0,1,0,'','V','mg/dl  (Amperometry)','mg/dl  (Amperometry)',''),
(9000,'QC Equipment','None','{\"type\":\"select\",\"option\":\",XL_640,XL_1000,VITROS3600,HPLC_723GX,Erba Chem 5 Plus semiauto(060379) 2,Rapidpoint-500e_Siemens,Rapidpoint-500_Siemens\"}','','Misc/QC/Sample Details','Sample Details/QC','','','','','',1,1,0,1,NULL,'','','','',''),
(10001,'sample_request','None','{\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Header','Header','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(10002,'sample_collection','None','{\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Header','Header','','95','','compact_report',1,1,0,1,NULL,'','','','',''),
(10003,'sample_receipt','None','{\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Sample Details','Sample Details','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(10004,'sample_processing','None','{\"hide\":\"yes\",\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Sample Details','Sample Details','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(10006,'sample_analysis','None','{\"hide\":\"yes\",\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Sample Details','Sample Details','','','','compact_report',1,1,0,1,NULL,'','','','',''),
(10007,'sample_verification','None','{\"readonly\":\"readonly\",\"hide\":\"yes\",\"type\":\"datetime-local\",\"readonly\":\"readonly\"}','','Misc/Sample Details/Sample Status','Sample Details','Sample Details','','','','compact_report',1,1,0,1,1,'','','','',''),
(10008,'sample_release','None','{\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Header','Header','','98','','compact_report',2,3,0,3,1,'','','','',''),
(10010,'sample_interim_release','None','{\"type\":\"datetime-local\"}','','Misc/Sample Details/Sample Status','Header','Header','','96','','compact_report',2,2,0,2,1,'','','','',''),
(10011,'Accreditation Symbol','None','{\"type\":\"config_value_blob\",\"readonly\":\"readonly\",\"img\":\"png\",\"width\":\"100\",\"height\":\"130\"}','','Misc/Laboratory Details','Header','Header','','10','','compact_report',2,2,0,2,NULL,'','','','',''),
(10012,'Laboratory','None','{\"type\":\"examination_field_specification\"}','','Misc/Laboratory Details','Header','Header','','15','','compact_report',2,2,0,2,NULL,'','','','',''),
(105033,'Ca+','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 136-145 (Direct ISE)\",\"interval_l\":\"136\",\"interval_h\":\"145\",\"equipment\":\"V\"}','','','','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L 136-145 (Direct ISE)','mmol/L 136-145 (Direct ISE)',''),
(105034,'Cl-','Heparinised-Venous_Blood','{\"type\":\"number\",\"help\":\"mmol/L 136-145 (Direct ISE)\",\"interval_l\":\"136\",\"interval_h\":\"145\",\"equipment\":\"V\"}','','','','Venous Blood Examination','','','','',1,1,0,1,NULL,'','V','mmol/L 136-145 (Direct ISE)','mmol/L 136-145 (Direct ISE)',''),
(105038,'Albumin','Plain-Pleural_Fluid','{\"type\":\"number\",\"help\":\" g/dL N/A (BCG)\",\"step\":\"0.1\",\"equipment\":\"C\"}','','','Clinical chemistry/Fluid','Pleural Fluid Examination','','','','',1,1,0,1,NULL,'','c',' g/dL N/A (BCG)',' g/dL N/A (BCG)',NULL);
/*!40000 ALTER TABLE `examination` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `host_code`
--

DROP TABLE IF EXISTS `host_code`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `host_code` (
  `examination_id` int(11) NOT NULL,
  `equipment` enum('XL_640','XL_1000','VITROS3600','RP500','TOSOH') NOT NULL,
  `code` varchar(10) NOT NULL,
  PRIMARY KEY (`equipment`,`examination_id`),
  KEY `examination_id` (`examination_id`),
  CONSTRAINT `host_code_ibfk_1` FOREIGN KEY (`examination_id`) REFERENCES `examination` (`examination_id`)
) ENGINE=InnoDB DEFAULT CHARSET=latin1 COLLATE=latin1_swedish_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `host_code`
--

LOCK TABLES `host_code` WRITE;
/*!40000 ALTER TABLE `host_code` DISABLE KEYS */;
INSERT INTO `host_code` VALUES
(5001,'XL_640','CR'),
(5002,'XL_640','UREA'),
(5006,'XL_640','ALT'),
(5007,'XL_640','ALP'),
(5008,'XL_640','AMY'),
(5009,'XL_640','TBIL'),
(5010,'XL_640','DBIL'),
(5011,'XL_640','ALB'),
(5012,'XL_640','TP'),
(5013,'XL_640','AST'),
(5014,'XL_640','CAL'),
(5015,'XL_640','CHO'),
(5016,'XL_640','CHOH'),
(5017,'XL_640','CHOL'),
(5018,'XL_640','TG'),
(5019,'XL_640','Na'),
(5020,'XL_640','K'),
(5021,'XL_640','IRON'),
(5022,'XL_640','TIBC'),
(5023,'XL_640','UIBC'),
(5024,'XL_640','IBIL'),
(5025,'XL_640','LDH'),
(5026,'XL_640','LIP'),
(5027,'XL_640','UA'),
(5028,'XL_640','CHOV'),
(5029,'XL_640','GLC'),
(5030,'XL_640','MPR'),
(5031,'XL_640','GLC'),
(5032,'XL_640','ADA'),
(5033,'XL_640','ADA'),
(5034,'XL_640','ADA'),
(5035,'XL_640','GLC'),
(5036,'XL_640','GLC'),
(5037,'XL_640','TP'),
(5038,'XL_640','TP'),
(5039,'XL_640','LIP'),
(5040,'XL_640','AMY'),
(5041,'XL_640','LDH'),
(5042,'XL_640','CHO'),
(5043,'XL_640','TG'),
(5044,'XL_640','AMY'),
(5045,'XL_640','LIP'),
(5046,'XL_640','LDH'),
(5047,'XL_640','LDH'),
(5048,'XL_640','Na'),
(5049,'XL_640','K'),
(5050,'XL_640','CAL'),
(5051,'XL_640','PHO'),
(5052,'XL_640','CR'),
(5053,'XL_640','TP'),
(5054,'XL_640','KTO'),
(5055,'XL_640','UA'),
(5080,'XL_640','TP'),
(5081,'XL_640','MPR'),
(5082,'XL_640','MPR'),
(5083,'XL_640','Na'),
(5084,'XL_640','CAL'),
(5085,'XL_640','MPR'),
(5092,'XL_640','CK'),
(5093,'XL_640','CKMB'),
(5100,'XL_640','PHO'),
(5105,'XL_640','LDH'),
(5106,'XL_640','AMY'),
(5107,'XL_640','LIP'),
(5108,'XL_640','GLC'),
(5109,'XL_640','CHO'),
(5110,'XL_640','TG'),
(5111,'XL_640','MPR'),
(5112,'XL_640','TP'),
(5113,'XL_640','CHE'),
(5121,'XL_640','CRPPP'),
(5122,'XL_640','DIMER'),
(5132,'XL_640','MGGG'),
(5135,'XL_640','UREA'),
(5136,'XL_640','GLC'),
(5137,'XL_640','CR'),
(5138,'XL_640','HCL'),
(5001,'XL_1000','CRR'),
(5002,'XL_1000','UREE'),
(5006,'XL_1000','ALTT'),
(5007,'XL_1000','ALPP'),
(5008,'XL_1000','AMYY'),
(5009,'XL_1000','TBILL'),
(5010,'XL_1000','DBILL'),
(5011,'XL_1000','ALBB'),
(5012,'XL_1000','TPP'),
(5013,'XL_1000','ASTT'),
(5014,'XL_1000','CALL'),
(5015,'XL_1000','CHOO'),
(5016,'XL_1000',''),
(5018,'XL_1000','TGG'),
(5019,'XL_1000','Naa'),
(5020,'XL_1000','Kk'),
(5021,'XL_1000','IRONN'),
(5023,'XL_1000','UIBCC'),
(5025,'XL_1000','LDHH'),
(5026,'XL_1000','LIPP'),
(5027,'XL_1000','UAA'),
(5029,'XL_1000','GLCC'),
(5030,'XL_1000','MPRR'),
(5031,'XL_1000','GLCC'),
(5032,'XL_1000','ADAA'),
(5033,'XL_1000','ADAA'),
(5034,'XL_1000','ADAA'),
(5035,'XL_1000','GLCC'),
(5036,'XL_1000','GLCC'),
(5037,'XL_1000','TPP'),
(5038,'XL_1000','TPP'),
(5039,'XL_1000','LIPP'),
(5040,'XL_1000','AMYY'),
(5041,'XL_1000','LDHH'),
(5042,'XL_1000','CHOO'),
(5043,'XL_1000','TGG'),
(5044,'XL_1000','AMYY'),
(5045,'XL_1000','LIPP'),
(5046,'XL_1000','LDHH'),
(5047,'XL_1000','LDHH'),
(5048,'XL_1000','Naa'),
(5049,'XL_1000','Kk'),
(5050,'XL_1000','CALL'),
(5051,'XL_1000','PHOO'),
(5052,'XL_1000','CRR'),
(5053,'XL_1000','TPP'),
(5054,'XL_1000','KTOO'),
(5055,'XL_1000','UAA'),
(5080,'XL_1000','TPP'),
(5081,'XL_1000','MPRR'),
(5082,'XL_1000','MPRR'),
(5083,'XL_1000','Naa'),
(5084,'XL_1000','CALL'),
(5085,'XL_1000','MPRR'),
(5092,'XL_1000','CKK'),
(5093,'XL_1000','CKMBB'),
(5100,'XL_1000','PHOO'),
(5105,'XL_1000','LDHH'),
(5106,'XL_1000','AMYY'),
(5107,'XL_1000','LIPP'),
(5108,'XL_1000','GLCC'),
(5109,'XL_1000','CHOO'),
(5110,'XL_1000','TGG'),
(5111,'XL_1000','MPRR'),
(5112,'XL_1000','TPP'),
(5113,'XL_1000','CHEE'),
(5114,'XL_1000','HCLL'),
(5121,'XL_1000','CRPP'),
(5122,'XL_1000','DDMR'),
(5132,'XL_1000','MGG'),
(5137,'XL_1000','CRR'),
(5138,'XL_1000','HCLL'),
(5182,'XL_1000','UALBB'),
(5212,'XL_1000','GLCC'),
(5115,'VITROS3600','002'),
(5117,'VITROS3600','035'),
(5118,'VITROS3600','031'),
(5120,'VITROS3600','086'),
(5123,'VITROS3600','082'),
(5125,'VITROS3600','052'),
(5127,'VITROS3600','004'),
(5128,'VITROS3600','005'),
(5129,'VITROS3600','011'),
(5130,'VITROS3600','010'),
(5131,'VITROS3600','009'),
(5133,'VITROS3600','013'),
(5140,'VITROS3600','014'),
(5141,'VITROS3600','074'),
(5142,'VITROS3600','032'),
(5171,'VITROS3600','087'),
(5175,'VITROS3600','091'),
(5143,'RP500','mpH'),
(5144,'RP500','mPCO2'),
(5145,'RP500','mPO2'),
(5148,'RP500','mNa+'),
(5149,'RP500','mK+'),
(5150,'RP500','mCa++'),
(5151,'RP500','mCL-'),
(5154,'RP500','cHCO3act'),
(5158,'RP500','mGlucose'),
(5159,'RP500','mLactate'),
(5160,'RP500','mtHB'),
(5162,'RP500','mCOHb'),
(5163,'RP500','mMetHb'),
(5184,'RP500','mpH'),
(5185,'RP500','mPCO2'),
(5186,'RP500','mPO2'),
(5187,'RP500','cHCO3act'),
(5188,'RP500','mNa+'),
(5189,'RP500','mK+'),
(5190,'RP500','mLactate'),
(5192,'RP500','mCa++'),
(5211,'RP500','mGlucose'),
(5215,'RP500','mCL-'),
(5174,'TOSOH','SA1C'),
(5178,'TOSOH','chrom'),
(5179,'TOSOH','F');
/*!40000 ALTER TABLE `host_code` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `labels`
--

DROP TABLE IF EXISTS `labels`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `labels` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `examination_id` varchar(30) DEFAULT NULL,
  `caption` varchar(10) DEFAULT NULL,
  `barcode_format` varchar(50) DEFAULT NULL,
  `data` text NOT NULL,
  `other_data` varchar(5000) NOT NULL,
  `border` int(11) NOT NULL,
  `fontsize` varchar(100) NOT NULL,
  `fontweight` varchar(100) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=16 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `labels`
--

LOCK TABLES `labels` WRITE;
/*!40000 ALTER TABLE `labels` DISABLE KEYS */;
INSERT INTO `labels` VALUES
(7,'1045','R1','C128','{\r\n\"1\":\"1045,h,b,05,05,40,10\",\r\n\"2\":\"1001,h,t,20,15,25,03\",\r\n\"3\":\"1045,h,t,5,15,15,03\",\r\n\"4\":\"other_data,h,t,5,18,25,03\",\r\n\"5\":\"1002,h,t,30,18,15,03\"\r\n}','select group_concat(sample_id separator \",\") other_data from request_id where id in(select id from request_id where sample_id={sample_id})',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(10,'sample_id','S1','C128','{\r\n \"1\":\"sample_id,h,b,05,05,40,10\",\r\n \"2\":\"1000,h,t,25,15,20,03\",\r\n \"3\":\"1001,h,t,10,15,15,03\",\r\n \"4\":\"sample_id,h,t,10,18,15,03\",\r\n \"5\":\"1002,h,t,25,18,20,03\",\r\n \"6\":\"other_data,h,t,5,15,5,6\"\r\n}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(11,'1047','W1','C128','{\r\n\"1\":\"1047,h,b,05,05,40,10\",\r\n\"2\":\"1000,h,t,25,15,20,03\",\r\n\"3\":\"1047,h,t,10,15,15,03\",\r\n\"4\":\"sample_id,h,t,10,18,15,03\",\r\n\"5\":\"1002,h,t,25,18,20,03\",\r\n\"6\":\"other_data,h,t,5,15,5,6\"\r\n}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(12,'sample_id','S2','C39','{\r\n \"1\":\"sample_id,h,b,05,05,40,10\",\r\n \"2\":\"1000,h,t,25,15,20,03\",\r\n \"3\":\"1001,h,t,10,15,15,03\",\r\n \"4\":\"sample_id,h,t,10,18,15,03\",\r\n \"5\":\"1002,h,t,25,18,20,03\",\r\n \"6\":\"other_data,h,t,5,15,5,6\"\r\n}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(13,'1049','N2','C128','{\"1\":\"1049,h,b,05,05,40,10\",\"2\":\"1000,h,t,25,15,20,03\",\"3\":\"1049,h,t,10,15,20,03\",\"4\":\"sample_id,h,t,10,18,15,03\",\"5\":\"1002,h,t,25,18,20,03\",\"6\":\"other_data,h,t,5,15,5,6\"}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(14,'1046','P1','C128','{\r\n\"1\":\"1046,h,b,05,05,40,10\",\r\n\"2\":\"1000,h,t,25,15,20,03\",\r\n\"3\":\"1046,h,t,10,15,15,03\",\r\n\"4\":\"sample_id,h,t,10,18,15,03\",\r\n\"5\":\"1002,h,t,25,18,20,03\",\r\n\"6\":\"other_data,h,t,5,15,5,6\"\r\n}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}'),
(15,'1050','E1','C128','{\"1\":\"1050,h,b,05,05,40,10\",\"2\":\"1000,h,t,20,15,15,03\",\"3\":\"1050,h,t,05,15,15,03\",\"4\":\"sample_id,h,t,05,18,15,03\",\"5\":\"1002,h,t,20,18,15,03\"}','select group_concat(distinct equipment SEPARATOR \'\') other_data from result,examination where sample_id={sample_id} and examination.examination_id=result.examination_id',0,'{\"6\":\"9\"}','{\"6\":\"helveticaB\"}');
/*!40000 ALTER TABLE `labels` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `label_group`
--

DROP TABLE IF EXISTS `label_group`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `label_group` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `name` varchar(100) NOT NULL,
  `lable_list` varchar(100) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=9 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `label_group`
--

LOCK TABLES `label_group` WRITE;
/*!40000 ALTER TABLE `label_group` DISABLE KEYS */;
INSERT INTO `label_group` VALUES
(1,'OPD','{\"14\":\"1\",\"7\":\"1\"}'),
(5,'Niramaya','{\"13\":\"1\",\"7\":\"1\"}'),
(6,'WARD','{\"11\":\"1\",\"7\":\"1\"}'),
(7,'Emergency','{\"15\":\"1\",\"7\":\"1\"}'),
(8,'Sample ID(2)','{\"10\":\"2\"}');
/*!40000 ALTER TABLE `label_group` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `lis_to_vitros_sample_type`
--

DROP TABLE IF EXISTS `lis_to_vitros_sample_type`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `lis_to_vitros_sample_type` (
  `lis_sample_type` varchar(100) NOT NULL,
  `vitros_sample_type` varchar(10) NOT NULL,
  PRIMARY KEY (`lis_sample_type`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `lis_to_vitros_sample_type`
--

LOCK TABLES `lis_to_vitros_sample_type` WRITE;
/*!40000 ALTER TABLE `lis_to_vitros_sample_type` DISABLE KEYS */;
INSERT INTO `lis_to_vitros_sample_type` VALUES
('Plain-Blood','5'),
('Plain-Swab','10');
/*!40000 ALTER TABLE `lis_to_vitros_sample_type` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `Laboratory`
--

DROP TABLE IF EXISTS `Laboratory`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `Laboratory` (
  `Laboratory` varchar(200) NOT NULL,
  PRIMARY KEY (`Laboratory`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `Laboratory`
--

LOCK TABLES `Laboratory` WRITE;
/*!40000 ALTER TABLE `Laboratory` DISABLE KEYS */;
INSERT INTO `Laboratory` VALUES
('Biochemistry Laboratory, Beside Bllod Bank, New Civil Hospital, Majura Gate, Surat'),
('NCHS Pathology Section');
/*!40000 ALTER TABLE `Laboratory` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `menu_new`
--

DROP TABLE IF EXISTS `menu_new`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `menu_new` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `caption` varchar(100) NOT NULL,
  `ex_list` varchar(600) NOT NULL,
  `route` varchar(200) NOT NULL,
  `default_value` varchar(200) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=902 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `menu_new`
--

LOCK TABLES `menu_new` WRITE;
/*!40000 ALTER TABLE `menu_new` DISABLE KEYS */;
INSERT INTO `menu_new` VALUES
(100,'Ward Request','1001,1002,1004,1005,1006,10003,1023,10011,10012,1045,1047','','10012^NCHS Biochemistry Section'),
(200,'OPD Request','1001,1002,1004,1005,1006,10003,1023,10011,10012,1045,1046','','10012^NCHS Biochemistry Section,1006^OPD'),
(300,'ABG Request','1001,1002,1004,1005,1006,5195,5143,5144,5145,5148,5159,5150,5158,10012,5163,5149,5151,5154,5159,5160,5162,10011','','10012^NCHS Biochemistry Section'),
(400,'NIRAMAYA Request','1001,1002,1004,1006,10003,5018,5031,5015,5001,1049,10011,10012,1045','','10012^NCHS Biochemistry Section,1004^Medicine,1006^Niramaya_Camp'),
(601,'Glucose  pp2bs-OPD','1001,1002,1004,1005,1006,10003,1023,5031,10011,10012,1046,1045','','10012^NCHS Biochemistry Section,1023^Postprendial-2HR,1006^OPD'),
(602,'Glucose fasting-OPD','1001,1002,1004,1005,1006,10003,1023,5031,10011,10012,1046,1045','','10012^NCHS Biochemistry Section,1023^Fasting,1006^OPD'),
(700,'Glucose  pp2bs-ward','1001,1002,1004,1005,1006,10003,1023,5031,10011,10012,1045,1047','','10012^NCHS Biochemistry Section,1023^Postprendial-2HR'),
(800,'Glucose fasting-ward','1001,1002,1004,1005,1006,10003,1023,5031,10011,10012,1045,1047','','10012^NCHS Biochemistry Section,1023^Fasting'),
(900,'QC','3001,9000,10006,10012,1048','','10012^NCHS Biochemistry Section,9000^XL_1000'),
(901,'Emergency Request','1001,1002,1004,1005,1006,10003,1023,10011,10012,1045,1050','','10012^NCHS Biochemistry Section');
/*!40000 ALTER TABLE `menu_new` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `menu_view`
--

DROP TABLE IF EXISTS `menu_view`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `menu_view` (
  `id` int(11) NOT NULL,
  `caption` varchar(100) NOT NULL,
  `unique_id` varchar(200) NOT NULL,
  `additional_search_id` varchar(200) NOT NULL,
  `additional_range_search_id` varchar(200) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `menu_view`
--

LOCK TABLES `menu_view` WRITE;
/*!40000 ALTER TABLE `menu_view` DISABLE KEYS */;
INSERT INTO `menu_view` VALUES
(1,'sample_id','sample_id','1001,1002,1006,10003','sample_id,10006'),
(2,'OPD','1046','1001,1002,1006,10003','1046'),
(3,'Niramaya','1049','1001,1002,1006,10003','1049'),
(4,'QC','1048','3001,9000,10006','1048'),
(5,'ward','1047','1001,1002,1006,10003','1047');
/*!40000 ALTER TABLE `menu_view` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `route_priority`
--

DROP TABLE IF EXISTS `route_priority`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `route_priority` (
  `route` varchar(100) NOT NULL,
  `node` varchar(100) NOT NULL,
  `request_route_priority` varchar(10) NOT NULL,
  `display_route_priority` varchar(10) NOT NULL,
  `print_route_priority` varchar(10) NOT NULL,
  PRIMARY KEY (`route`,`node`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `route_priority`
--

LOCK TABLES `route_priority` WRITE;
/*!40000 ALTER TABLE `route_priority` DISABLE KEYS */;
INSERT INTO `route_priority` VALUES
('AMY-LIP-ALP','AMY-LIP-ALP','080','',''),
('BIG1','BIG1','060','',''),
('Fluid','Fluid','100','',''),
('GLU','GLU','015','',''),
('GLU-LIP','GLU-LIP','020','',''),
('Header','Header','','200',''),
('IDs','IDs','','100',''),
('Laboratory Details','Laboratory Details','150','500',''),
('LRE','LRE','010','',''),
('LRE-ALBTP-CRPLDH','LRE-ALBTP-CRPLDH','050','',''),
('LRE-CALCRP','LRE-CALCRP','040','',''),
('LREG','LREG','030','',''),
('Misc','Misc','095','',''),
('Misc/Cardiac Profile','Cardiac Profile','120','',''),
('Misc/CRP','CRP','110','',''),
('Misc/QC','QC','100','',''),
('Misc/QC/c.c more','c.c more','620','',''),
('Misc/QC/clinical chemistry','clinical chemistry','600','',''),
('Misc/QC/HbA1c','HbA1c','630','',''),
('Misc/QC/immunochemistry','immunochemistry','610','',''),
('Misc/VBG','VBG','130','',''),
('Others','Others','160','',''),
('Patient Details','Patient Details','140','400',''),
('Reference','Reference','120','',''),
('Sample Details','Sample Details','150','300','010'),
('TSH','TSH','070','',''),
('Urine','Urine','110','','');
/*!40000 ALTER TABLE `route_priority` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `sample_id_strategy`
--

DROP TABLE IF EXISTS `sample_id_strategy`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `sample_id_strategy` (
  `sample_requirement` varchar(100) NOT NULL,
  `lowest_id` bigint(20) DEFAULT NULL,
  `highest_id` bigint(20) DEFAULT NULL,
  `description` varchar(500) NOT NULL,
  PRIMARY KEY (`sample_requirement`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb3 COLLATE=utf8mb3_bin;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `sample_id_strategy`
--

LOCK TABLES `sample_id_strategy` WRITE;
/*!40000 ALTER TABLE `sample_id_strategy` DISABLE KEYS */;
INSERT INTO `sample_id_strategy` VALUES
('Citrate-Blood',1000,1999999,'Biochemistry'),
('EDTA-Blood',1000,1999999,'Biochemistry'),
('Fluoride-Blood',1000,1999999,'Biochemistry'),
('HCL-Urine',1000,1999999,'Biochemistry'),
('Heparinised-Arterial_Blood',1000,1999999,'Biochemistry'),
('Heparinised-Venous_Blood',1000,1999999,'Biochemistry'),
('Plain-Blood',1000,1999999,'Biochemistry'),
('Plain-CSF',1000,1999999,'Biochemistry'),
('Plain-Other',1000,1999999,'Biochemistry'),
('Plain-Peritoneal_Fluid',1000,1999999,'Biochemistry'),
('Plain-Pleural_Fluid',1000,1999999,'Biochemistry'),
('Plain-Swab',1000,1999999,'Biochemistry'),
('Plain-Urine',1000,1999999,'Biochemistry');
/*!40000 ALTER TABLE `sample_id_strategy` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `sample_status`
--

DROP TABLE IF EXISTS `sample_status`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `sample_status` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `priority` decimal(10,3) NOT NULL,
  `name` varchar(50) NOT NULL,
  `examination_id` int(11) NOT NULL,
  `color` varchar(50) NOT NULL,
  `shortcut` int(11) NOT NULL,
  `dependancy_examination_id` varchar(50) NOT NULL,
  `readonly` varchar(50) NOT NULL,
  PRIMARY KEY (`id`),
  UNIQUE KEY `examination_id` (`examination_id`),
  CONSTRAINT `sample_status_ibfk_1` FOREIGN KEY (`examination_id`) REFERENCES `examination` (`examination_id`)
) ENGINE=InnoDB AUTO_INCREMENT=14 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `sample_status`
--

LOCK TABLES `sample_status` WRITE;
/*!40000 ALTER TABLE `sample_status` DISABLE KEYS */;
INSERT INTO `sample_status` VALUES
(1,100.000,'sample_request',10001,'white',1,'0',''),
(2,200.000,'sample_collection',10002,'#bdb9b9',1,'0',''),
(3,350.000,'sample_receipt',10003,'yellow',1,'0',''),
(6,400.000,'sample_processing',10004,'#f59207',1,'0',''),
(8,500.000,'sample_analysis',10006,'#f2d8ee',1,'0',''),
(9,600.000,'sample_verification',10007,'#8d89f5',0,'0',''),
(10,700.000,'sample_release',10008,'#67c23a',0,'10007',''),
(12,650.000,'sample_interim_release',10010,'#c7edb4',0,'10007','');
/*!40000 ALTER TABLE `sample_status` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `sql`
--

DROP TABLE IF EXISTS `sql`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `sql` (
  `name` varchar(100) NOT NULL,
  `sql` text NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `sql`
--

LOCK TABLES `sql` WRITE;
/*!40000 ALTER TABLE `sql` DISABLE KEYS */;
INSERT INTO `sql` VALUES
('export specific colum as sql','select concat (\"update examination set print_route=\'\",\r\n                print_route,\r\n               \"\' where examination_id = \'\"\r\n               ,examination_id,\r\n               \"\'\")\r\nfrom examination\r\norder by print_route desc');
/*!40000 ALTER TABLE `sql` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `examination_field_specification`
--

DROP TABLE IF EXISTS `examination_field_specification`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `examination_field_specification` (
  `id` int(11) NOT NULL AUTO_INCREMENT,
  `examination_id` int(11) DEFAULT NULL,
  `ftype` varchar(50) DEFAULT NULL,
  `table` varchar(50) DEFAULT NULL,
  `field` varchar(50) DEFAULT NULL,
  `field_description` varchar(50) DEFAULT NULL,
  `where` varchar(500) DEFAULT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB AUTO_INCREMENT=3 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `examination_field_specification`
--

LOCK TABLES `examination_field_specification` WRITE;
/*!40000 ALTER TABLE `examination_field_specification` DISABLE KEYS */;
INSERT INTO `examination_field_specification` VALUES
(1,10012,'table','Laboratory','Laboratory','',''),
(2,3001,'dtable','qc_lot','qc_lot','qc_lot,remark','where in_use=1');
/*!40000 ALTER TABLE `examination_field_specification` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `user`
--

DROP TABLE IF EXISTS `user`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `user` (
  `user` bigint(20) NOT NULL,
  `name` varchar(100) NOT NULL,
  `password` varchar(1000) NOT NULL,
  `expirydate` date NOT NULL,
  `authorization` varchar(300) NOT NULL,
  `insert_authorization_level` int(11) NOT NULL,
  `update_authorization_level` int(11) NOT NULL,
  `select_authorization_level` int(11) NOT NULL,
  `delete_authorization_level` int(11) NOT NULL,
  PRIMARY KEY (`user`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `user`
--

LOCK TABLES `user` WRITE;
/*!40000 ALTER TABLE `user` DISABLE KEYS */;
INSERT INTO `user` VALUES
(1,'shailesh','U5aSciO38lRp6','2024-04-21','lock,unlock,interimlock',3,3,3,3),
(2,'Sarita','IcNtCQGAzp7VE','2024-04-21','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(4,'request reception','I4jVz9vb5jF1k','2024-04-21','lock,unlock,interimlock',1,0,1,0),
(12345,'Doctor','uNs3jYN7IFYAg','2026-04-21','',0,0,0,0),
(6351535170,'Hemlata Patel ','WntX7ZEcuDRCY','2028-06-05','interimlock',2,2,2,2),
(7284091830,'Payal Patel','O0jIXUDqyn52M','2024-11-19','interimlock',2,2,2,2),
(7487028262,'Dr KRISHNA THAKKAR','$2y$10$ZWWSMOFedHcVFsXVr0PTh.QzJF2igYnU47RaRB.NB3Fsz4WGLdgt6','2024-04-19','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(7490022677,'Dr.Nilam','bl.IZH8hheaDk','2025-03-05','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(7567024314,'Dr. Champak','2mt1qohdZblfI','2028-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(7600008019,'Rina Prajapati','0qvmnUPogS7KI','2030-01-23','interimlock',2,2,2,2),
(7990328826,'Dr Purvi Tailor','ZtTQrpZieuZtc','2026-05-08','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(7990709978,'Sandeep Goyal','$2y$10$JUHR4ms/FifK5Q6kmftBTeuKw3iO4xTNNEsOL7FTcFwTa3gt5DRDa','2020-11-11','',2,2,2,2),
(8160541939,'Dr. Arvachi','TkA9hhfzt3ovM','2028-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(8238468795,'Sonali ','XZamQ.w.ZfvUI','2024-11-19','interimlock',2,2,2,2),
(8320142037,'Rutvi Vadadoriya','$2y$10$bvfrMRs4aeB9BaX/rTqY9Ova5PBp6N2z4VhseFjTtRsSwPUrs3AWC','2024-02-19','interimlock',2,2,2,2),
(8469787088,'Dr. Vidhya','Sqc07MFn6bNBQ','2028-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(8500791867,'Dr. Shruti','$2y$10$XjtvB3LQaAZHKybzEY6te.IUcofBthuCDG17By8DMQ6a43rhgXwSS','2024-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(8866580625,'Dr. Dhvani Jethva','$2y$10$DujBQ1a9vcTVSktBFYUyn.DENl6qIfsL.NraBa7j6umij9tizB/.i','2025-04-29','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(8866829055,'Dr. Niral Savaliya ','s5sDnfQBwAYp6','2040-11-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9067457098,'Kishor Vaghani','$2y$10$UiSIbjCI22NcrSbGsC2Mveu4Q2.DHe2VvDyMaQhRYIoiBxjaGPjtC','2023-11-05','interimlock',2,2,2,2),
(9074412465,'Dr. Abhay','hnIagkwLEipVw','2028-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9099666466,'Manisha Patel','$2y$10$CXf.G8P1rGKJfAG4/Ukws.Tc19KOkyj2BtQ1T0IbrzX5WAx2c7A66','2022-11-25','interimlock',2,2,2,2),
(9408029245,'Anshu Yadav','5KU7yWVaceGI2','2023-11-04','interimlock',2,2,2,2),
(9408906519,'Preeti Pandya','$2y$10$4.AOEMyk/Cx4hVFKoZvb6.mcHikswLMp5z4tMTAzwx4XaR2NvHiUW','2024-12-02','interimlock',2,2,2,2),
(9409510124,'Dr Drashti Detroja','EYVeq4zJUFol2','2026-05-08','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9426713235,'Dr. Shyam','tpwyGH4W.sfFc','2028-03-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9427460293,'Viresh Patel','YRD/i/KKh9t3o','2030-11-20','interimlock',2,2,2,2),
(9428743513,'Dr. Alok Parekh','ebykSezGMuDCk','2040-11-11','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9512177451,'Dharmesh Patel','yRI8Pcvcx48Eg','2025-04-22','interimlock',2,2,2,2),
(9537308448,'Kirti Pagada','$2y$10$OTwYyrR7MSrAkOocSuRSve6T9Rei9mCQJshlpIyZWVXCNxyfK3zXu','2024-01-27','interimlock',2,2,2,2),
(9586395084,'Abhishek','$2y$10$ShvBG7iu70PpnWyXDwp9C.6uSB2VlB3cz9nx1qCqdtrCBaXhCG3Ge','2024-04-17','interimlock',2,2,2,2),
(9586455544,'Dr Snehal Patel','$2y$10$RtDTboQFOYCPA.eQCRbgze2YfM0EGhiU8yi1wOxXAXoKzuWWI.GIm','2023-11-25','lock,unlock,interimlock,limit_request=2',3,3,3,3),
(9687271872,'Trupti Ghevariya','$2y$10$WV4XVlJ1DQJlD.ZCECIgN.aJZ/I6vQgRjlQPNgdHCQETXAR2K5xUS','2023-11-27','interimlock',2,2,2,2),
(9726765502,'Priyanka Vasava','$2y$10$86l8lBDpHcFMmVMJCGQoIudvayHj0X9tbE/oWNAwtVGKKC0lzTDka','2023-01-02','interimlock',2,2,2,2),
(9824716448,'Ramesh Patel','FivZZbdlKwv/c','2025-06-26','interimlock',2,2,2,2),
(9825259368,'Niharika Patel','b/EsTjkaCB0zI','2025-11-21','interimlock',2,2,2,2),
(9925442232,'Divyesh Patel','$2y$10$X.kZhbC5pOd/sMy4iTQX2uusH2pnLHA3QAxAkIStH5bb5cLG5VYcq','2023-12-29','interimlock',2,2,2,2);
/*!40000 ALTER TABLE `user` ENABLE KEYS */;
UNLOCK TABLES;

--
-- Table structure for table `view_info_data`
--

DROP TABLE IF EXISTS `view_info_data`;
/*!40101 SET @saved_cs_client     = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `view_info_data` (
  `id` int(11) NOT NULL,
  `info` varchar(100) NOT NULL,
  `Fields` varchar(2000) NOT NULL,
  `sql` varchar(1000) NOT NULL,
  PRIMARY KEY (`id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;

--
-- Dumping data for table `view_info_data`
--

LOCK TABLES `view_info_data` WRITE;
/*!40000 ALTER TABLE `view_info_data` DISABLE KEYS */;
INSERT INTO `view_info_data` VALUES
(0,'Scope','','select * from scope'),
(1,'Total Sample On a Day','<input type=date name=__p1 title=\'Give Date\'>','select count(examination_id) as Total_Sample from result where examination_id=1017 and result=\"__p1\"'),
(2,'Test count on a date','<input type=date name=__p1 title=\'Give Date\'>','select  	r1.examination_id A ,e1.name B ,  	r2.examination_id C ,e2.name D, 	r2.result E, 	count(r2.result) F from  	examination e1,examination e2,  	result r1,result r2  where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	r2.result=\"__p1\" and 	e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  group by r1.examination_id order by r1.examination_id'),
(3,'Max ID (series 2,3,1)','','select 2 as series, max(sample_id) from result where sample_id between 2000000 and 2999999 union select 3 as series, max(sample_id) from result where sample_id between 3000000 and 3999999 union select 1 as series, max(sample_id) from result where sample_id between 1000000 and 1999999'),
(4,'Test count on a date (a bit better)','<input type=date name=__p1 title=\'Give Date\'>','select  	r1.examination_id examination_id ,e1.name Test,  r2.result Date, 	count(r2.result) Test_Count  from  	examination e1,examination e2,  	result r1,result r2  where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	r2.result=\"__p1\" and 	e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  and e1.sample_requirement!=\'None\' group by r1.examination_id order by r1.examination_id'),
(5,'Test count on between two dates','From:<input type=date name=__p1 title=\'Give From  Date\'>To:<input type=date name=__p2 title=\'Give To Date\'>','select r1.examination_id examination_id ,e1.name Test,  	count(r2.result) Test_Count   from  	examination e1,examination e2,  	result r1,result r2   where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	 r2.result between str_to_date(\'__p1\',\'%Y-%m-%d\') and str_to_date(\'__p2\',\'%Y-%m-%d\') and 	 e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id   and e1.sample_requirement!=\'None\' group by r1.examination_id order by r1.examination_id'),
(6,'(Worklist) Sample_ID,Test name and result of a date','Date:<input type=date name=__p1 title=\'Give From  Date\'>Ex_ID:<input type=number name=__p2 title=\'Give Examination_id\'>','select  	 r1.sample_id sample_id, r1.examination_id examination_id ,e1.name Test, r1.result , r2.result Date  from  	 examination e1,examination e2,  	 result r1,result r2    where  	 r1.sample_id=r2.sample_id and  	 r2.examination_id=1017 and  	 r2.result=\"__p1\" and 	 e1.examination_id=r1.examination_id and  	 e2.examination_id=r2.examination_id  and  e1.examination_id=\"__p2\" and e1.sample_requirement!=\'None\'   order by r1.examination_id'),
(7,'Test ID and their Name','','select examination_id,name,sample_requirement from examination order by name'),
(8,'Profile count between two dates','From:<input type=date name=__p1 title=\'Give From  Date\'>To:<input type=date name=__p2 title=\'Give To Date\'>','select  p.profile_id, p.name,  	count(r2.result) Test_Count   from  	 examination e1,examination e2, result r1,result r2, profile p  where  	 r1.sample_id=r2.sample_id and  	 r2.examination_id=1017 and  	  r2.result between str_to_date(\'__p1\',\'%Y-%m-%d\') and str_to_date(\'__p2\',\'%Y-%m-%d\') and e1.examination_id=r1.examination_id and  	 e2.examination_id=r2.examination_id   and  e1.sample_requirement!=\'None\' and substring_index(p.examination_id_list,\',\',1)=e1.examination_id  group by  r1.examination_id   order by  p.profile_id'),
(9,'sample count: age more than 60 years','From:<input type=date name=__p1 title=\'Give From Date\'>To<input type=date name=__p2 title=\'Give To Date\'>','select count(sample_id) from result where examination_id=1007  and (recording_time between \"__p1\" and \"__p2\" )and result>=60'),
(10,'Sample Location with  Specific Date','<input type=date name=__p1 title=\'Give Date\'>','select s1.sample_id as sample_id ,s1.result as date ,s2.result as location  from result s1, result s2  where    s1.examination_id=1017 and s1. result like \"__p1\" and  s2.examination_id=1006    and  s1.sample_id=s2.sample_id'),
(11,'Sample Location with  Specific Date(color)','<input type=date name=__p1 title=\'Give Date\'>','select s1.sample_id as sample_id ,s1.result as date ,if(s2.result=\"OPD\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location  from result s1, result s2  where    s1.examination_id=1017 and s1. result like \"__p1\" and  s2.examination_id=1006    and  s1.sample_id=s2.sample_id'),
(12,'Sample Release Status(between two sample_id)','<input type=number name=__p1><input type=number name=__p2>','select sample_id,if(examination_id=1017,\"Received on\",\"Released_by\"),result from result where examination_id in (1017,1014) and sample_id between \"__p1\" and \"__p2\" order by sample_id'),
(13,'Test count of a date with total','<input type=date name=__p1 title=\'Give Date\'>','(select  r1.examination_id examination_id ,e1.name Test,  r2.result Date, 	count(r2.result) Test_Count  from  	examination e1,examination e2,  	result r1,result r2  where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	r2.result=\"__p1\" and 	e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  and e1.sample_requirement!=\'None\' group by r1.examination_id order by r1.examination_id) UNION (select  \'Grand \' ,\'Total \',  \' \', 	count(r2.result) Test_Count  from  	examination e1,examination e2,  	result r1,result r2  where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	r2.result=\"__p1\" and 	e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  and e1.sample_requirement!=\'None\')'),
(14,'Test count between two dates with total','From:<input type=date name=__p1 title=\'Give Date\'>To:<input type=date name=__p2 title=\'Give Date\'>','(select  r1.examination_id examination_id ,e1.name Test,  r2.result Date, 	count(r2.result) Test_Count    from  	examination e1,examination e2,  	result r1,result r2  where  	 r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	r2.result between \"__p1\" and \"__p2\"	and  e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  and e1.sample_requirement!=\'None\'  group by r1.examination_id order by r1.examination_id) UNION   (select  \'Grand \' ,\'Total \',  \' \', 	count(r2.result) Test_Count  from  	examination e1,examination e2,  	 result r1,result r2  where  	r1.sample_id=r2.sample_id and  	r2.examination_id=1017 and  	 (r2.result between \"__p1\" and \"__p2\")	and e1.examination_id=r1.examination_id and  	e2.examination_id=r2.examination_id  and e1.sample_requirement!=\'None\')'),
(15,'Samples Types count between two dates','From:<input type=date name=__p1 title=\'Give Date\'>To:<input type=date name=__p2 title=\'Give Date\'>','select r1.result,count(r1.sample_id)  from result  r1, result r2   where  r2.examination_id=1017  and (r2.result between \"__p1\" and \"__p2\")  and r1.examination_id=1000 and r1.sample_id=r2.sample_id  group by result '),
(16,'Samples Types count between two dates (only OPD)','From:<input type=date name=__p1 title=\'Give Date\'>To:<input type=date name=__p2 title=\'Give Date\'>','select r1.result,count(r1.sample_id)  from result  r1, result r2 ,result r3  where  r2.examination_id=1017  and (r2.result between \"__p1\" and \"__p2\")  and r1.examination_id=1000 and r1.sample_id=r2.sample_id and r1.sample_id=r3.sample_id and r3.examination_id=1006  and (r3.result =\'OPD\')   group by result  '),
(17,'Worklist between two dates','From:<input type=date name=__p1 title=\'Give From  Date\'>To:<input type=date name=__p2 title=\'Give From  Date\'>Ex_ID:<input type=number name=__p3 title=\'Give Examination_id\'>','select  	  r1.sample_id sample_id, r1.examination_id examination_id ,e1.name Test, r1.result , r2.result Date    from  	  examination e1,examination e2,  	 result r1,result r2      where  	   r1.sample_id=r2.sample_id and  	 r2.examination_id=1017 and  	  (r2.result between \"__p1\" and \"__p2\") and 	 e1.examination_id=r1.examination_id and  	  e2.examination_id=r2.examination_id  and  e1.examination_id=\"__p3\"  and e1.sample_requirement!=\'None\'     order by r1.examination_id'),
(18,'OPD Samples on a date','<input type=date name=__p1 title=\'Give Date\'>','select s1.sample_id as sample_id ,s1.result as date ,if(s2.result=\"OPD\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location   from result s1, result s2   where    s1.examination_id=1017 and s1. result like \"__p1\" and  s2.examination_id=1006    and  s1.sample_id=s2.sample_id and s2.result=\'OPD\''),
(19,'non-OPD Samples on a date','<input type=date name=__p1 title=\'Give Date\'>','select s1.sample_id as sample_id ,s1.result as date ,if(s2.result!=\"OPD\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location   from result s1, result s2   where    s1.examination_id=1017 and s1. result like \"__p1\" and  s2.examination_id=1006    and  s1.sample_id=s2.sample_id and s2.result!=\'OPD\''),
(20,'QC Statistics on between two dates','From:<input type=date name=__p1 title=\'Give From  Date\'>To:<input type=date name=__p2 title=\'Give To Date\'>','select  	r1.examination_id examination_id , 	e1.name Test,  	 	r3.result MRD, 	count(r2.result) Test_Count  ,  	avg(r1.result) mean,    	STDDEV(r1.result) SD    	 from  	 	examination e1,examination e2, 	result r1,result r2,result r3     where  	 	r1.sample_id=r2.sample_id  		and  	 	r1.sample_id=r3.sample_id  		and 		 	r2.examination_id=1015  		and 	r3.examination_id=1001  		and		 	r2.result between str_to_date(\'__p1\',\'%Y-%m-%d\') and str_to_date(\'__p2\',\'%Y-%m-%d\')  		and 	  		 	e1.examination_id=r1.examination_id  		and  	 	e2.examination_id=r2.examination_id    		and  		 	e1.sample_requirement!=\'None\' 		and 	r1.sample_id between 9000000 and 9999999 		 group by  	r1.examination_id, r3.result  order by  	r1.examination_id'),
(21,'Current QC Target and Mean','','SELECT mrd,examination.examination_id,examination.name,lab_reference_value.equipment,mean,sd,start_date,start_time FROM `lab_reference_value`,examination WHERE `end_date`>sysdate() and `lab_reference_value`.examination_id=examination.examination_id order by examination.examination_id,mrd, equipment'),
(101,'Sample Release Status(between two sample_id)','<input type=number name=__p1><input type=number name=__p2>','select sample_id,result from result where examination_id =1014  and sample_id between \"__p1\" and \"__p2\" order by sample_id'),
(102,'OPD Release Status of Samples on a date','<input type=date name=__p1 title=\'Give Date\'>','select \r\n	s1.sample_id as sample_id ,\r\n	s1.result as date ,\r\n	if(s2.result=\"OPD\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location,   \r\n	s3.result as release_status\r\nfrom \r\n	result s1, result s2, result s3\r\n	\r\nwhere\r\n    s1.examination_id=1017 \r\n    and \r\n    s1. result like \"__p1\" and  s2.examination_id=1006    \r\n    and  \r\n	s3.examination_id=1014    \r\n    and      \r\n    \r\n    s1.sample_id=s2.sample_id \r\n    and\r\n    s1.sample_id=s3.sample_id \r\n    \r\n    and\r\n    s2.result=\'OPD\''),
(103,'OPD Release Status of Samples on a date','<input type=date name=__p1 title=\'Give Date\'>','select \r\n	s1.sample_id as sample_id ,\r\n\r\nconcat(\'<div class=\"d-inline-block\" ><form target=_blank method=post action=edit_general.php class=print_hide>\r\n	<button class=\"btn btn-outline-primary btn-sm\" name=sample_id value=\\\'\',s1.sample_id,\'\\\' >\',s1.sample_id,\'</button>\r\n	<input type=hidden name=session_name value=\\\'\\\'.$_POST[\\\'session_name\\\'].\\\'\\\'>\r\n	<input type=hidden name=action value=edit_general>\r\n	</form></div>\')\r\n\r\nas sample_id,\r\n\r\n	s1.result as date ,\r\n	if(s2.result=\"OPD\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location,   \r\n	s3.result as release_status\r\nfrom \r\n	result s1, result s2, result s3\r\n	\r\nwhere\r\n    s1.examination_id=1017 \r\n    and \r\n    s1. result like \"__p1\" and  s2.examination_id=1006    \r\n    and  \r\n	s3.examination_id=1014    \r\n    and      \r\n    \r\n    s1.sample_id=s2.sample_id \r\n    and\r\n    s1.sample_id=s3.sample_id \r\n    \r\n    and\r\n    s2.result=\'OPD\''),
(104,'Location + Date Specific Release Status','<input type=date name=__p1 title=\'Give Date\'><input type=text name=__p2 title=\'Give Location\' placeholder=OPDWard>','select \r\n	s1.sample_id as sample_id ,\r\n	s1.result as date ,\r\n	if(s2.result=\"__p2\",concat(\'<span class=bg-danger>\',s2.result,\'</span>\'),s2.result) as location,   \r\n	s3.result as release_status\r\nfrom \r\n	result s1, result s2, result s3\r\n	\r\nwhere\r\n    s1.examination_id=1017 \r\n    and \r\n    s1. result like \"__p1\" and  s2.examination_id=1006    \r\n    and  \r\n	s3.examination_id=1014    \r\n    and      \r\n    \r\n    s1.sample_id=s2.sample_id \r\n    and\r\n    s1.sample_id=s3.sample_id \r\n    \r\n    and\r\n    s2.result=\'__p2\''),
(105,'NMC (date + department sample numbers)','<input type=date name=__p1 title=\'Give Date\'><input type=text name=__p2 title=\'Give Department\' placeholder=Department>','select r.result as date,o.result as department ,count(r.sample_id) as Total_Samples\r\n\r\nfrom \r\nresult r, result o \r\n\r\nwhere \r\nr.examination_id=1017 and r.result like \"%__p1%\" \r\nand \r\no.examination_id=1004 and o.result like \"%__p2%\"\r\n\r\nand o.sample_id=r.sample_id'),
(106,'(problem)','','select * from result where result like \"%(problem)%\"');
/*!40000 ALTER TABLE `view_info_data` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;

/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;

-- Dump completed on 2023-10-25  0:40:27
